# Chapter 133: Major or Mild Neurocognitive Disorder Due to Another Medical Condition

## The Biological and Neurological Basis of Neurocognitive Disorder Due to Another Medical Condition

## Introduction

Neurocognitive Disorders (NCDs), as delineated in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), represent a significant departure from the previous nosology, replacing the category of "Delirium, Dementia, Amnestic and Other Cognitive Disorders" with a more unified framework (Presečki et al., 2014). This category encompasses a group of disorders primarily characterized by an acquired clinical deficit in cognitive function that reflects a decline from a previous level of functioning (Presečki et al., 2014; Moore, 2015). Within this framework, Major or Mild Neurocognitive Disorder Due to Another Medical Condition stands as a crucial and diagnostically complex entity. It is defined by evidence from history, physical examination, or laboratory findings that the cognitive disturbance is the direct pathophysiological consequence of a medical condition other than a primary neurodegenerative or psychiatric illness (Rucci & Feinstein, 2014; Presečki et al., 2014).

The conceptual shift in DSM-5 moves away from the historically arbitrary distinction between "organic" conditions with a clear pathological basis and "functional" psychiatric disorders that lacked obvious disease processes (Isenberg & Garcia, 2008; Pincus & Tucker, 2002). This modern perspective acknowledges that virtually all mental functioning is brain-related and that psychiatric symptoms can be the direct physiological consequence of a general medical condition (Steinhausen & Gillberg, 2006; Moore, 2008; Poole & Higgo, 2006). Indeed, the brain can suffer injury in diverse ways, including metabolic or structural abnormalities, trauma, toxicity, infections, tumors, and cerebrovascular accidents, all of which can manifest as cognitive and behavioral disturbances (Oscar‐Berman & Mosher, 2010). The diagnosis of NCD due to another medical condition requires that the cognitive deficits are not better explained by another mental disorder and do not occur exclusively during the course of a delirium, although delirium may be superimposed (Presečki et al., 2014; Smith & Seirafi, 2013).

The range of medical conditions capable of producing a major or mild NCD is vast, underscoring the necessity of a comprehensive diagnostic approach. These etiologies include, but are not limited to, neurodegenerative diseases (e.g., Parkinson's disease, Huntington's disease), cerebrovascular disease, traumatic brain injury (TBI), substance/medication use, HIV infection, prion disease, and a host of other systemic illnesses (Subramanian & Palanisamy, 2023; Presečki et al., 2014). Systemic diseases such as endocrine disorders (e.g., hypothyroidism), metabolic abnormalities (e.g., vitamin B12 deficiency, hepatic or renal failure), autoimmune conditions (e.g., systemic lupus erythematosus), and infections can all present with cognitive impairment as a primary or significant feature (Tripathi & Vibha, 2009; Peterson & Martin, 1973; Busby & Burns, 2002). For instance, endocrine and metabolic disorders are frequently associated with disability and may cause or exacerbate cognitive deficits (Santeusanio, 2012). Similarly, systemic inflammatory disorders like systemic lupus erythematosus (SLE) and Sjögren's syndrome are known to cause a wide variety of central nervous system (CNS) manifestations, including cognitive dysfunction (Bluestein, 1987; Helfgott & Bhattacharyya, 2014; Sugiyama & Kuwabara, 2019).

The clinical presentation of these NCDs is highly heterogeneous, reflecting the diversity of the underlying pathologies (Gertz, 2001). While some conditions may lead to a classic amnestic syndrome, others might predominantly affect executive functions, social cognition, or processing speed (Presečki et al., 2014; Stewart, 2006). The onset can be abrupt, as seen after a stroke or TBI (D’Abreu & Ott, 2005), or insidious and progressive, mimicking primary neurodegenerative dementias (Hainline et al., 2019; Ortiz-Gonzalez, 2024). This clinical variability makes differential diagnosis a significant challenge. A new onset of psychiatric or cognitive symptoms, particularly in an individual over 40 with no prior psychiatric history, necessitates a thorough evaluation for an underlying medical etiology (Rucci & Feinstein, 2014; Schaffer & Donlon, 1983). This chapter will explore the diverse biological and neurological mechanisms that underpin the development of Major or Mild NCD Due to Another Medical Condition, examining the pathophysiology from the level of neurotransmitter systems and neural circuits to the cellular and molecular machinery disrupted by systemic illness and direct brain injury.

## Neurobiological Systems

The cognitive and behavioral manifestations of NCD due to another medical condition arise from the disruption of complex and finely tuned neurobiological systems. The specific nature of the disruption depends on the underlying medical etiology, but many pathologies converge on common pathways involving neurotransmitter dysregulation, neuroinflammation, neuroendocrine abnormalities, and autonomic dysfunction. These systems do not operate in isolation; rather, they are intricately interconnected, and a disturbance in one can cascade to affect the others, culminating in the clinical syndrome of neurocognitive decline.

### Neurotransmitter Systems and Neuropharmacology

Dysfunction in major neurotransmitter systems is a cornerstone of the pathophysiology of cognitive impairment across numerous medical conditions. The balance of excitatory and inhibitory signals, crucial for all brain functions from basic arousal to complex cognition, is frequently perturbed (Yang et al., 2021).

**Cholinergic System:** The central cholinergic system, particularly projections originating from the basal forebrain, is critical for learning and memory (Kim et al., 2012; Wu et al., 2007). Its dysfunction is a well-established feature of Alzheimer's disease (AD) but is also implicated in cognitive deficits seen in other conditions (Dickson & Orr, 2011; McGurk & Powchik, 2000). For example, cognitive impairment in Parkinson's disease (PD) is associated with cortical cholinergic deficits in addition to dopamine depletion (Cummings, 1988). Medical conditions that induce a state of delirium, a common precipitant or feature of NCD, often involve anticholinergic mechanisms, either from the illness itself or from medications used in treatment (Tonković et al., 2012; Rucci & Feinstein, 2014). The efficacy of cholinesterase inhibitors in some dementia syndromes, which increase synaptic acetylcholine availability, provides clinical evidence for the importance of this system (Malek & Greene, 2014; Pereira & Marinho, 2015).

**Monoaminergic Systems (Dopamine, Norepinephrine, Serotonin):** These systems are integral to mood, motivation, attention, and executive function (Liu et al., 2019). Their disruption is a key feature in many psychiatric disorders but also contributes significantly to the cognitive and behavioral symptoms of NCDs secondary to medical conditions.
*   **Dopamine:** Degeneration of the dopaminergic nigrostriatal system is the pathological hallmark of PD, leading to motor symptoms (Gerlach & Riederer, 1993). However, dysfunction of mesolimbic and mesocortical dopamine projections also contributes to non-motor symptoms such as apathy, depression, and executive dysfunction (Fibiger, 1984; Martínez‐Castrillo et al., 2011; Ebadi et al., 2011). The high incidence of depression in PD may be directly related to damage to these reward-related dopamine systems (Fibiger, 1984; Bell, 2008). Furthermore, drugs that antagonize dopamine receptors, such as antipsychotics, can induce or worsen parkinsonism and cognitive deficits (Krenn et al., 2020).
*   **Norepinephrine (NE) and Serotonin (5-HT):** These neurotransmitters are deeply implicated in mood and anxiety disorders, which frequently co-occur with or are manifestations of NCDs (Liu et al., 2019; Goodwin, 2006). A proposed "monoamine axon disorder" suggests that degeneration of these axons underlies not only depression but also the negative and cognitive symptoms of schizophrenia and other disorders (Nakamura, 2022; Nakamura, 2022). Stress, a common factor in many medical illnesses, profoundly impacts these systems, contributing to both affective and cognitive symptoms (Sandi, 2013). Dysfunction in 5-HT and NE signaling has been specifically linked to the somatic symptoms, such as pain and fatigue, that are common in many chronic illnesses and often overlap with depressive syndromes (Liu et al., 2019; Greden, 2003).

**Glutamate and GABA:** The balance between the primary excitatory neurotransmitter, glutamate, and the primary inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), is essential for neuronal function. Excitotoxicity, a process of neuronal damage caused by excessive glutamate receptor activation, is a common final pathway in numerous brain insults, including stroke, TBI, and hypoxia (Yang et al., 2021; Volpe, 1997). This process is central to the neuronal death seen in conditions like ischemic stroke, which is a major cause of vascular NCD (Hossmann, 1998; Kopach & Pivneva, 2018). Conversely, dysfunction in GABAergic inhibition can lead to hyperexcitability and seizures, which themselves can cause or worsen cognitive impairment (Lothman, 1990; Kamenskiy et al., 2017).

### Neuroendocrine and Immune Systems

The nervous, endocrine, and immune systems are linked in a complex, bidirectional network, and their dysregulation is a frequent consequence of systemic medical illness, contributing significantly to NCDs.

**Hypothalamic-Pituitary-Adrenal (HPA) Axis:** The HPA axis is the body's central stress response system. Chronic stress, whether psychological or from a physical illness, can lead to HPA axis dysregulation, often characterized by hypercortisolism (Uribe Londoño et al., 2005; von Zerssen et al., 1986). Prolonged exposure to high levels of glucocorticoids is known to be neurotoxic, particularly to the hippocampus, a key structure for memory (Sandi, 2013; Wolkowitz et al., 2010). This mechanism is thought to contribute to cognitive impairment in conditions like Cushing's syndrome and major depression (Whelan et al., 1980; Uribe Londoño et al., 2005). Endocrine disorders, such as adrenal insufficiency (Addison's disease) or thyroid dysfunction, directly impact this axis and frequently present with neuropsychiatric symptoms, including cognitive decline and mood changes (Melnichenko & Фадеев, 1997; Mistry et al., 2009; Lauriat & Samson, 2015).

**Neuroinflammation and Immune Activation:** There is growing evidence that inflammation is a key pathogenic process in many neurological and psychiatric disorders (Martone, 2019; Yirmiya et al., 2015). Systemic inflammation, a hallmark of infections, autoimmune diseases (e.g., SLE, Sjögren's syndrome), and even metabolic disorders, can have profound effects on the brain (Bluestein, 1987; Cojocaru et al., 2010). Pro-inflammatory cytokines can cross the blood-brain barrier (BBB) or signal across it, activating resident immune cells in the brain (microglia) and astrocytes (Yirmiya et al., 2015). This neuroinflammatory state can disrupt neurotransmitter metabolism, impair synaptic plasticity and neurogenesis, and contribute to neuronal dysfunction and death (Najjar et al., 2013; Uzoni et al., 2015). Conditions like multiple sclerosis (MS), a primary neuroinflammatory disease, are characterized by cognitive impairment and fatigue, which are linked to these immune-mediated processes (Joffe, 2005; Roelcke, 2001). Similarly, the neuroinflammation associated with stroke and TBI is a major driver of secondary brain injury and subsequent cognitive deficits (Uzoni et al., 2015; Chen et al., 2014). Autoimmune encephalitis, where antibodies target neuronal surface proteins, is a prime example of immune-mediated NCD, often presenting with acute psychosis, memory loss, and seizures (Dalmau & Graus, 2022; Matsumoto et al., 2017).

### Autonomic Nervous System

The autonomic nervous system (ANS) regulates visceral functions and is crucial for homeostasis. Autonomic dysfunction, or dysautonomia, is a common feature of many neurodegenerative diseases like PD and multiple system atrophy (MSA), as well as systemic conditions such as diabetes mellitus (Goldstein, 2002; Cheshire, 2016; Ziemssen, 2013). Symptoms can include orthostatic hypotension, gastrointestinal dysmotility, and bladder dysfunction (Vernino & Vincent, 2013). These systemic effects can indirectly impact cognitive function through mechanisms like cerebral hypoperfusion during orthostatic hypotension (Juvarra et al., 1976). Furthermore, the ANS is tightly integrated with the immune and endocrine systems, and its dysregulation can contribute to the systemic pro-inflammatory and stress states that negatively affect brain function (Lührs & Haensch, 2018; Goldstein, 2002).

## Genetic and Molecular Basis

The development of NCD due to another medical condition is rooted in a complex interplay between the primary disease's pathophysiology and the brain's intrinsic vulnerability. While the NCD is "secondary" to a medical condition, genetic and molecular factors are fundamental in both causing the primary illness and modulating the brain's response to it.

### Genetic Factors and Heritability

The role of genetics in this context is multifaceted. In some cases, a single gene defect is the direct cause of a systemic or neurological disease that invariably leads to cognitive impairment. In other instances, genetic factors confer susceptibility or modify the disease course.

**Monogenic Disorders:** A number of rare, inherited medical conditions present with NCD as a core feature. For example, lysosomal storage disorders (LSDs) are inborn errors of metabolism where enzyme deficiencies lead to the accumulation of substrates in lysosomes, causing multisystem organ dysfunction, including progressive neurodegeneration (Maegawa, 2017; Ozand & Alessa, 2012). Similarly, mitochondrial disorders, caused by mutations in either mitochondrial or nuclear DNA, impair cellular energy production and frequently manifest with neurological syndromes involving cognitive decline, seizures, and myopathy (Funalot, 2014; Magner, 2019). Huntington's disease, an autosomal dominant disorder, is defined by a triad of motor, cognitive, and psychiatric symptoms stemming from a CAG repeat expansion in the HTT gene (Subramanian & Palanisamy, 2023). Other examples include genetic syndromes associated with intellectual disability from birth, such as SYNGAP1-related intellectual disability, which is characterized by developmental delay and epilepsy (Holder et al., 2019), and certain forms of progressive myoclonic epilepsy (Vasquez-Baiocchi & Burneo, 2021). While many of these are considered neurodevelopmental disorders, their progressive nature and impact on cognition place them within the broader landscape of NCDs (Blázquez, 2025).

**Genetic Risk and Susceptibility:** For many common medical conditions, genetics plays a role in susceptibility rather than causation. For example, genetic factors contribute to the risk of developing cardiovascular disease, hypertension, and diabetes mellitus, all of which are major risk factors for vascular NCD (Parfenov, 2002; Wreksoatmodjo, 2014). The apolipoprotein E (APOE) ε4 allele, the strongest genetic risk factor for late-onset Alzheimer's disease, has also been linked to poorer outcomes after TBI, suggesting it modulates the brain's response to injury (Mendez, 2017). Genetic factors are also strongly implicated in the risk for primary psychiatric disorders like schizophrenia and bipolar disorder, which can themselves be associated with significant cognitive impairment and may be difficult to distinguish from NCDs due to other medical conditions (Winokur, 1970; Cadoret & Winokur, 1972; Heckers, 2009). The presence of a genetic predisposition can lower the threshold for a medical or environmental insult to trigger cognitive decline (Pauling, 1968; Bramon & Murray, 2001).

### Cellular and Synaptic Mechanisms

At the cellular level, various medical conditions converge on a limited number of pathological pathways that result in neuronal dysfunction and death, the ultimate substrate of cognitive decline.

**Neuronal Death Pathways:** The loss of neurons is a fundamental process in progressive NCDs (Bigio, 2021; Agid & Blin, 2007). This can occur through accidental cell death (necrosis), typically seen in acute, severe insults like ischemic stroke, or through regulated cell death pathways such as apoptosis (programmed cell death) (Yang et al., 2021; Hossmann, 1998). Chronic conditions, including neurodegenerative diseases and some metabolic disorders, often involve a slower, more insidious activation of apoptotic pathways (Martin, 2002; Hajj et al., 2012). For example, in SLE, autoantibodies and inflammatory cytokines may trigger neuronal apoptosis, contributing to neuropsychiatric symptoms (Volpe, 1997).

**Synaptic Dysfunction and Loss:** Long before neurons die, their connections (synapses) can become dysfunctional and ultimately lost. Synaptic loss is now recognized as the strongest pathological correlate of cognitive impairment in many dementing illnesses, including AD (Özugur, 2016; Martin, 2002). Systemic insults can disrupt synaptic plasticity, the molecular mechanism underlying learning and memory (Lamour et al., 1994). For example, systemic inflammation can impair long-term potentiation (LTP), a key form of synaptic strengthening, through the action of pro-inflammatory cytokines (Uzoni et al., 2015). Metabolic disturbances, such as hypoglycemia or thiamine deficiency, deprive synapses of the energy required to maintain ionic gradients and neurotransmitter cycling, leading to synaptic failure (Calingasan et al., 1996; Micić et al., 2002).

**Axonal and Myelin Pathology:** The integrity of axons and their myelin sheaths is critical for efficient neural communication. Axonal damage (axonopathy) and demyelination are central features of many neurological conditions leading to NCD. In MS, autoimmune attacks on myelin disrupt nerve conduction, leading to a wide range of neurological and cognitive symptoms (Theodoridou & Settas, 2006; Martínez‐Lapiscina et al., 2014). TBI is characterized by diffuse axonal injury, where mechanical shearing forces cause widespread damage to axons, disconnecting neural circuits (Mendez, 2017; Arciniegas et al., 2005). Axonal degeneration is also a primary feature of many peripheral neuropathies, which can be caused by diabetes, alcohol, or toxins, and reflects a failure of neuronal metabolic support (Howard, 1971; Scelsi & Candura, 2013).

**Protein Misfolding and Aggregation:** A key molecular mechanism in many primary neurodegenerative diseases is the misfolding and aggregation of specific proteins (e.g., amyloid-β and tau in AD; α-synuclein in PD and DLB) (Wierenga & Bondi, 2011; Dickson, 2005). While NCD due to another medical condition is defined as being distinct from these, there is significant pathological overlap. For instance, Lewy body pathology (α-synuclein) is the defining feature of PD and Dementia with Lewy Bodies (DLB), which are classified as NCDs due to their respective conditions (Dickson & Orr, 2011; McKeith et al., 2005). Furthermore, medical conditions can promote the pathology of primary neurodegenerations. TBI, for example, is known to acutely trigger amyloid-β deposition and is a risk factor for later development of chronic traumatic encephalopathy (CTE), a tauopathy (Mendez, 2017; Gavett et al., 2010; Hainline et al., 2019). This highlights that systemic or focal insults can initiate or accelerate the core molecular processes associated with primary dementias.

## Brain Structure and Function

The cognitive and behavioral syndromes seen in NCD due to another medical condition are the clinical expression of pathological changes in brain structure and function. Advances in neuroimaging and electrophysiology have provided invaluable windows into these processes, allowing clinicians and researchers to visualize macroscopic lesions, quantify atrophy, assess metabolic activity, and probe the integrity of neural circuits.

### Neuroimaging Findings: Structural

Structural imaging, primarily computed tomography (CT) and magnetic resonance imaging (MRI), is a cornerstone in the evaluation of cognitive impairment (Kipps, 2005; Chouliaras et al., 2015). Its primary role is to identify or exclude specific structural causes and to characterize the pattern of brain injury.

**Focal Lesions:** Many medical conditions cause focal brain lesions that result in specific cognitive syndromes depending on their location (Caselli, 2021; Brower, 1890).
*   **Vascular Lesions:** Stroke is a major cause of NCD (Parfenov, 2002; Maud, 2006). Large-vessel infarcts can produce classic syndromes like aphasia or neglect (Negreiros et al., 2007). So-called "strategic infarcts" in areas like the thalamus or specific frontal-subcortical circuits can cause significant cognitive impairment, particularly in executive function and memory, even with a small lesion volume (Renjen et al., 2023; D’Abreu & Ott, 2005). Chronic cerebrovascular disease often manifests as multiple lacunar infarcts in subcortical structures or as diffuse white matter hyperintensities (leukoaraiosis) on T2-weighted MRI, which are hallmarks of subcortical vascular dementia (Wright et al., 2006; DeCarli et al., 2009; Loeb, 1989). These white matter changes are thought to reflect ischemic damage and disrupt the connectivity of large-scale neural networks (Olsen & Clasen, 1998; Caranzano & Michel, 2023).
*   **Tumors and Other Space-Occupying Lesions:** Primary or metastatic brain tumors can present with cognitive decline or psychosis, depending on their location and growth rate (Romero-Luna et al., 2022; Medeiro F. et al., 2021). Frontal lobe tumors, for instance, are notorious for causing personality changes, apathy, and executive dysfunction that can be mistaken for a primary psychiatric disorder (Pawełczyk et al., 2013). Subdural hematomas and normal pressure hydrocephalus are important reversible causes of dementia that are readily identifiable on CT or MRI (Tripathi & Vibha, 2009; Barbosa et al., 2023).
*   **Inflammatory and Infectious Lesions:** Diseases like MS are defined by the presence of demyelinating plaques disseminated in time and space, typically seen as T2-hyperintense lesions in the white matter on MRI (Brochet, 1999; Brownlee, 2019). Autoimmune encephalitis can cause characteristic T2/FLAIR hyperintensities in the limbic system (Dalmau & Graus, 2022), while infectious processes like herpes encephalitis can lead to hemorrhagic necrosis of the temporal lobes (Uğurlu et al., 2020).

**Diffuse Atrophy:** Generalized or regional brain atrophy (volume loss) is a common, though nonspecific, finding in many progressive NCDs. While most prominent in primary neurodegenerative diseases like AD (characterized by medial temporal lobe atrophy) (Wierenga & Bondi, 2011), significant atrophy can also be seen in chronic alcoholism, HIV-associated neurocognitive disorder, and late-stage epilepsy (Wolter, 2006; Grant et al., 2005; Heerwig et al., 2022). The pattern of atrophy can sometimes provide diagnostic clues; for example, frontotemporal lobar degeneration presents with focal atrophy of the frontal and/or temporal lobes (Dickerson & Sperling, 2007).

### Neuroimaging Findings: Functional

Functional neuroimaging techniques, such as Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT), provide information about regional brain metabolism and blood flow.
*   **Metabolism and Perfusion:** FDG-PET, which measures glucose metabolism, often reveals patterns of hypometabolism that can help differentiate dementia types. For instance, AD is typically associated with bilateral temporoparietal hypometabolism, whereas frontotemporal dementia shows frontal and/or anterior temporal hypometabolism (Dickerson & Sperling, 2007; Merissa et al., 2011). In dementia with Lewy bodies (DLB), occipital hypoperfusion is a characteristic finding (Derouesné, 2006). These techniques can detect brain dysfunction even before significant structural changes are visible on MRI (Kim et al., 2012).
*   **Dopamine Transporter Imaging (DaTscan):** This SPECT technique visualizes the dopamine transporter in the striatum and is a valuable tool for differentiating neurodegenerative parkinsonism (like PD or MSA, where it is abnormal) from conditions that do not affect the presynaptic dopaminergic system, such as essential tremor or drug-induced parkinsonism (where it is typically normal) (Schulz et al., 2005). It is particularly useful in the diagnostic workup of DLB, where an abnormal scan is a supportive criterion (McKeith et al., 2005).

### Electrophysiology and Neural Circuits

Electrophysiological methods like electroencephalography (EEG) and magnetoencephalography (MEG) measure the brain's electrical or magnetic activity, providing high temporal resolution insights into neural function and connectivity.
*   **EEG:** EEG is crucial for detecting seizure activity, which can cause transient or chronic cognitive impairment (Kügler et al., 1977; Amin & Benbadis, 2019). Nonconvulsive status epilepticus (NCSE), in particular, can present as an acute confusional state or delirium, and EEG is the only definitive diagnostic test (Kaplan, 2003; Ferlazzo, 2010; Hovorka et al., 2006). In metabolic encephalopathies, EEG typically shows a nonspecific diffuse slowing of background rhythms, the degree of which often correlates with the severity of cognitive impairment (Brigo & Mecarelli, 2019; Niedermeyer et al., 1999). Certain patterns, like the triphasic waves seen in hepatic encephalopathy, can be diagnostically suggestive (Groeneweg, 1998).
*   **Neural Circuits and Connectivity:** The brain operates through large-scale, interconnected neural networks. Cognitive functions are not localized to single regions but emerge from the coordinated activity of these circuits (Yamadori, 2009). Many medical conditions leading to NCD do so by disrupting these networks. Vascular white matter disease disconnects cortical and subcortical regions, leading to a "disconnection syndrome" that underlies executive dysfunction (Olsen & Clasen, 1998; Coste & Krolak‐Salmon, 2010). TBI also causes widespread axonal injury, disrupting network integrity (Mendez, 2017). Functional imaging studies have shown that even in the absence of gross structural lesions, conditions like depression are associated with altered functional connectivity within networks like the default mode network and fronto-parietal control network (Lee et al., 2009; Tedeschi et al., 2015). This network-based perspective helps explain why diverse pathologies can produce similar cognitive and behavioral syndromes by targeting common, vulnerable brain circuits.

## Developmental Neurobiology

The impact of a medical condition on cognitive function is profoundly influenced by the developmental stage of the brain at the time of insult. The concept of developmental neurobiology is crucial for understanding why certain conditions lead to specific neurocognitive profiles and how the brain's maturational state creates periods of unique vulnerability (Reichard & Zimmer‐Bensch, 2021). Brain development is not a monolithic process but a protracted sequence of events, including neurogenesis, migration, synaptogenesis, and myelination, each with its own timeline and susceptibility to disruption (Davison, 1977).

### Critical Periods and Vulnerability

The developing brain has "critical periods" during which specific circuits are being established and are particularly sensitive to environmental and biological influences (Stafstrom et al., 2006). An insult during one of these periods can have far-reaching consequences that may not become fully apparent until later in life when those circuits are called upon to support more complex functions (Gillberg, 1995; Shaffer, 1973).

For instance, perinatal brain injury, resulting from factors like hypoxia-ischemia or preterm birth, is a major cause of static encephalopathy, such as cerebral palsy (Romero Esquiliano et al., 2004; Zappert, 1933). While the primary lesion is non-progressive, the clinical expression of cognitive and motor deficits evolves as the child's nervous system matures (Krägeloh‐Mann, 2010; Shevell, 2010). Early damage to white matter tracts in premature infants, for example, can disrupt cortical connectivity, leading to later difficulties in executive function and learning (Krägeloh‐Mann, 2010). Similarly, metabolic disorders presenting in the neonatal period can cause irreparable brain damage if not diagnosed and treated promptly, as the brain's high metabolic requirements make it exquisitely vulnerable to substrate deficiencies or toxic accumulations during this phase of rapid growth (Clarke, 2005; Kahler & Fahey, 2003).

Neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are, by definition, rooted in atypical brain development (Fernández‐Jaén et al., 2017; Güney & İşeri, 2013). These conditions are characterized by cognitive and behavioral profiles that emerge in childhood and often persist into adulthood, highlighting how early developmental trajectories can set the stage for lifelong cognitive patterns (Fernández‐Jaén et al., 2018). Importantly, these disorders frequently co-occur with other medical conditions like epilepsy, further complicating the clinical picture and suggesting shared underlying neurobiological pathways (Ijeoma C, 2019; Tuchman et al., 2005).

### Brain Insults Across the Lifespan

The consequences of a specific medical condition can differ dramatically depending on whether it occurs in a developing, mature, or aging brain.
*   **Childhood and Adolescence:** Brain injury or disease in childhood can disrupt the acquisition of new skills and knowledge (Middleton, 2001). A TBI in a child may not only cause immediate deficits but also "unmask" latent problems or alter the subsequent course of brain maturation, leading to the emergence of new psychiatric or cognitive problems years later (Gerring, 1986; Beverly, 1924). For example, a child who sustains a frontal lobe injury may appear to recover well initially, but then exhibit significant executive dysfunction and social disinhibition during adolescence when those functions would normally mature (Middleton, 2001). Epilepsy beginning in childhood can also have a profound impact on cognitive development, not only through the direct effects of seizures and interictal discharges but also by disrupting the normal maturation of neural networks essential for learning and memory (Deonna, 2010; Stafstrom et al., 2006; Berg, 2011).
*   **Adulthood:** In adulthood, the brain has less neuroplastic capacity than in childhood, but still retains the ability to reorganize. An insult such as a stroke typically results in the loss of established functions (Bannister, 1992). However, the premorbid cognitive and psychiatric status of the individual is a powerful determinant of outcome (Henderson, 1987).
*   **Late Life:** The aging brain is characterized by a decline in "neural reserve," making it more vulnerable to the cognitive effects of medical stressors (Morris & McManus, 1991; Rinn, 1988). A systemic illness like a urinary tract infection or pneumonia, which might cause minimal cognitive change in a younger adult, can precipitate a severe delirium in an older person, especially one with pre-existing, even subclinical, brain pathology like early AD or cerebrovascular disease (Martins & Fernandes, 2012; Espino et al., 1998). This concept of "pathological aging" suggests that many age-related cognitive declines are not natural but are due to an accumulation of subclinical pathological changes that lower the threshold for cognitive decompensation (Rinn, 1988; Frýdl & Závodská, 1989). Late-onset depression, for example, is strongly associated with underlying vascular brain disease, suggesting that cerebrovascular pathology makes the aging brain more susceptible to mood disorders (Variend & Gopal, 2008; Blazer & Hybels, 2005).

In summary, a developmental perspective is essential for understanding NCD due to another medical condition. The timing of the insult interacts with the brain's maturational stage to shape the specific pattern of cognitive vulnerability and the long-term clinical trajectory. This framework helps explain why the same disease can have vastly different cognitive consequences at different points in the lifespan.

## Treatment Mechanisms

The management of Major or Mild NCD Due to Another Medical Condition is fundamentally guided by its etiology. The primary therapeutic principle is to identify and treat the underlying medical condition, as this offers the best, and sometimes only, opportunity to reverse or stabilize cognitive decline (Tripathi & Vibha, 2009; Busby & Burns, 2002). Beyond treating the primary cause, interventions often target the downstream neurobiological consequences, such as neurotransmitter imbalances and behavioral symptoms.

### Treating the Underlying Medical Condition

The most direct therapeutic approach involves addressing the root medical problem. The biological mechanisms of these treatments are as diverse as the conditions themselves.
*   **Metabolic and Endocrine Correction:** In cases of NCD due to conditions like hypothyroidism, vitamin B12 deficiency, or thiamine deficiency (Wernicke-Korsakoff syndrome), replacement therapy can correct the metabolic imbalance and often leads to significant cognitive improvement, especially if initiated early (Tripathi & Vibha, 2009; Calingasan et al., 1996). Similarly, managing hypoglycemia in diabetes or correcting electrolyte disturbances can resolve acute confusional states and prevent long-term neuronal damage (Micić et al., 2002; Welti, 1956).
*   **Infection and Inflammation Control:** Treatment of CNS infections with appropriate antimicrobial agents or management of systemic autoimmune diseases like SLE or neurosarcoidosis with immunosuppressants (e.g., corticosteroids, cyclophosphamide) can halt the inflammatory process damaging the brain (Bluestein, 1987; Özgöçmen & Gür, 2008). In autoimmune encephalitis, immunotherapies such as steroids, intravenous immunoglobulins, or plasma exchange aim to remove or suppress the pathogenic autoantibodies, which can lead to dramatic neurological and cognitive recovery (Dalmau & Graus, 2022; Falcicchio et al., 2022).
*   **Cardiovascular and Cerebrovascular Management:** In vascular NCD, the cornerstone of management is the aggressive control of vascular risk factors like hypertension, diabetes, and hyperlipidemia (Parfenov, 2002; Moretti et al., 2005). These interventions aim to prevent further cerebrovascular events (strokes) and slow the progression of white matter ischemic damage, thereby preserving remaining brain function (Wright et al., 2006).
*   **Surgical Interventions:** For NCDs caused by structural lesions, surgical intervention may be curative. Removal of a brain tumor, evacuation of a subdural hematoma, or shunting for normal pressure hydrocephalus can alleviate mass effect and restore normal CSF dynamics, leading to cognitive improvement (Tripathi & Vibha, 2009; Barbosa et al., 2023).

### Symptomatic Pharmacotherapy

When the underlying condition is not fully reversible or when cognitive and behavioral symptoms persist, symptomatic pharmacotherapy is employed. These treatments target the neurotransmitter systems and neural circuits disrupted by the disease process.
*   **Cognitive Enhancers:** Drugs developed for Alzheimer's disease are sometimes used off-label for other NCDs, based on the hypothesis of shared neurochemical deficits. Acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine) increase the availability of acetylcholine in the synapse and may provide modest symptomatic benefit in conditions with cholinergic deficits, such as dementia with Lewy bodies or vascular dementia (Rucci & Feinstein, 2014; Malek & Greene, 2014; Moretti et al., 2005). Memantine, an NMDA receptor antagonist, modulates glutamatergic transmission and may protect against excitotoxicity, offering another avenue for symptomatic treatment (Malek & Greene, 2014). The development of cognitive enhancers is a major focus of research for a wide range of neurological and psychiatric disorders (Cummings & Zhong, 2017; Allain et al., 2007).
*   **Psychotropic Medications:** Neuropsychiatric symptoms such as depression, psychosis, and agitation are common and highly disabling features of many NCDs (Harvey, 2011; Demey et al., 2004).
    *   **Antidepressants:** Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are frequently used to treat depression and anxiety (Pitchot & Ansseau, 1995; Solmi et al., 2019). Their mechanism involves modulating monoaminergic systems that are crucial for mood regulation (Liu et al., 2019). Treating depression is critical, as it can significantly exacerbate cognitive impairment (a phenomenon sometimes called "pseudodementia") and reduce quality of life (Delgado & Schillerstrom, 2009; Ownsworth & Oei, 1999).
    *   **Antipsychotics:** These agents, which primarily act by blocking dopamine D2 receptors, are used to manage psychosis (delusions, hallucinations) and severe agitation (Masand, 2000). However, their use in elderly patients with dementia requires extreme caution due to a high risk of severe side effects, including worsening cognition, parkinsonism, and increased mortality (Galasko, 2019). Patients with DLB are particularly sensitive to these adverse effects (McKeith et al., 2005).

### Non-Pharmacological and Rehabilitative Interventions

Beyond medication, a range of non-pharmacological approaches can improve function and quality of life by harnessing principles of neuroplasticity and providing compensatory strategies.
*   **Cognitive Rehabilitation and Training:** These interventions aim to improve cognitive function through targeted exercises and the teaching of compensatory strategies (Radanovic et al., 2015). The underlying biological mechanism is thought to be the strengthening of existing neural circuits and the recruitment of alternative networks to perform tasks—a form of experience-dependent neuroplasticity (Castillo et al., 2020).
*   **Physical Exercise:** There is growing evidence that regular physical activity can improve cognitive function and may slow cognitive decline in at-risk individuals (Archer, 2016; Senzaki, 2018). The proposed mechanisms are diverse, including increased cerebral blood flow, enhanced expression of neurotrophic factors like brain-derived neurotrophic factor (BDNF) which supports synaptic health and neurogenesis, and reduction of systemic inflammation and vascular risk factors (Archer, 2016; Smith & Blumenthal, 2015).
*   **Neuromodulation:** Techniques such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are being explored as potential treatments for cognitive and mood symptoms in a variety of neurological and psychiatric disorders (Koops et al., 2017). These methods non-invasively alter cortical excitability and may modulate the activity of dysfunctional neural circuits.

The treatment of NCD due to another medical condition is inherently multidisciplinary, requiring careful diagnosis of the underlying cause, targeted medical intervention, symptomatic pharmacotherapy for cognitive and behavioral symptoms, and comprehensive rehabilitative strategies to maximize function.

## Future Directions

The study of Neurocognitive Disorder Due to Another Medical Condition is a rapidly evolving field, propelled by advances in neuroimaging, molecular biology, and clinical neuroscience. While significant progress has been made in identifying the diverse etiologies and characterizing the clinical syndromes, numerous critical questions remain unanswered. Future research must focus on refining diagnostic accuracy, elucidating shared and distinct pathophysiological mechanisms, and developing more effective, targeted therapies.

A primary challenge is the immense heterogeneity of this diagnostic category (Gertz, 2001; Huda, 2019). The term encompasses everything from post-stroke cognitive decline to the neuropsychiatric sequelae of systemic lupus erythematosus. A key future direction is to move beyond a purely descriptive, syndromic classification towards a biologically-based nosology. This will require the development and validation of robust biomarkers that can identify specific underlying pathophysiological processes, irrespective of the named medical condition (Kapczinski, 2015). For example, markers of neuroinflammation (e.g., specific cytokine profiles, microglial activation on PET imaging), synaptic dysfunction, or specific neurotransmitter system failure could help stratify patients for targeted treatments (Yirmiya et al., 2015; Martone, 2019). The α-synuclein seed amplification assay, for instance, shows promise in identifying the underlying synucleinopathy in patients with parkinsonism and cognitive impairment (Samudra et al., 2024).

The relationship between neuropsychiatric symptoms and the onset of cognitive decline requires deeper investigation. Symptoms like depression, anxiety, and apathy are not merely reactive comorbidities but may be early manifestations of the underlying neuropathological process, potentially representing a prodromal phase of dementia (Stella et al., 2014; Lyketsos, 2012). Longitudinal studies combining detailed clinical phenotyping with serial biomarker assessment are needed to clarify whether these symptoms are risk factors for, or early symptoms of, neurodegeneration (Johansson, 2023; Sinclair et al., 2023). Understanding this link could open new avenues for early detection and preventative interventions (Donaghy & McKeith, 2014).

Furthermore, the concept of "functional cognitive disorder" (FCD), where cognitive symptoms are present without a clear neurodegenerative or structural cause and show internal inconsistency, is gaining recognition (Stone et al., 2015; Ball et al., 2020). A significant portion of individuals presenting with cognitive complaints, even those initially labeled with Mild Cognitive Impairment (MCI), may have a functional etiology rather than a prodromal neurodegenerative disease (Ball et al., 2020; Bidaki & Salimi, 2023). Future research must develop positive diagnostic criteria for FCD and distinguish it reliably from early-stage organic NCDs to avoid misdiagnosis and guide appropriate psychological and rehabilitative therapies instead of potentially harmful dementia medications (Stone et al., 2015).

Advances in neuroimaging will continue to be critical. While structural MRI is essential for identifying macroscopic lesions, advanced techniques offer deeper insights. Diffusion tensor imaging (DTI) can quantify white matter tract integrity, providing a more sensitive measure of the disconnection caused by vascular disease or TBI (Shah & Ross, 2016). Functional MRI (fMRI) can map alterations in brain network connectivity, providing a functional correlate for cognitive deficits (Tedeschi et al., 2015). The development of novel PET tracers for specific proteinopathies (e.g., tau), neuroinflammation, and synaptic density will revolutionize our ability to characterize the molecular pathology in living patients, aiding in differential diagnosis and tracking response to treatment (Merissa et al., 2011).

Finally, therapeutic development must move beyond repurposing drugs from Alzheimer's disease. A better understanding of the specific mechanisms at play in different medical conditions will allow for the rational design of targeted therapies. This could include anti-inflammatory or immunomodulatory agents for NCDs driven by immune dysregulation (Moreno & Villoslada, 2007), drugs that support mitochondrial function or reduce oxidative stress in metabolic encephalopathies (Li et al., 2022), or interventions that enhance neuroplasticity and cognitive reserve (Castillo et al., 2020). The integration of artificial intelligence and machine learning approaches to analyze complex, multimodal data (clinical, imaging, genetic, biomarker) will likely be essential for identifying patient subgroups and predicting treatment response, paving the way for a future of personalized medicine for NCDs (Nappo & Simeoli, 2024; Joucla, 2020).

## Conclusion

Major or Mild Neurocognitive Disorder Due to Another Medical Condition represents a vast and complex intersection of neurology, psychiatry, and general medicine. It is not a single disease but a clinical syndrome that serves as a final common pathway for a multitude of underlying pathologies, ranging from acute brain insults like stroke and trauma to chronic systemic diseases such as autoimmune disorders, infections, and metabolic derangements (Isenberg & Garcia, 2008; Gertz, 2001). The biological and neurological underpinnings are correspondingly diverse, involving a complex web of interacting mechanisms that include direct neuronal injury, neurotransmitter system dysregulation, neuroinflammation, cerebrovascular compromise, and metabolic failure (Najjar et al., 2013; Yang et al., 2021).

The clinical presentation is profoundly heterogeneous, dictated by the location and nature of the brain dysfunction rather than the specific etiology (Pincus & Tucker, 2002). A vascular lesion in a frontal-subcortical circuit, an autoimmune attack on the limbic system, or a systemic metabolic disturbance can all produce overlapping syndromes of executive dysfunction, memory impairment, or mood changes (Parfenov, 2002; Dalmau & Graus, 2022; Clarke, 2005). This clinical and etiological heterogeneity underscores the fundamental importance of a rigorous and comprehensive diagnostic process. The essential first step is the recognition that an acquired cognitive or behavioral change may be the presenting sign of a treatable systemic illness, a principle that mandates a high index of suspicion and the exclusion of reversible causes in every patient presenting with cognitive decline (Tripathi & Vibha, 2009; Peterson & Martin, 1973).

Our understanding of these disorders has moved beyond a simplistic "organic" versus "functional" dichotomy, embracing a more nuanced neurobiological framework where psychiatric and neurological symptoms are seen as manifestations of brain dysfunction, regardless of the primary pathology (Moore, 2008; Poole & Higgo, 2006). Research has illuminated the critical roles of synaptic and axonal integrity, immune activation, and large-scale neural network connectivity as key substrates of cognitive health. Disruptions in these systems, whether by a focal stroke, a diffuse inflammatory process, or a systemic toxic state, lead to the clinical manifestations of NCD.

While many of the underlying medical conditions are progressive and incurable, a focus on the biological mechanisms offers hope. Treatment is evolving from a purely symptomatic approach to one that targets the underlying pathophysiology—controlling vascular risk factors, modulating the immune system, correcting metabolic deficiencies, and supporting synaptic function. The ultimate goal is to move from merely managing symptoms to implementing strategies that preserve brain health and prevent cognitive decline. The study of NCD due to another medical condition is a testament to the inextricable link between the brain and the body, reminding us that cognitive function is a sensitive barometer of overall physiological health. Continued research into these complex interactions is essential for improving diagnostic accuracy, developing effective treatments, and enhancing the quality of life for the millions affected by these challenging disorders.

## References

1. Ab, S., Al, S., VIa, G., NIu, K., & Mo, L. (1989). [Problem of "organic neuroses" (data on functional disorders of cardiac activity)].. PubMed.
2. Abduraimova, S. K. (2018). Cognitive, emotional, and behavioral disorders in hypertensive patients. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2018-4-116-122
3. Abhishek, A., & Doherty, M. (2016). Placebo, nocebo, and contextual effects. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199668847.003.0027
4. Abou‐Saleh, M. T. (2002). Neuro‐imaging. Neuro‐imaging Studies of Depression. https://doi.org/10.1002/0470846410.ch73
5. Adler, G. (2006). Diagnostik der Demenz. Notfall & Hausarztmedizin (Notfallmedizin). https://doi.org/10.1055/s-2006-959110
6. Agid, Y., & Blin, J. (2007). Nerve Cell Death in Degenerative Diseases of the Central Nervous System: Clinical Aspects. Novartis Foundation symposium. https://doi.org/10.1002/9780470513422.ch2
7. Ahmed, S., Baker, I., & Butler, C. (2016). Diagnosing young onset dementia can be challenging.. PubMed.
8. Akbarzadeh, M., Akbarzadeh, R., & Akbarzadeh, R. (2006). Cognitive dysfunction in multiple sclerosis: a clinical perspective of neuropsychological investigations. Annals of General Psychiatry. https://doi.org/10.1186/1744-859x-5-s1-s257
9. Akwa, Y., Allain, H., Lacomblez, L., Lieury, A., & Bentué‐Ferrer, D. (2007). Impaired cognition and attention in adults: pharmacological management strategies. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/nedt.2007.3.1.103
10. Alecha, M. Á. I., & Rodríguez, M. S. (2008). Procesamiento auditivo en el trastorno específico del lenguaje. Revista de Neurología. https://doi.org/10.33588/rn.46s01.2008007
11. Alexander, R., & Bhaumik, S. (2015). Personality Disorders. https://doi.org/10.1002/9781118897164.ch19
12. Alkan, S., Brande, L. V., Barrea, C., & Leroy, P. (2022). [How I explore... macrocephaly].. PubMed.
13. Allende-Rayme, F. R., Acuña-Vila, J. H., Quezada, J. C. R., & Correa-López, L. E. (2021). Lifestyle Medicine and Sleep Quality in Medical Students. Revista de la Facultad de Medicina Humana. https://doi.org/10.25176/rfmh.v21i2.3716
14. Almakhanova, K. K., Nurguzhaev, E. S., Nurzhanova, R., Demesinova, B., Mukasheva, T. Z., & Stepuk, N. V. (2022). Idiopathic longitudinally extensive myelitis: a brief historical excursion (review) and own clinical observation. Journal of clinical practice. https://doi.org/10.17816/clinpract100341
15. Almondes, K. M. D., Azevedo, J. P. D., Santos, M. B. D., & Soares, W. B. (2021). Case Report in the Brazilian Context: Cognitive and Behavioral Changes Following an Electric Injury. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.684817
16. Alt, M. (2011). Lethargie bei Hungernden; Überlebensstrategie oder klinische Depression? Kognitive und psychovegetative Depressionssymptome im Hungerstoffwechsel unter besonderer Berücksichtigung der Anorexia Nervosa.
17. Alvarez, M. C., Royes, R. B., Launde, M. S., Vidal, M. L., & Martín, J. A. (2010). Síndrome de fatiga crónica, mucho más que fatiga. Revista ROL de enfermería.
18. Amer, S. A. M., & Akkad, M. (2016). Correlation between Mild Cognitive Impairment and Functional Status among Elderly. Egyptian Journal of Geriatrics and Gerontology. https://doi.org/10.21608/ejgg.2016.30870
19. Amihăesei, I. C., & Cojocaru, E. (2014). Main neuroendocrine features, diagnosis and therapeutic possibilities in the chronic fatigue syndrome, an underdiagnosed entity.. PubMed.
20. Amin, U., & Benbadis, S. R. (2019). The Role of EEG in the Erroneous Diagnosis of Epilepsy. Journal of Clinical Neurophysiology. https://doi.org/10.1097/wnp.0000000000000572
21. Amoah, C., Heck, D. E., & Kim, H. D. (2022). Sensing metabolomics landscape unfold molecular connectivity between mental illness and drug abuse. GSC Biological and Pharmaceutical Sciences. https://doi.org/10.30574/gscbps.2022.18.3.0102
22. Ana, A., Raluca, Sandu, Fragaki, M., Buga, Adriana, A., Uzoni, Eugen, Bogdan, Petcu, Aurel, & Popa‐Wagner (2015). Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology. 中国神经再生研究：英文版.
23. Anderson, T., Heitger, M., & Macleod, A. D. (2006). Concussion and mild head injury. Practical Neurology. https://doi.org/10.1136/jnnp.2006.106583
24. Anderson, W. H. (1980). The physical examination in office practice. American Journal of Psychiatry. https://doi.org/10.1176/ajp.137.10.1188
25. Andreev, M. N., & Fedotova, E. Y. (2022). Clinical polymorphism of multiple system atrophy: a clinical case series. Almanac of Clinical Medicine. https://doi.org/10.18786/2072-0505-2022-50-044
26. Angkat, C. I., Sianturi, I. M., Sinambela, S. H., Sitorus, Z., & Khairul, K. (2024). Penerapan Algoritma Certainty Factor dalam Diagnosa Penyakit Guillain-Barre Syndrome. Jurnal Ilmu Komputer dan Sistem Informasi (JIKOMSI). https://doi.org/10.55338/jikomsi.v7i1.2609
27. Anisman, H., & Hayley, S. (2012). Illness comorbidity as a biomarker?. Journal of Psychiatry and Neuroscience. https://doi.org/10.1503/jpn.120092
28. Antoniuk, S. A. (2013). Debilidad muscular aguda: diagnósticos diferenciales. Revista de Neurología. https://doi.org/10.33588/rn.57s01.2013252
29. Antsyborov, A. V., & Dubatova, I. V. (2021). Depressive Spectrum Disorders in Neurological Practice: Is There a Place Under the Sun, or Who Should Treat Patients?. Interactive science. https://doi.org/10.21661/r-553461
30. Antunes, A., Dias, M. C., & Verdelho, A. (2016). Neuropsychiatric Symptoms in Reversible Dementias. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-39138-0_6
31. Aranda, G. L. (2015). Disfunción Visual Cerebral: mejora de la calidad de vida tras el desarrollo de una unidad específica.
32. Arandjelovic, D., Misic, P., Serafimovic, S., & Petrovic, M. (2010). P01-366 - Psychiatric Syndromes and Disorders in Older Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70574-5
33. Archer, T. (2016). Amelioration of Symptoms and Biomarkers of Alzheimers Disease by Physical Exercise. Clinical and Experimental Psychology. https://doi.org/10.4172/2471-2701.1000e105
34. Arciniegas, D. B., Anderson, C. A., Topkoff, J., & McAllister, T. W. (2005). Mild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.. PubMed.
35. Arenson, C., Busby‐Whitehead, J., Brummel‐Smith, K., O’Brien, J. G., Palmer, M. H., & Reichel, W. (2010). Evaluation and Management of Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575952.017
36. Argilés, J. M., Busquets, S., López‐Soriano, F. J., & Fernández‐Figueras, M. T. (2006). Fisiopatología de la caquexia neoplásica. Nutrición Hospitalaria.
37. Ariff, K. M., & Hassan, Z. A. (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals).
38. Armstrong, D. (2004). The mobile phone as an imaging tool in SLE. British journal of rheumatology. https://doi.org/10.1093/rheumatology/keh286
39. Arsanti, N. M., & Wreksoatmodjo, B. R. (2025). Tata Laksana Gangguan Kognitif di Layanan Primer. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v52i9.1653
40. Autor, J. L. M. C., & Principal, C. M. A. C. O. T. (2018). Demencia tipo Alzheimer vs pseudo demencia por depresión. Estudio neuropsicológico de un caso. XII CONGRESO DE POSGRADO EN PSICOLOGÍA | UNAM | 2018.
41. Autora, M. C. D. T., & Principal, C. I. Y. D. R. P. T. (2017). Funcionamiento cognitivo y alteraciones pragmáticas en pacientes con Esclerosis Múltiple.
42. Axelrod, B. N. (2008). Fabrication of psychiatric symptoms: Somatoform and psychotic disorders. Psychology Press eBooks. https://doi.org/10.4324/9780203890042-23
43. Ayerbe, I., & Négrevergne, M. (2005). [Vertigo and pathology of the cerebellospinal system].. PubMed.
44. Ayoob, A., & Janakiram, C. (2021). Let's Focus on Frailty. Journal of Indian Association of Public Health Dentistry. https://doi.org/10.4103/jiaphd.jiaphd_93_21
45. Azmath, J. (2020). Case Study on Parkinson’s Disease. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2020.31178
46. Bach, A. S., Oertel, W. H., & Bach, J.-P. (2010). Kognitive Defizite als Komorbidität neurologischer Erkrankungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628839
47. Bakheet, M. R., & Boyce, H. W. (2005). Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.. PubMed.
48. Bakheit, A. M. O. (2006). Recognition of acute illness in people with chronic neurological disability. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.2005.040253
49. Bali, J., & Bali, O. (2024). A Practical Approach to Medically Unexplained Visual Loss. IntechOpen eBooks. https://doi.org/10.5772/intechopen.115222
50. Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., Isaacs, J. D., Larner, A. J., Nicholson, T. R., Pennington, C., Poole, N., Price, G., Price, J. P., Reuber, M., Ritchie, C., ... Carson, A. (2020). Functional cognitive disorder: dementia’s blind spot. Brain. https://doi.org/10.1093/brain/awaa224
51. Bannister, S. R. (1992). Introduction. https://doi.org/10.1093/oso/9780192619891.003.0001
52. Baquero, M. (2015). Depressive symptoms in neurodegenerative diseases. World Journal of Clinical Cases. https://doi.org/10.12998/wjcc.v3.i8.682
53. Barakat, B., Agosti, R., Ruggeri, E., Tonini, V., Cervellera, M., Guidetti, E., Cevenini, M., Imbrogno, A., Fabbri, D., Pareo, I., Fucili, A., Corinaldesi, R., Stanghellini, V., Pezzilli, R., & Giorgio, R. D. (2012). Atypical presentation of acute idiopathic megacolon in a 14-year-old patient. Emergency Care Journal. https://doi.org/10.4081/ecj.2012.3.5
54. Baran, A. S., & Chervin, R. D. (2009). Approach to the Patient with Sleep Complaints. Seminars in Neurology. https://doi.org/10.1055/s-0029-1237116
55. Barbosa, R., Postal, M., Costallat, L. T. L., Cendes, F., & Appenzeller, S. (2012). Cognitive Impairment in Systemic Lupus Erythematosus: Prevalence and Clinical Importance. Current Rheumatology Reviews. https://doi.org/10.2174/157339712801318975
56. Barbosa, T. A., Machado, R. R., Moeda, A. S. G., Gloria, I. R., Shidiq, S., & Brandão, P. (2023). Importância da hidrocefalia como diagnóstico diferencial de síndromes demenciais. Congresso Médico Acadêmico UniFOA.. https://doi.org/10.47385/cmedunifoa.315.5.2018
57. Bargiotas, P., & Bassetti, C. L. (2017). Sleep-related movement disorders and disturbances of motor control. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000000466
58. Barker, R. A. (2005). The neurological assessment of patients in vegetative and minimally conscious states. Neuropsychological Rehabilitation. https://doi.org/10.1080/09602010443000344
59. Barker, R. A., & Redfern, C. (2019). Parkinson’s Disease, Religious Belief and Spirituality. Cambridge University Press eBooks. https://doi.org/10.1017/9781316014165.011
60. Barnhill, J. W. (2014). DSM-5TM clinical cases. American Psychiatric Publishing eBooks.
61. Barrera, K., Yochim, B. P., & Yutsis, M. (2015). Neuropsychological Assessment. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa188
62. Barrera, M. N. (2005). Afasias adquiridas: síndrome de Landau-Kleffner y otros. Revista de Neurología. https://doi.org/10.33588/rn.41s01.2005384
63. Barth, R. J., & Brigham, C. R. (2005). Chapter 14 or 18 for Pain Complaints? Avoiding the Common but Mistaken Dichotomy of Psychological vs Organic. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2005.janfeb01
64. Barton, B., & Goetz, C. G. (2013). Movement Disorders due to Systemic Disease. https://doi.org/10.1002/9781118414019.ch9
65. Basagni, B., & Navarrete, E. (2025). Suggestions for the decision making in subjective cognitive complaints. Aging Clinical and Experimental Research. https://doi.org/10.1007/s40520-024-02875-8
66. Baser, S., Leichliter, T., Whiting, D., & Oh, M. (2023). Movement Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781316338513.021
67. Bassant, M., Lamour, Y., Potier, B., Billard, J., & Dutar, P. (1994). [Aging of memory mechanisms].. Comptes rendus des séances de la Société de biologie et de ses filiales.
68. Bassotti, G., Giorgio, R. D., Stanghellini, V., Tonini, M., Barbara, G., Salvioli, B., Fiorella, S., & Corinaldesi, R. (1998). Constipation: a common problem in patients with neurological abnormalities.. PubMed.
69. Batchelor, T., & Cudkowicz, M. (2001). Principles of neuroepidemiology.
70. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
71. Baumard, J., Lesourd, M., Guezouli, L., & Osiurak, F. (2021). Physical understanding in neurodegenerative diseases. Cognitive Neuropsychology. https://doi.org/10.1080/02643294.2022.2071152
72. Baxter, P. (2015). States of consciousness: new insights and further questions. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.12666
73. Beaudreau, S. A., & Gould, C. E. (2015). Definition of Mental Disorder. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa190
74. Bebek, N., & Ertaş, M. (2007). [Neuropathic pain].. PubMed.
75. Beggs, S., Trang, T., & Salter, M. W. (2012). Microglia and Pain. Neuroglia. https://doi.org/10.1093/med/9780199794591.003.0068
76. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
77. Begué, N. M., Cobos, E., Quiñones, S. M., & Ginebreda, J. A. (2011). Alteraciones morfologícas del disco óptico. Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears.
78. Behrens, M. I., & Donoso, A. (2005). Variabilidad y variantesde la enfermedad de Alzheimer. Revista médica de Chile. https://doi.org/10.4067/s0034-98872005000400013
79. Bejenaru, A., & Ellison, J. M. (2020). Medicolegal Implications of Mild Neurocognitive Disorder. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988720957092
80. Beleza, P., Machado, Á., Soares‐Fernandes, J., Carneiro, G., Jordão, M. J., Almeida, F., & Figueiredo, J. (2008). Isolated oculomotor nerve paresis as the presenting sign of multiple sclerosis. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2008000200024
81. Bell, B. (2008). Depression and Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2008.04.01.67
82. Bell, D., Turnbull, A., & Kidd, W. (2008). Differential diagnosis of dementia in the field of learning disabilities: a case study. British Journal of Learning Disabilities. https://doi.org/10.1111/j.1468-3156.2008.00524.x
83. Belli, H., Akbudak, M., Ural, C., & Kulacaoğlu, F. (2012). Solitary lesion in ponto-mesencephalic area related secondary mania: a case report.. PubMed.
84. Benatmane, M., Benhabiles, S., Machane, R., Hammal, K., & Sinaceur, S. (2014). La dépression peut mimer n’importe quelle maladie : à propos d’un cas clinique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.241
85. Benaur, M., Burgut, F. T., & Henchcliffe, C. (2006). Late-life depression: a neuropsychiatric approach. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.1.65
86. Bencs, V., Bencze, J., Módis, V. L., Simon, V., Kálmán, J., & Hortobágyi, T. (2020). A Parkinson-kórhoz társuló demencia és a Lewy-testes demencia patológiai és klinikai összehasonlítása. Orvosi Hetilap. https://doi.org/10.1556/650.2020.31715
87. Bender, D. V., Jordá, C. P., Carroll, P., & Tumuluru, R. (2021). Differential diagnosis of auditory hallucinations in teenagers. Assessment and difficulties: Case report of a 13 year old patient. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.625
88. Benedetti, F., Bernasconi, A., & Pontiggia, A. (2005). Depression and neurological disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/01.yco.0000194147.88647.7f
89. Benson, C., & Lusardi, P. (1995). Neurologic Antecedents to Patient Falls. Journal of Neuroscience Nursing. https://doi.org/10.1097/01376517-199512000-00003
90. Berenberg, R. A., Pellock, J. M., DiMauro, S., Schotlan, D. L., Bonilla, E., Eastwood, A. B., Hays, A. G., Vicale, C. T., Behrens, M. M., Chutorian, A. M., & Rowland, L. P. (1977). Lumping or splitting? “ophthalmoplegia‐plus” or kearns‐sayre syndrome?. Annals of Neurology. https://doi.org/10.1002/ana.410010104
91. Berg, A. T. (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
92. Bernstam, V. A. (2019). Neurological and Mental Disorders. CRC Press eBooks. https://doi.org/10.1201/9780429187421-25
93. Berrut, G., & Cubillé, M. (2019). Multimorbidity and epilepsia in the elderly.. PubMed. https://doi.org/10.1684/pnv.2019.0780
94. Bersani, F. S., Mellon, S. H., Reus, V. I., & Wolkowitz, O. M. (2019). Accelerated aging in serious mental disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000525
95. Bersani, F. S., Prevete, E., & Vicinanza, R. (2024). Schizophrenia and Other Late-Life Psychoses. Geriatric medicine. https://doi.org/10.1007/978-3-030-74720-6_87
96. Bertrand, E., Azar, M., Rizvi, B., Brickman, A. M., Huey, E. D., Habeck, C., Landeira-Fernandez, J., Mograbi, D. C., & Cosentino, S. (2018). Cortical thickness and metacognition in cognitively diverse older adults.. Neuropsychology. https://doi.org/10.1037/neu0000458
97. Beverly, B. I. (1924). POSTENCEPHALITIC BEHAVIOR DISTURBANCE WITHOUT PHYSICAL SIGNS. Archives of Pediatrics and Adolescent Medicine. https://doi.org/10.1001/archpedi.1924.01920120027004
98. Bhattachan, S. S., & Sharma, P. (2024). Lewy body dementia – A case report. Journal of Psychiatrists Association of Nepal. https://doi.org/10.3126/jpan.v13i2.74885
99. Bhise, V., & Krupp, L. (2015). Fatigue. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-18464-7_11
100. Bidaki, R., & Salimi, Z. (2023). Functional cognitive impairment: A new concept in neuropsychiatry. Shenakht Journal of Psychology and Psychiatry. https://doi.org/10.32598/shenakht.10.1.1
101. Bigio, M. R. D. (2021). Neuronal Death. Cambridge University Press eBooks. https://doi.org/10.1017/9781316671863.030
102. Binder, L. M., Spector, J. J., & Youngjohn, J. R. (2012). Psychogenic Stuttering and Other Acquired Nonorganic Speech and Language Abnormalities. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acs051
103. Binder, M. D., Peuskens, J., Janssen, F., Hulselmans, J., Haenens, G. D., & Sabbe, B. (2002). Geheugenstoornissen bij schizofrenie. Tijdschrift voor psychiatrie.
104. Bird, S. J., & Rich, M. M. (2000). NEUROMUSCULAR COMPLICATIONS OF CRITICAL ILLNESS. The Neurologist. https://doi.org/10.1097/00127893-200006010-00002
105. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
106. Bjorvatn, B., Jernelöv, S., & Pallesen, S. (2021). Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.639198
107. Black, K. J. (2020). Case Report: DSM–5 misses an edge case in tic disorders nosology. F1000Research. https://doi.org/10.12688/f1000research.23991.1
108. Blanc, F., & Verny, M. (2017). Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0675
109. Blanco, K. E. J., Velásquez, J. M. A., Balthazar, V., Alejandra, N., Espinosa, Z., & Maya, G. C. (2011). Talla baja de causas no endocrinas Short stature due to non-endocrine causes.
110. Blaney, P. H. (2015). Medical Model of Mental Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp382
111. Blazer, D. G., & Hybels, C. F. (2005). Origins of depression in later life. Psychological Medicine. https://doi.org/10.1017/s0033291705004411
112. Bluestein, H. G. (1987). Neuropsychiatric Manifestations of Systemic Lupus Erythematosus. New England Journal of Medicine. https://doi.org/10.1056/nejm198707303170509
113. Blázquez, A. (2025). Nuevos retos en la atención a la discapacidad intelectual en población infantil y juvenil. Revista de Psiquiatría Infanto-Juvenil. https://doi.org/10.31766/revpsij.v42n1a1
114. Bondric‐Popescu, E.-C., & Cozman, D. (2022). Comorbidities associated with depression. Psihiatru ro. https://doi.org/10.26416/psih.68.1.2022.6308
115. Boon, P., Breuer, L. E. M., Grevers, E., Bernas, A., Bergmans, J., Besseling, R. M., Klooster, D., Louw, A. D., Mestrom, R., Vonck, K., Zinger, S., & Aldenkamp, A. P. (2016). Cognitive deterioration in adult epilepsy: clinical characteristics of “Accelerated Cognitive Ageing”. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.12700
116. Borrelli, S., Genoud-Prachex, T., Meyer, M., Démonet, J., & Rouaud, O. (2020). Unsuspected Alzheimer disease in a patient with Multiple sclerosis and progressive aphasia. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2020.102349
117. Bottini, A. G. (2005). Spinal Cord Injury. CRC Press eBooks. https://doi.org/10.1201/b14532-22
118. Bramon, E., & Murray, R. (2001). A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2001.3.4/ebramon
119. Bransfield, R. C., & Friedman, K. J. (2019). Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses and Medical Uncertainty. Healthcare. https://doi.org/10.3390/healthcare7040114
120. Brasil, I. S. P. D. S., & Rafihi‐Ferreira, R. E. (2024). Insomnia. https://doi.org/10.1007/978-3-031-50710-6_4
121. Bravo, M. D. L. (2011). Ansiedad y depresión en la vejez.
122. Brdiczka, P. (2014). Drugs Can Only Affect Symptoms. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0489a
123. Brick, J. E., Brick, J., & Elnicki, D. M. (1991). Musculoskeletal disorders. Postgraduate Medicine. https://doi.org/10.1080/00325481.1991.11701106
124. Brigo, F., & Mecarelli, O. (2019). Systemic and Dismetabolic Disorders. Clinical Electroencephalography. https://doi.org/10.1007/978-3-030-04573-9_42
125. Brochet, B. (1999). [Diagnosis of multiple sclerosis].. PubMed.
126. Brody, D. L. (2019). How Do You Make the Diagnosis of Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190054793.003.0003
127. Broglin, D. (2009). Troubles sexuels chez les patients épileptiques. Epilepsies. https://doi.org/10.1684/epi.2009.0277
128. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
129. Brower, D. (1890). THE MEDICO-LEGAL RELATIONS OF PARALYSIS FROM BRAIN DISEASE.. Journal of the American Medical Association. https://doi.org/10.1001/jama.1890.02410230017002c
130. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
131. Brownlee, W. (2019). Differential diagnosis of multiple sclerosis. Neurology. https://doi.org/10.1212/wnl.0000000000007566
132. Bruecker, G. D., & Sweden, B. V. (1986). Patterns of EEG Dysfunction in General Hospital Psychiatry. Neuropsychobiology. https://doi.org/10.1159/000118313
133. Brunnström, H. (2011). Neuropathological findings and staging in dementia.
134. Bryant, R. A. (2022). Post‐traumatic stress disorder as moderator of other mental health conditions. World Psychiatry. https://doi.org/10.1002/wps.20975
135. Brüne, M. (2008). Dementia. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199207688.003.0009
136. Buckley, T. M., & Guilleminault, C. (2008). Index. CRC Press eBooks. https://doi.org/10.3109/9781420019926-54
137. Buist‐Bouwman, M. A. (2007). Functional limitations associated with mental disorders : inescapable fact or avoidable reality?.
138. Bujosa, H. B. C., Rodríguez-Montalbán, R., & Rosario-Rodríguez, A. (2017). Análisis de las Propiedades Psicométricas de la Escala Crespo-Bujosa de Síntomas Neurológicos Discretos.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.7714/cnps/11.1.2012
139. Burgess, J., Costa, T., & Cousins, D. A. (2020). Clinical assessment and investigation in psychiatry. Medicine. https://doi.org/10.1016/j.mpmed.2020.08.009
140. Burn, D. J. (2006). Movement disorders: a brief practical approach to diagnosis and management. The Journal of the Royal College of Physicians of Edinburgh. https://doi.org/10.1177/1478271520063604014
141. Busby, C., & Burns, A. (2002). Differential Diagnosis of Dementia. https://doi.org/10.1002/0470846410.ch54
142. Butler, J. T., & Tolleson, C. (2014). New Targets for Treating the Underlying Pathophysiology and Nonmotor Aspects of Parkinson’s Disease. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527313666140917104850
143. Byard, R. W. (2023). Sports-Related Deaths. CRC Press eBooks. https://doi.org/10.1201/9781003138754-42
144. Bykov, Y. N., & Kalyagin, A. N. (2015). Differential diagnosis of neuropathic pain. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2015-1-4-10
145. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Le retard mental. Le point sur... Psychologie.
146. Bösebeck, F. (2022). Epilepsy and other comorbidities in Down syndrome. Zeitschrift für Epileptologie. https://doi.org/10.1007/s10309-022-00506-8
147. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
148. Calabrese, P. (2002). Neuropsychologie der multiplen Sklerose. Aktuelle Neurologie. https://doi.org/10.1055/s-2002-36030
149. Calingasan, N. Y., Sheu, K. R., Baker, H., Gandy, S., & Gibson, G. E. (1996). Thiamine Deficiency as a Model of Selective Neurodegeneration with Chronic Oxidative Deficits. Neurodegenerative Diseases. https://doi.org/10.1007/978-1-4899-0209-2_25
150. Calvani, M., Anania, C., Cuomo, B., D’Auria, E., Decimo, F., Indirli, G. C., Mastrorilli, V., Santoro, A., Sartorio, M. U. A., & Veronelli, E. (2020). Summation anaphylaxis: A challenging diagnosis. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.13347
151. Campoy, A. T., Rotger, M. Y., Gutiérrez, L. R. D. L. H., & Pastorelli, R. V. (2011). ¿Psicosis mental injertada o retraso mental? A propósito de un caso.. Psiquiatria.com.
152. Candura, S. M., & Scelsi, R. (2013). [Occupational toxic neuropathies: morphology in peripheral nerve biopsies].. PubMed.
153. Cannon, J. A. (2016). Cognitive impairment in heart failure.
154. Cao, F., Salem, H., Nagpal, C., & Teixeira, A. L. (2017). Prolonged delirium misdiagnosed as a mood disorder. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642016dn11-020014
155. Caputo, F., Barranco, R., Ricci, P., Gratteri, S., Frigiolini, F., Rocca, G., & Ventura, F. (2021). An Unusual case of Functional Neurological Disorders and Psychogenic Coma Following Physical Assault. Journal of Forensic Science and Medicine. https://doi.org/10.4103/jfsm.jfsm_62_20
156. Caranzano, L., & Michel, P. (2023). Microangiopathie cérébrale. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2023.19.824.814
157. Carney, R. M., & Freedland, K. E. (2012). Are Somatic Symptoms of Depression Better Predictors of Cardiac Events Than Cognitive Symptoms in Coronary Heart Disease?. Psychosomatic Medicine. https://doi.org/10.1097/psy.0b013e3182405ac4
158. Carolina, P. J., & William, B. (2013). Neuropsicología en epilepsia. Revista Médica Clínica Las Condes. https://doi.org/10.1016/s0716-8640(13)70253-0
159. Carota, A., Diéguez, S., & Bogousslavsky, J. (2005). Psychopathology of stroke. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
160. Carrada-Bravo, T. (2015). Síndromes neuropsiquiátricos causados por Treponema pallidum Neuropsychiatric syndromes caused by Treponema pallidum.
161. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
162. Caselli, R. J. (2021). Focal Cognitive Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0023
163. Castillo, G., Fernández, B., & Chamorro, D. (2020). Neuroplasticidad: Ejercicios para retrasar los efectos de la Enfermedad de Alzheimer mediante Estimulación Cognitiva. Revista de Investigación Científica y Tecnológica. https://doi.org/10.36003/rev.investig.cient.tecnol.v4n2(2020)12
164. Cernovsky, Z. Z., Ferrari, J. R., & Mendonça, J. D. (2019). Deceptive Clinical Diagnosing of Malingering via Structured Inventory of Malingered Symptomatology. Archives of Psychiatry and Behavioral Sciences. https://doi.org/10.22259/2638-5201.0201009
165. Chadha, Y., Toshniwal, S., & Patil, R. (2024). Diagnostic Dilemma: Unraveling Meige Disorder Mistaken for Functional Neurological Disorder. Cureus. https://doi.org/10.7759/cureus.61465
166. Chadwick, D. (2011). Seizures, epilepsy, and other episodic disorders in adults. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198569381.003.0709
167. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
168. Chaudhary, B., & Chaudhary, A. (2020). Multiple sclerosis: making the invisibles visible. International Journal of Research in Medical Sciences. https://doi.org/10.18203/2320-6012.ijrms20202093
169. Chaudhuri, K., Samarakoon, S., Chandola, H., Kumar, R., & Ravishankar, B. (2011). Evaluation of diet and life style in etiopathogenesis of senile dementia: A survey study. AYU (An International Quarterly Journal of Research in Ayurveda). https://doi.org/10.4103/0974-8520.92554
170. Chen, S. T., Sultzer, D. L., Hinkin, C. H., Mahler, M. E., & Cummings, J. L. (1998). Executive Dysfunction in Alzheimer's Disease. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.10.4.426
171. Chen, Y., Garcia, G. E., Huang, W., & Constantini, S. (2014). The Involvement of Secondary Neuronal Damage in the Development of Neuropsychiatric Disorders Following Brain Insults. Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00022
172. Chen, Y.-S. (2012). Association between chronic insomnia and depression in elderly adults. Journal of the Chinese Medical Association. https://doi.org/10.1016/j.jcma.2012.04.001
173. Cheshire, W. P. (2016). Autonomic Physiology. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190259631.003.0035
174. Chic, S. R. R. A., Marchioni, G. G., Lavado, R. R., Takara, B. S., Noronha, T. A., & Zanco, N. A. (2018). MIELOENCEFALITE PROTOZOÓTICA EQUINA (MEP): RELATO DE CASO CLÍNICO.
175. Chicharro-Ciuffardi, A., González-Silva, M., Marinis-Palombo, A. D., & Gabler-Santalices, G. (2012). Psychiatric disorders secondary to nonconvulsive status epilepticus of frontal origin. Two clinical case reports.. PubMed.
176. Chiliza, B., & Vythilingum, B. (2011). Consultation liaison psychiatry in Africa – essential service or unaffordable luxury?. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v14i4.1
177. Cho, J. H. (2023). Nociplastic pain. Annals of Clinical Neurophysiology. https://doi.org/10.14253/acn.2023.25.2.78
178. Choi, M. S., & Kim, S.-Y. (2010). P3-110: Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2010.05.1607
179. Chouliaras, L., Topiwala, A., Cristescu, T., & Ebmeier, K. P. (2015). Establishing the cause of memory loss in older people.. PubMed.
180. Chow, T. W., Pollock, B. G., & Milgram, N. W. (2007). Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease.. PubMed.
181. Chávez, M. C. M., & Palmero, M. C. G. D. (2015). Síndromes genéticos y otros trastornos asociados a autolesiones bucales. Acta odontológica venezolana.
182. Clarke, J. T. (2005). Acute metabolic illness in the newborn. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544682.010
183. Clasen, M. E., & Olsen, C. G. (1998). Senile dementia of the Binswanger's type.. PubMed.
184. Cobeñas, R., Aguilar, M., Aranguren, J. O., Gallo, J., Espil, G., & Kozima, S. (2015). Cefalea… ¿y algo más? Neuroimágenes en el estudio de la cefalea. Revista Argentina de Radiología / Argentinian Journal of Radiology. https://doi.org/10.1016/j.rard.2015.09.006
185. Cohen, J. A., & Vebell, R. M. (2006). Neuromuscular Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-960-8_13
186. Cojocaru, I. M., Cojocaru, M., Siloşi, I., & Vrabie, C. D. (2010). Central Nervous System Manifestations in Rheumatic Diseases. Journal of Medical Biochemistry. https://doi.org/10.2478/v10011-010-0014-y
187. Colaci, M., Cassone, G., Manfredi, A., Sebastiani, M., Giuggioli, D., & Ferri, C. (2014). Neurologic Complications Associated with Sjögren’s Disease: Case Reports and Modern Pathogenic Dilemma. Case Reports in Neurological Medicine. https://doi.org/10.1155/2014/590292
188. Colán, T. C., Gálvez, G. A., & Zevallos, D. C. (2013). Síntomas psiquiátricos e insulinoma: reporte de caso Psychiatric symptoms and insulinoma: a case report.
189. Constantinescu, C. S., & Lim, S. (2018). Weakness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0044
190. Cooper, L., Copeland, S., Dailey, S., Downey, D., Petersen, M. C., Stimson, C., & Dyke, D. C. V. (2008). Feeding and swallowing dysfunction in genetic syndromes. Developmental Disabilities Research Reviews. https://doi.org/10.1002/ddrr.19
191. Cooper, S. (2005). The clinical assessment of the patient with early dementia. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.081133
192. Coste, M.-H., & Krolak‐Salmon, P. (2010). Fléchissement des fonctions exécutives chez la personne âgée dans un contexte anxio-dépressif et vasculaire. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2010.0076
193. Coste, M.-H., & Krolak‐Salmon, P. (2010). Fléchissement des fonctions exécutives chez la personne âgée dans un contexte anxio-dépressif et vasculaire. Revue de neuropsychologie. https://doi.org/10.3917/rne.025.0022
194. Costello, K., & Newsome, S. D. (2017). Symptoms of Multiple Sclerosis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0085
195. Cousins, D. A., McAllister‐Williams, R. H., & Lunn, B. (2016). Clinical assessment and investigation in psychiatry. Medicine. https://doi.org/10.1016/j.mpmed.2016.08.004
196. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
197. Cummings, J. L. (1988). Intellectual Impairment in Parkinson's Disease: Clinical, Pathologic, and Biochemical Correlates. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198878800100106
198. Cummings, J. L., & Zhong, K. (2017). Promise and Challenges in Drug Development and Assessment for Cognitive Enhancers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214401.003.0001
199. Curto, M. P. M., & Quintana, M. V. M. (2009). [Co-morbility during depression].. PubMed.
200. Curto, P. M., & Quintana, V. M. (2009). Comorbilidad en depresión. Revista ROL de enfermería.
201. Cvijanović, M., Simić, S., Banic-Horvat, S., Jovin, Z., Slankamenac, P., & Ilin, M. (2011). Contemporary treatment neuropathic pain. Medicinski pregled. https://doi.org/10.2298/mpns1110443c
202. Dalmau, J., & Graus, F. (2022). CNS Syndromes at the Frontier of Autoimmune Encephalitis. Cambridge University Press eBooks. https://doi.org/10.1017/9781108696722.019
203. Dalmau, J., & Graus, F. (2022). General Approach to Diagnosis. Cambridge University Press eBooks. https://doi.org/10.1017/9781108696722.003
204. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
205. Davison, A. (1977). The Biochemistry of Brain Development and Mental Retardation. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.131.6.565
206. Debiais, S., Bonnaud, I., Ferreira-Maldent, N., Mercier, E., & Toffol, B. D. (2009). NEUROPSYCHIATRIC DISORDERS REVEALING PRIMARY ANTIPHOSPHOLIPID SYNDROME IN AN ELDERLY PATIENT. Neurology. https://doi.org/10.1212/wnl.0b013e3181a0fd69
207. DeCarli, C., Mayda, A. V., & Nordahl, C. W. (2009). Cerebrovascular contributions to amnestic mild cognitive impairment. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581410.012
208. Delcea, C. (2019). Sexual deviances. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.119
209. Delgado, M. G., & Bogousslavsky, J. (2013). Aggravation neurologique après une crise d’épilepsie post-AVC : une paralysie de Todd persistante?.
210. Delgado, P. L., & Schillerstrom, J. E. (2009). Cognitive Difficulties Associated With Depression What Are the Implications for Treatment.
211. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
212. Demey, I., Zimerman, M., Allegri, R., Serrano, C., & Taragano, F. (2004). Neuropsychiatric symptoms of mild cognitive impairment. CRC Press eBooks. https://doi.org/10.3109/9780203492857-7
213. Deonna, T. (2010). [Cognitive and behavioral consequences of epilepsy during the course of brain development].. PubMed.
214. Derouesné, C. (2006). Dementia with Lewy bodies: third report of DLB consortium. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
215. Derouesné, C. (2006). Démence à corps de Lewy : nouveau consensus. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
216. Derry, C. P., & Welch, K. A. (2013). Mild traumatic brain injury and epilepsy: alcohol misuse may underpin the association. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-306267
217. Deses, C. D. D. L. (2018). Alteraciones del sueño en personas adultas mayores. Revista de la Facultad de Medicina (México).
218. Desseilles, M., Sterpenich, V., Dang‐Vu, T. T., & Schwartz, S. (2011). REM sleep and emotion regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511921179.044
219. Deuschl, G., & Bain, P. G. (2002). Deep brain stimulation for trauma: Patient selection and evaluation. Movement Disorders. https://doi.org/10.1002/mds.10150
220. Dickenson, D., & Fulford, B. (2001). Basic concepts: your myth or mine?. https://doi.org/10.1093/oso/9780192628589.003.0003
221. Dickerson, B. C., & Sperling, R. A. (2007). Dementia: mild cognitive impairment and Alzheimer’s disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566298.003.0005
222. Dickson, D. W. (2005). Neuropathology of Parkinson's disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.040
223. Dickson, D. W., & Orr, C. (2011). Neuropathology of Dementia in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch14
224. DiLossi, J., & Harrison, M. (2023). Understanding Eating Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781009186865.004
225. DiMaio, V. J., & Dana, S. E. (2006). Handbook of forensic pathology.
226. Dimberg, E. L. (2011). The Office Evaluation of Weakness. Seminars in Neurology. https://doi.org/10.1055/s-0031-1271307
227. Dobrakowski, P., Pierzchała, K., & Łabuz-Roszak, B. (2013). [Sexual dysfunctions and sexual satisfaction among multiple sclerosis patients].. PubMed.
228. Dobre, M., Popa, P., Aurel, N., & Georgescu, L. P. (2009). Clinical and paraclinical aspects in mental retarda tion and autism spectrum disorders Retardul mentali tulbur ările din spectrul autist - aspecte clinicei paraclinice.
229. Domingos, A., Silva, V., Correia, C., Rocha, L., Costa, T., Faria, M., & Mota, M. C. (2021). MO1023BARDET-BIEDL SYNDROME OR SENIOR-LOKEN SYNDROME? GOING BEYOND THE OBVIOUS. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfab108.0020
230. Domoto‐Reilly, K., Sapolsky, D., & Dickerson, B. C. (2014). Mild Cognitive Impairment (MCI) Stage of the Frontotemporal Dementias: Early Diagnosis and Management. Perspectives on Gerontology. https://doi.org/10.1044/gero19.2.57
231. Donaghy, P. C., & McKeith, I. G. (2014). The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimer s Research & Therapy. https://doi.org/10.1186/alzrt274
232. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
233. Doğan, P., Şen, A., Ülker, M., Sari, S., Ataklı, D., & Arpacı, B. (2010). Paraneoplastik Limbik Ensefalit: Olgu Sunumu. Balkan Medical Journal.
234. Drake, M. J. (2015). Assessment of nocturia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198719113.003.0003
235. Drislane, F. W., Herman, S. T., & Kaplan, P. W. (2017). Nonconvulsive Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190228484.003.0021
236. Drossel, C. (2020). Neurocognitive Disorders and Health Psychology. The Wiley Encyclopedia of Health Psychology. https://doi.org/10.1002/9781119057840.ch143
237. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
238. Duncan, J. S., Sander, J. W., Alim‐Marvasti, A., Balestrini, S., Baxendale, S., Bindman, D., Chinthapalli, K., Chowdhury, F. A., Diehl, B., Eriksson, S., Foong, J., Heaney, D., Khan, S., Koepp, M. J., Kullmann, D. M., Rajakulendran, S., Rugg‐Gunn, F., Sidhu, M. K., Sisodiya, S. M., ... Yogarajah, M. (2024). Epilepsy and Related Disorders. Neurology. https://doi.org/10.1002/9781119715672.ch10
239. Dupont, C., Bougnères, P., & Baud, O. (2002). La substance blanche et la maladie cœliaque. Médecine thérapeutique / Pédiatrie.
240. Dutta, A., Paudel, R., Thapa, L. J., Bhattarai, S., Shrestha, M., & Shrestha, M. (2023). Blurred boundaries of the brain-1 (Aide-memoire for patient narrative). Journal of Psychiatrists Association of Nepal. https://doi.org/10.3126/jpan.v12i1.59430
241. D’Abreu, A., & Ott, B. R. (2005). Poststroke Dementia. Humana Press eBooks. https://doi.org/10.1385/1-59259-824-2:231
242. Ebadi, M., Tippin, J., Chou, K. L., Erickson, B. A., Doerschug, K. C., & Fletcher, D. M. J. (2011). Non-motor Symptoms in Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2011.07.02.113
243. Ebadi, M., Tippin, J., Chou, K. L., Erickson, B. A., Doerschug, K. C., & Fletcher, D. M. J. (2012). Non-motor Symptoms in Parkinson’s Disease. European Neurological Review. https://doi.org/10.17925/enr.2012.07.01.35
244. Ebner, R. (2014). Incomplete Description. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0488a
245. Efrosini, Z., & Dimitrios, T. (2012). Non-Conventional MRI Techniques in Neurophychiatric Systemic Lupus Erythematosus (NPSLE): Emerging Tools to Elucidate the Pathophysiology and Aid the Diagnosis and Management. InTech eBooks. https://doi.org/10.5772/24627
246. Egloff, N., Maecker, F., Stauber, S., Sabbioni, M., Tunklova, L., & Känel, R. V. (2013). Hysterie? Nicht dermatombezogene somatosensorische Defizite. Journal Club Schmerzmedizin. https://doi.org/10.1055/s-0033-1334068
247. Elkan, E.-M., Papuc, A.-M., Goroftei, R. E. B., Banu, E. A., Zlati, M. L., Albeanu, A. G., & Pleșea-Condratovici, A. (2023). DREAMING AND PARASOMNIAS FROM A CEREBRAL STRUCTURAL VIEW. https://doi.org/10.35630/2022/12/psy.ro.6
248. Elst, L. T. V., Stich, O., & Endres, D. (2015). Depressionen und Psychosen bei immunologischen Enzephalopathien. PSYCH up2date. https://doi.org/10.1055/s-0041-102941
249. Engstad, R. T., Engstad, T. T., Davanger, S., & Wyller, T. B. (2013). Eksekutiv svikt etter hjerneslag. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.12.0686
250. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
251. Epelbaum, S., & Cacciamani, F. (2023). Clinical Assessment of Brain Disorders. Neuromethods. https://doi.org/10.1007/978-1-0716-3195-9_7
252. Epelbaum, S., & Dubois, B. (2013). [Subjective cognitive complaint. From anxiety to prodromal Alzheimer's disease?].. PubMed.
253. Eskay-Auerbach, M., & Brooks, C. N. (2014). Clinical Assessment of Cervical Myelopathy. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2014.janfeb03
254. Esparcia, A. J., & Marín, M. A. (2009). DSM, MENTAL HEALTH AND PARENTAL ALIENATION SYNDROME.
255. Espay, A. J., Aybek, S., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., LaFaver, K., LaFrance, W. C., Lang, A. E., Nicholson, T. R., Nielsen, G., Reuber, M., Voon, V., Stone, J., & Morgante, F. (2018). Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2018.1264
256. Espeleta, C. L. (2014). La terapia Vojta como herramienta de tratamiento de las alteraciones neuromotoras en la marcha de niños y adultos. https://doi.org/10.14201/gredos.125451
257. Espino, D. V., Jules-Bradley, A. C., Johnston, C. L., & Mouton, C. P. (1998). Diagnostic approach to the confused elderly patient.. PubMed.
258. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
259. Fabbrni, B. L., & Cysneiros, R. M. (2018). As crises neonatais produzem efeitos neurológicos deletérios de longo prazo: evidências clínicas experimentais.
260. Fadem, B. H., & Simring, S. S. (1998). High-Yield Psychiatry.
261. Falcicchio, G., Boero, G., Francavilla, T., Alicino, A., Sgobio, R., Trojano, M., & Neve, A. L. (2022). A case of repeated focal motor seizures as expression of an inflammatory cerebral process with suspected dysimmune etiology. Epilepsy & Behavior Reports. https://doi.org/10.1016/j.ebr.2022.100576
262. Falk, M. J., & Moreno, M. A. (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
263. Farina, B., Liotti, M., & Imperatori, C. (2019). The Role of Attachment Trauma and Disintegrative Pathogenic Processes in the Traumatic-Dissociative Dimension. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2019.00933
264. Farne, H., Norris-Cervetto, E., & Warbrick‐Smith, J. (2015). Limb weakness. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198716228.003.0032
265. Fasano, A., Lehnerer, S., & Elia, A. E. (2014). Symptoms of dystonia. https://doi.org/10.2217/ebo.13.269
266. Fatma, S., Sunarti, S., Mardhiyah, F., Wirabhatari, A., & Winstonly, B. (2024). Tantangan Dalam Penilaian Klinis Gejala Depresi pada Usia Lanjut. Jurnal Klinik dan Riset Kesehatan. https://doi.org/10.11594/jk-risk.03.2.6
267. Fayolle, D., Théaudin, M., Ochsner, F., Echaniz‐Laguna, A., Magy, L., Vicino, A., & Hübers, A. (2022). Crampes musculaires. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2022.18.779.785
268. Fenichel, G. M. (2005). Psychomotor Retardation and Regression.
269. Ferguson, T. A., & Elman, L. (2007). Clinical presentation and diagnosis of Amyotrophic Lateral Sclerosis. Neurorehabilitation. https://doi.org/10.3233/nre-2007-22602
270. Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015). REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039822014238
271. Ferini‐Strambi, L., Sforza, M., Poletti, M., Giarrusso, F., & Galbiati, A. (2017). Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA). La Medicina del lavoro. https://doi.org/10.23749/mdl.v108i4.6497
272. Ferioli, S., & Shutter, L. (2016). Normal anatomy and physiology of the brain. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199600830.003.0219
273. Ferlazzo, E. (2010). Confusional status epilepticus in elderly. BMC Geriatrics. https://doi.org/10.1186/1471-2318-10-s1-l35
274. Fernández-Egea, E., & Jones, P. B. (2023). Schizophrenia. Cambridge University Press eBooks. https://doi.org/10.1017/9781911623137.065
275. Fernández‐Jaén, A., Fernández‐Mayoralas, D. M., Fernández‐Perrone, A. L., Jiménez, A. L., Albert, J., López‐Martín, S., Calleja‐Pérez, B., Tirado, P., & López-Arribas, S. (2018). [Neurodevelopment and phenocopies of attention deficit hyperactivity disorder: differential diagnosis].. PubMed.
276. Fernández‐Jaén, A., Fernández‐Mayoralas, D. M., Perrone, A. L. F., Domingo, A. J. D., Albert, J., Martín, S. L., Pérez, B. C., Requero, M. P. T., & Arribas, S. L. (2018). Neurodesarrollo y fenocopias del trastorno por déficit de atención/hiperactividad: diagnóstico diferencial. Revista de Neurología. https://doi.org/10.33588/rn.66s01.2017532
277. Fernández‐Jaén, A., Martín, S. L., Albert, J., Mayoralas, D. M. F., Perrone, A. L. F., Pérez, B., & Arribas, S. L. (2017). Trastorno por déficit de atención/hiperactividad. Revista de Neurología.
278. Ferreira, R. B., & Bottino, C. M. C. (2011). Transtornos do humor em idosos. Debates em Psiquiatria. https://doi.org/10.25118/2763-9037.2011.v1.869
279. Fibiger, H. (1984). The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100046230
280. Fierro, Á. D. J. L., Aparicio, S. Y. L., Morgado‐Valle, C., Beltrán‐Parrazal, L., García, L. I., Hernández‐Aguilar, M. E., Manzo, J., & Pérez-Estudillo, C. A. (2022). Trastornos de las neuronas motoras: causas, síntomas, factores de riesgo, diagnósticos y tratamientos. eNeurobiología. https://doi.org/10.25009/eb.v13i31.2599
281. Filipa, N., & Sergio, S. (2015). Phenomenology of Depression in Alzheimer's Disease. Advances in Alzheimer's disease. https://doi.org/10.3233/978-1-61499-542-5-3
282. Filley, C. M. (2001). Neuropsychiatric Syndromes. https://doi.org/10.1093/oso/9780195135619.003.0017
283. Fiszman, A. (2007). As crises não-epilépticas psicogênicas como manifestações clínicas do transtorno de estresse pós-traumático. Journal of Epilepsy and Clinical Neurophysiology. https://doi.org/10.1590/s1676-26492007000500007
284. Fitten, L. J. (2015). Psychological Frailty in the Aging Patient. Nestlé Nutrition Institute Workshop series. https://doi.org/10.1159/000382060
285. Flachenecker, P. (2015). Fatigue bei Multipler Sklerose. Nervenheilkunde. https://doi.org/10.1055/s-0038-1627622
286. Foa, E. B., Stein, D. J., & McFarlane, A. C. (2006). Symptomatology and psychopathology of mental health problems after disaster.. PubMed.
287. Foerster, K., Joergens, S., & Baune, B. T. (2019). Clinical Characteristics of Social Cognitive Processes in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0015
288. Folkerth, R. D. (2021). Accidental and Nonaccidental Death. Cambridge University Press eBooks. https://doi.org/10.1017/9781316671863.066
289. Folks, D. G., & Ford, C. V. (2002). Clinical Features of Depression and Dysthymia. https://doi.org/10.1002/0470846410.ch74
290. Fontana, M. H., Scoppetta, C., Quadrini, R., Cesa, I. L., Lello, R. D., Peppe, A., Tolli, V. S., & Casali, C. (1991). [Miller Fisher syndrome: review of the literature and presentation of 2 cases].. PubMed.
291. Forss, N., & Kuiper, M. (2019). Special Sessions. European Journal of Neurology. https://doi.org/10.1111/ene.14022
292. Franco, J. J. D. (2007). Estrés alimentario y salud laboral vs. estrés laboral y alimentación equilibrada. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2007000400012
293. Freynhagen, R., & Bennett, M. (2009). Diagnosis and management of neuropathic pain. BMJ. https://doi.org/10.1136/bmj.b3002
294. Fries, W., Netz, J., Bötzel, K., Steinhoff, B., Hartje, W., & Lachenmayr, B. (2005). Leitlinie zur Beurteilung der Fahreignung bei neurologischen Erkrankungen. Aktuelle Neurologie. https://doi.org/10.1055/s-2005-866913
295. Frohnhofen, H., & Popp, R. (2022). Schlaf und Schlafstörungen im hohen Lebensalter. DMW - Deutsche Medizinische Wochenschrift. https://doi.org/10.1055/a-1495-3348
296. Frías, Á., Palma, C., & Farriols, N. (2015). Traumatismo craneoencefálico en pacientes con síndrome psicótico: etiopatogenia y estatus nosológico. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352015000400011
297. Frölich, J., & Lehmkuhl, G. (2013). Differenzialdiagnostische Zusammenhänge von Schlaf- und Vigilanzstörungen im Kindesalter - Verbindungen zu psychischen Störungen und organischen Erkrankungen.
298. Frýdl, & Závodská, H. (1989). [Changes in dendrites in disease and aging].. PubMed.
299. Funalot, B. (2014). Peripheral neuropathies in mitochondrial disorders. https://doi.org/10.1002/9781118618424.ch17
300. Furukawa, K., Kamada, M., Ishiki, A., Tomita, N., & Arai, H. (2014). [Clinical diagnosis].. PubMed.
301. Galasko, D. (2019). Pharmacological Approaches To Behavioral Symptoms In Alzheimer’s Disease. CRC Press eBooks. https://doi.org/10.1201/9780429260353-28
302. Galderisi, S. (2012). W04-03 - Psychosocial functioning - relationship with symptoms and cognitive impairment. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75680-8
303. Gale, R., & Rockwood, K. (2015). Dementia/Neurocognitive Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp379
304. Gallego, D., Figueroa, J., & Orozco, C. (2010). Síndrome de disfunción cognitiva de perros geriátrico. Revista Mvz Córdoba. https://doi.org/10.21897/rmvz.313
305. Galletta, D., Confuorto, M., Lauria, I., Suarato, V., Califano, A., Mastrola, A., & Micanti, F. (2016). Association between Epilepsy and Psychogenic Non-Epileptic Seizures: A Case Report. Open Journal of Psychiatry. https://doi.org/10.4236/ojpsych.2017.71004
306. Gallois, P., Vallée, J.-P., & Noc, Y. L. (2012). Mémoire et âge : « mais que suis-je donc venu faire là ? ». Médecine. https://doi.org/10.1684/med.2012.0837
307. Gameleira, G. H., & Barbosa, M. L. S. (2019). MANIFESTAÇÕES ATÍPICAS DAS CRISES EPILÉPTICAS. Semana de Pesquisa do Centro Universitário Tiradentes - SEMPESq - Alagoas.
308. García, M. D. S., & Calderón, R. M. (2010). Síntomas no motores en la enfermedad de Parkinson y estimulación cerebral profunda. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009745
309. García-Rubio, M. J. (2023). The neuropsychological effects of some childhood neurodevelopmental disorders. https://doi.org/10.32388/jph4dh
310. Gardella, E., Tassinari, C. A., & Rubboli, G. (1995). Negative myoclonus.. PubMed.
311. Gardner, J. W., Gibbons, R. V., Hooper, T. I., Cunnion, S. O., Kroenke, K., & Gackstetter, G. D. (2003). Identifying New Diseases and Their Causes: The Dilemma of Illnesses in Gulf War Veterans. Military Medicine. https://doi.org/10.1093/milmed/168.3.186
312. Garnacho‐Montero, J., Madrazo-Osuna, J., a-Garmendia, J. L. G., & Ortíz-Leyba, C. (2001). Neuromuscular Disorders of the Critically Ill Patient. Clinical Pulmonary Medicine. https://doi.org/10.1097/00045413-200111000-00008
313. Garrett, M., Merissa, N., & Scott, P. J. H. (2011). Diagnosis of Dementia Using Nuclear Medicine Imaging Modalities. InTech eBooks. https://doi.org/10.5772/25283
314. Garriga-Grimau, L., Laín, G. A., Nascimiento, M. T., & Aleman, A. P. (2015). Síndrome cerebeloso cognitivo-afectivo. Archivos Argentinos de Pediatria. https://doi.org/10.5546/aap.2015.e268
315. Gaspar, B. L. (2023). Diagnostic Evaluation of Immune-Mediated Neuropathies. https://doi.org/10.1007/978-981-19-8421-1_15
316. Gavett, B. E., Stern, R. A., Cantu, R. C., Nowinski, C. J., & McKee, A. C. (2010). Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimer s Research & Therapy. https://doi.org/10.1186/alzrt42
317. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
318. Gerards, M. (2014). Leigh syndrome: the genetic heterogeneity story continues. Brain. https://doi.org/10.1093/brain/awu264
319. Gerc, K., & Makiełło-Jarzowa, G. (1998). [Psychological consequences of neurologic motor impairment from a developmental perspective].. PubMed.
320. Gerring, J. P. (1986). Psychiatric Sequelae of Severe Closed Head Injury. Pediatrics in Review. https://doi.org/10.1542/pir.8-4-115
321. Gertz, H.-J. (2001). Dementias in Other Brain Diseases. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_74
322. Ghoneim, M. M., & Block, R. I. (2012). Clinical, methodological and theoretical issues in the assessment of cognition after anaesthesia and surgery. European Journal of Anaesthesiology. https://doi.org/10.1097/eja.0b013e328356bd6e
323. Giazkoulidou, A., Messinis, L., & Nasios, G. (2019). Cognitive functions and social cognition in multiple sclerosis: An overview.. PubMed.
324. Gilbert‐Barness, E., Debich-Spicer, D., & Opitz, J. M. (2001). Malformation Syndromes. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547423.010
325. Gillberg, C. (1995). Neuorodevelopmental examination of the child with neuropsychiatric problems. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511570094.016
326. Gillberg, C. (1995). Neuropsychological work-up. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511570094.018
327. Gioacchino, M. D., Boscolo, P., Reale, M., Muraro, R., & Giampaolo, L. D. (2011). Work stress and innate immune response.. International Journal of Immunopathology and Pharmacology.
328. Gireadă, B., Chiriță, V., Chiriță, R., & Dobrin, R. (2023). Young-onset dementia. New insights and a case report. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2023.2.12
329. Giubilei, F., Candela, S. F., & Orzi, F. (2013). Heterogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism.. PubMed.
330. Gnanamuthu, C. P. (1988). Confusional states and seizures. Postgraduate Medicine. https://doi.org/10.1080/00325481.1988.11700372
331. Gnädinger, L. C., Gagesch, M., & Schimmel, M. (2017). Relations entre le bruxisme et les troubles neurocognitifs. SWISS DENTAL JOURNAL SSO – Science and Clinical Topics. https://doi.org/10.61872/sdj-2017-12-04
332. Godefroy, O., Barbay, M., Andriuta, D., Tir, M., & Roussel, M. (2016). Global Hypoactivity and Apathy. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-3-319-39138-0_5
333. Goitia, L., & Horrillo, I. (2018). Depresioaren teoria neuroinflamatorioa. Osagaiz osasun-zientzien aldizkaria. https://doi.org/10.26876/osagaiz.1.2018.100
334. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
335. Goldstein, D. S. (2002). Dysautonomias: Clinical Disorders of the Autonomic Nervous System. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-137-9-200211050-00011
336. González, A. (2005). Fisiopatología y diagnóstico de la anorexia nerviosa y la bulimia.
337. González, C., Betés, M., López‐Muñoz, F., & Martín, J. D. D. M. (2011). Aportaciones de la psicofarmacología al tratamiento de los trastornos de la personalidad (II) = Contributions of psychopharmacology for the treatment of personality disorders (II: grupos farmacológicos empleados en el tratamiento de los trastornos de personalidad = pharmacological groups employed in the treatment of the disorders of personality /. Edupsykhé Revista de Psicología y Educación. https://doi.org/10.57087/edupsykhe.v10i2.3852
338. González-Medina, G., & Cerisola, A. (2002). Primera convulsión en apirexia. Archivos de Pediatría del Uruguay.
339. Goodin, D. S. (2006). Physical Trauma, Psychological Stress, and Multiple Sclerosis. https://doi.org/10.1093/oso/9780195170320.003.0037
340. Goodwin, G. M. (2006). Depression and associated physical diseases and symptoms. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/mgoodwin
341. Gordillo, R., Muñoz, L. H., López, E. S., Hernández, M. J., Borreguero, P. M., Méndez, M. A. R., Sánchez, V., Granados, T. G., & Burgos, R. I. Q. (2010). Trastorno bipolar en la infancia de causa orgánica. Revista de Psiquiatría Infanto-Juvenil.
342. Gorgas, D. L. (2022). Just Another Case of Gastro. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544464.003.0019
343. Gorjup, R., & Makovec, T. (2021). How Evidence-Based is Evidence-Biased Medicine. https://doi.org/10.26420/austinjpregnancychildbirth.2021.1003
344. Gottfries, C. G. (1998). Is there a difference between elderly and younger patients with regard to the symptomatology and aetiology of depression?. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199809005-00004
345. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
346. Greden, J. F. (2003). Physical symptoms of depression: unmet needs.. PubMed.
347. Greyson, B. (2011). Cosmological Implications of Near-Death Experiences.
348. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
349. Groeneweg, M. (1998). Clinical and experimental aspects of hepatic encephalopathy.
350. Grossberg, G. T., & Manepalli, J. (1995). The older patient with psychotic symptoms. Psychiatric Services. https://doi.org/10.1176/ps.46.1.55
351. Guajardo, J. H., Chejne, F., & Plancarte, R. (2012). Multimodal Analgesia for Neuropathic Pain. InTech eBooks. https://doi.org/10.5772/26238
352. Guedes, R., Silveira, C., Maia, D., Curral, R., & Coelho, R. (2019). Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art. Psychiatry Investigation. https://doi.org/10.30773/pi.2019.0106
353. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
354. Guiraud, V., & Touzé, E. (2013). Psychological and Psychiatric Triggers and Risk Factors for Stroke. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-1-4471-2428-3_12
355. Gunardi, M. V. R., Mariska, & Nabila, S. N. (2024). Successful Management of Ischemic Stroke : A Case Report and Literature Review. Asian Australasian Neuro and Health Science Journal (AANHS-J). https://doi.org/10.32734/aanhsj.v6i2.17691
356. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
357. Guthrie, T. R. (2021). Other Health Impairment (OHI) Disabilities Category and an In-Depth Look at the Most Common Neurobiological Condition for Students. Advances in higher education and professional development book series. https://doi.org/10.4018/978-1-7998-7359-4.ch003
358. Göbel, H., Heinze, A., Ingwersen, M., Niederberger, U., & Gerber, D. (2000). Wirkmechanismen von Harpagophytum-procumbens-Extrakt LI 174 bei der Behandlung von unspezifischen Rückenschmerzen. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57735-2_11
359. Güney, E., & İşeri, E. (2013). Genetic and Environmental Factors in Autism. InTech eBooks. https://doi.org/10.5772/53295
360. Hadi, I., Wijayati, F., Usman, R. D., & Rosyanti, L. (2017). Major Depressive Disorder: A Mini Review. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v9i1.102
361. Hafeza, M. J., Bourjia, H., & Sroura, H. (2020). Functional Neurological Deficit: one of the most controversial diagnosis- case report of a patient with paraplegia. International Journal of Case Reports. https://doi.org/10.28933/ijcr-2020-02-2305
362. Hainline, B., Gurin, L., & Torres, D. M. (2019). Chronic Traumatic Encephalopathy. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0036
363. Hainline, B., Gurin, L., & Torres, D. M. (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
364. Hainline, B., Gurin, L., & Torres, D. M. (2019). Unmasking Neuropsychiatric Disorders Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0035
365. Hajj, G. N. M., Tiago, G., Casini, M., & Marilene, H. (2012). Transmissible Spongiform Encephalopathies. InTech eBooks. https://doi.org/10.5772/29586
366. Hales, R. E., & Yudofsky, S. C. (1996). Synopsis of psychiatry.
367. Hamann, W. (2006). Non-Drug Management Of Chronic Pain. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566304.003.0032
368. Hamdan, F. F., Holder, J. L., & Michaud, J. L. (2019). SYNGAP1-Related Intellectual Disability.
369. Hanken, K., Eling, P., & Hildebrandt, H. (2014). Is there a cognitive signature for MS-related fatigue?. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458514549567
370. Harrison, J., Stow, I., & Owen, A. M. (2001). Parkinson’s disease. CRC Press eBooks. https://doi.org/10.3109/9780203213193-13
371. Harvey, A. G. (2006). What about patients who can’t sleep? Case formulation for insomnia. https://doi.org/10.4324/9780203965177-19
372. Harvey, P. D. (2011). Assessment of everyday functioning in schizophrenia.. PubMed.
373. Haupt, M. (2012). Geriatrische Patienten – Demenzdiagnostik. Lege artis - Das Magazin zur ärztlichen Weiterbildung. https://doi.org/10.1055/s-0032-1330931
374. Hawkes, M. A., & Wijdicks, E. F. M. (2021). Impaired Consciousness and Coma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0055
375. Heckers, S. (2009). Neurobiology of Schizophrenia Spectrum Disorders. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.v38n5p431
376. Heeren, T. J., & Crevel, H. V. (1998). [Revised consensus 'Diagnosis of the dementia syndrome'].. PubMed.
377. Heerwig, C., Möller, H., & Brückner, K. (2022). Neuropsychologie der Epilepsien im höheren Lebensalter. Zeitschrift für Epileptologie. https://doi.org/10.1007/s10309-022-00483-y
378. Helfgott, S. M., & Bhattacharyya, S. (2014). Neurologic Complications of Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis. Seminars in Neurology. https://doi.org/10.1055/s-0034-1390391
379. Helmer, C., & Lepetit, A. (2016). État de stress post-traumatique et démence chez la personne âgée. Une revue systématique de la littérature. L information psychiatrique. https://doi.org/10.1684/ipe.2016.1552
380. Henderson, V. W. (1987). Outcome prediction after severe closed head injury in adults.. PubMed.
381. Henkel, K. (2018). Gibt es einen psychogenen Kopfschmerz?. Nervenheilkunde. https://doi.org/10.1055/s-0038-1642076
382. Henriksson, K. G. (2003). Fibromyalgia - from syndrome to disease. Overview of pathogenetic mechanisms. Journal of Rehabilitation Medicine. https://doi.org/10.1080/16501960310010215
383. Herlambang, Y. M. (2009). ASUHAN KEPERAWATAN PADA Ny. P DENGAN GANGGUAN SISTIM PERSARAFAN : STROKE HEMORAGIK DI RUANG ANGGREK I RSUD Dr. MOEWARDI SURAKARTA.
384. Hermelink, K. (2012). Kontroversen um das „Chemobrain“. Deutsche Zeitschrift für Onkologie. https://doi.org/10.1055/s-0032-1314662
385. Hernández, C. D. L. (2022). Dislexia: manifestaciones socioemocionales en el trastorno de aprendizaje y su intervención multidisciplinar. Ciencia y Academia. https://doi.org/10.21501/2744838x.4486
386. Herrando, V. T. (2021). Prison psychiatry and faking symptoms. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.90
387. Herschbach, P. (1995). [The difference between ill persons and patients].. PubMed.
388. Ho, M.-K., & Siu, A. Y.-C. (2010). High Altitude Medicine.
389. Hodges, E. P., Mast, B. T., Lichtenberg, P. A., & Curyto, K. (1998). Disease and Depression in Older Medical Patients. Psychological Reports. https://doi.org/10.2466/pr0.1998.83.3.1081
390. Holloway, R. G. (2005). Neurological examination identified 61% of patients with focal cerebral hemisphere lesions but without obvious focal signs. Evidence-Based Medicine. https://doi.org/10.1136/ebm.10.6.183
391. Holtmann, G., Shah, A., & Morrison, M. (2017). Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview. Digestive Diseases. https://doi.org/10.1159/000485409
392. Holzer, D. (2006). Das Psychosyndrom nach frühkindlichen Hirnschäden: MCD -historischer Literatur- und Praxisbericht-. https://doi.org/10.23668/psycharchives.258
393. Hommet, C., & Verny, M. (2009). Épilepsie et syndromes démentiels. Epilepsies. https://doi.org/10.1684/epi.2009.0246
394. Hoof, E. V., & Meirleir, K. D. (2005). Chronic Fatigue syndrome and myalgic encephalomyelitis: Are both conditions on the same continuum?.
395. Hossmann, K. (1998). Experimental models for the investigation of brain ischemia. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(98)00075-3
396. Hovorka, J., Bajaček, M., Nežádal, T., Janicadisová, M., & Herman, E. (2006). Psychiatrické příznaky (psychomotorické zpomalení, kognitivní porucha, zmatenost, poruchy chování, delirium, demence, aj.) mohou být způsobeny nekonvulzivním epileptickým statem. Psychiatrie pro praxi.
397. Howard, F. (1971). Peripheral Neuropathy as a Sign of Systemic Disease. Postgraduate Medicine. https://doi.org/10.1080/00325481.1971.11697594
398. Howe, M. L., Goodman, G. S., & Cicchetti, D. (2008). Stress, Trauma, and Children's Memory Development. https://doi.org/10.1093/acprof:oso/9780195308457.001.0001
399. Huda, A. S. (2019). Biological factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0012
400. Huda, A. S. (2019). Social factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0013
401. Huda, A. S. (2019). Spectrums of conditions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0011
402. Huda, A. S. (2019). Spectrums of health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0009
403. Huda, A. S. (2019). Variability of clinical picture. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0010
404. Hunt, T. J., Thienhaus, O. J., & Ellwood, A. (2008). The mirror lies: body dysmorphic disorder.. PubMed.
405. Huss, A., & Vermeulen, R. (2014). Neurodegenerative Diseases and ELF-EMF. CRC Press eBooks. https://doi.org/10.1201/b16968-15
406. Hwang, H., Na, K., Kim, S. G., Lee, S. I., & Jung, H. (2012). Alteration of Cognitive Function in Mild Traumatic Brain Injury Patients Grouped by Subjective Depression. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2012.51.5.300
407. Häfele, M. (2001). Internistische Differenzialdiagnose bei unklaren Bewusstseinsstörungen in Verbindung mit synkopalen Zuständen oder epileptischen Anfällen. Aktuelle Neurologie. https://doi.org/10.1055/s-2001-15333
408. Iacono, D., Lee, P., Edlow, B. L., Gray, N., Fischl, B., Kenney, K., Lew, H. L., Lozanoff, S., Liacouras, P., Lichtenberger, J. P., Dams‐O'Connor, K., Cifu, D. X., Hinds, S. R., & Perl, D. P. (2019). Early-Onset Dementia in War Veterans: Brain Polypathology and Clinicopathologic Complexity. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlz122
409. Iacovides, A., & Siamouli, M. (2008). Comorbid mental and somatic disorders: an epidemiological perspective. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e328303ba42
410. Ijeoma, J.-A. (2019). Dyslexia, Neurodevelopmental Conditions and Comobidity: A Rule Rather than an Exception. Archives in Neurology & Neuroscience. https://doi.org/10.33552/ann.2019.04.000585
411. Iliev, B., & Pavlovska, I. (2021). Analysis of Clinical Features of Patients with Depressive Disorder. Journal of Health Medicine and Nursing. https://doi.org/10.7176/jhmn/92-01
412. Iorga, M., Stârcea, I. M., Munteanu, M., & Sztankovszky, L.-Z. (2014). PSYCHOLOGICAL AND SOCIAL PROBLEMS OF CHILDREN WITH CHRONIC KIDNEY DISEASE.
413. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
414. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Cognitive Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0429
415. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
416. Jennett, B. (2008). Scale, Scope and Philosophy of the Clinical Problem. Novartis Foundation symposium. https://doi.org/10.1002/9780470720165.ch2
417. Joffe, R. T. (2005). Depression and multiple sclerosis: a potential way to understand the biology of major depressive illness. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0501
418. Johansson, M. (2023). On the role of neuropsychiatric symptoms as markers for Alzheimer´s disease in an era of disease modifying treatments. Alzheimer s & Dementia. https://doi.org/10.1002/alz.070455
419. Jones, S., Howard, L. M., & Thornicroft, G. (2008). ‘Diagnostic overshadowing’: worse physical health care for people with mental illness. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.2008.01211.x
420. Jossein, T., Ruchat, D., Regina, J., Chiabotti, P. S., & Fisch, L. (2023). Démence rapidement progressive : prise en charge par l’interniste. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2023.19.840.1598
421. Joucla, C. (2020). Électroencéphalographie et machines à vecteurs de support dans le diagnostic différentiel des pathologies neuropsychiatriques : état des lieux, enjeux et applications.
422. Juven‐Wetzler, A., Sonnino, R., Bar-Ziv, D., & Zohar, J. (2009). Symptom exaggeration in posttraumatic stress disorder. CRC Press eBooks. https://doi.org/10.3109/9781841847207-16
423. Jáuregui‐Renaud, K., Ramos-Toledo, V., Aguilar-Bolaños, M., Montaño‐Velázquez, B. B., & Pliego-Maldonado, A. (2008). Symptoms of detachment from the self or from the environment in patients with an acquired deficiency of the special senses. Journal of Vestibular Research. https://doi.org/10.3233/ves-2008-182-306
424. Jónsdóttir, I. H., & Lindegård, A. (2007). Fysisk träning och stressrelaterad ohälsa. Socialmedicinsk tidskrift. https://doi.org/10.62607/smt.v84i2.46235
425. Kahler, S. G., & Fahey, M. (2003). Metabolic disorders and mental retardation. American Journal of Medical Genetics Part C Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.10018
426. Kajiki, H., Ochiai, Y., Tsuji, F., KOSOGABE, Y., Ishii, F., Tokioka, H., Furutani, S., & Kosaka, F. (1984). None. THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA. https://doi.org/10.2199/jjsca.4.62
427. Kalayjian, L. A., & Morrell, M. J. (2000). Female Sexuality and Neurological Disease. Journal of Sex Education and Therapy. https://doi.org/10.1080/01614576.2000.11074333
428. Kamenskiy, I., Kaymovskiy, I. L., Gersamiya, A. G., & Vavilina, I. (2017). Cognitive impairment. The effects of seizures?. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro20171179250-54
429. Kanner, A. M., & Dunn, D. W. (2004). Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy. Journal of Child Neurology. https://doi.org/10.1177/088307380401900108
430. Kapczinski, F. (2015). Biomarkers of Neuroprogression in Bipolar Disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31830-7
431. Kaplan, P. W. (2003). Delirium and epilepsy. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2003.5.2/pkaplan
432. Karličić, I. S., Djordjević, J., Stasevic, I., Dejanovic, S. D., Pavlovic, A., & Јаnkovic, S. (2016). Neuroleptic malignant syndrome: the diagnostic dilemma. Open Journal of Psychiatry & Allied Sciences. https://doi.org/10.5958/2394-2061.2016.00028.8
433. Karmiloff‐Smith, A. (2015). What can cognitive neuroscience tell us about development.
434. Karp, H. R. (1971). Dementia in Systemic Diseases. Postgraduate Medicine. https://doi.org/10.1080/00325481.1971.11697603
435. Kasatkin, D. S. (2006). [Possible mechanisms of chronic fatigue syndrome in multiple sclerosis].. PubMed.
436. Katarelos, K., Piechal, A., & Kurkowska‐Jastrzębska, I. (2020). Sleep disorders in patients with multiple sclerosis. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.33450/fpn.2020.05.001
437. Kato, M. (2006). Neuropsychological study on a diagnostic criterion in a five-year model project for supporting persons with higher brain dysfunctions. Higher Brain Function Research. https://doi.org/10.2496/hbfr.26.299
438. Kazymova, N., Kharlamenkova, N. Y., & Nikitina, D. A. (2019). Severe life events and their psychological consequences: loss or threat of loss of nearest. Vestnik Kostroma State University Series Pedagogy Psychology Sociokinetics. https://doi.org/10.34216/2073-1426-2019-25-2-96-101
439. Keil, V. C., Greschus, S., Schneider, C., Hadizadeh, D. R., & Schild, H. H. (2015). The Whole Spectrum of Alcohol-Related Changes in the CNS: Practical MR and CT Imaging Guidelines for Daily Clinical Use. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. https://doi.org/10.1055/s-0035-1553509
440. Kelly, J. J., & Karcher, D. S. (2004). Lymphoma and peripheral neuropathy: A clinical review. Muscle & Nerve. https://doi.org/10.1002/mus.20163
441. Kennerley, H. (2009). Cognitive therapy for post-traumatic dissociation. https://doi.org/10.4324/9780203874318-14
442. Kessels, R. P. C., & Savage, G. (2015). Amnestic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp060
443. Kholin, V., In, K., Kryzhanovskiy, S., Karasevich, N., Khodakovska, M., Shershanova, H., & Movchun, N. O. (2024). Cognitive disorders in Parkinson's disease. Ageing & Longevity. https://doi.org/10.47855/jal9020-2024-5-6
444. Kim, M., Lee, K., Son, Y., Jeon, H., Kim, Y.-B., & Cho, Z. (2012). Increased Basal Forebrain Metabolism in Mild Cognitive Impairment: An Evidence for Brain Reserve in Incipient Dementia. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2012-120133
445. Kim, S. M. (2000). The Strategy of Clinical Procedure for Determining Brain Death. Korean Journal of Medical Ethics. https://doi.org/10.35301/ksme.2000.3.1.1
446. Kim, S.-H., & Jung, S.-W. (2011). Psychiatric Approach of Fibromyalgia. Journal of Rheumatic Diseases. https://doi.org/10.4078/jrd.2011.18.4.242
447. King, B. H. (2001). Psychopharmacology in intellectual disabilities. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543616.020
448. Kipps, C. (2005). Cognitive assessment for clinicians. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.059758
449. Kishi, T., Kawahara, H., Tanaka, T., Kaneko, Y., Tsuji, T., Kawaguchi, H., Nishio, Y., Hata, S., Kawamura, T., Sakamoto, K., Tanaka, M., & Satoh, W. (1998). Superior Mesenteric Artery Syndrome Complicating Mitochondrial Encephalopathy. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/00005176-199804000-00020
450. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
451. Knapp, P., & Lightbody, C. E. (2019). Emotional and Cognitive Changes Following a Stroke. https://doi.org/10.1002/9781119581161.ch11
452. Kocabaşoğlu, N., Karaçetin, G., Bayar, R., & Demir, T. (2012). A Review of the Etiology Delirium. InTech eBooks. https://doi.org/10.5772/32411
453. Kokurcan, A., & Atbaşoğlu, C. (2015). [Differential Diagnosis of Schizophrenia: Psychotic Symptoms in Neurodevelopmental Disorders and Psychotic Disorders due to other Medical Conditions].. PubMed.
454. Komar, S. (2016). Zdravstvena njega dementnih bolesnika.
455. Konstantakopoulos, G. (2019). Insight across mental disorders: A multifaceted metacognitive phenomenon. Psychiatriki. https://doi.org/10.22365/jpsych.2019.301.13
456. Koo, B. B. (2011). Sleep-Related Movement Disorders. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805267711101010045
457. Koops, E. A., Belkum, S. V., Hanekamp, S., Noort, P., Broersma, M., & Beilen, M. V. (2017). Non-invasive neuromodulation as a new therapeutic strategy in the management of functional somatic symptoms.
458. Kopach, O., & Pivneva, T. (2018). Cell-based therapies for neural replacement strategies in stroke-related neurodegeneration: neurophysiological insights into stem progenitor cell neurogenesis within a host environment. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.235224
459. Koros, H., & Papageorgiou, S. G. (2014). Early onset dementia.
460. Kos, D., Kerckhofs, E., Nagels, G., D’hooghe, M., & Ilsbroukx, S. (2007). Origin of Fatigue in Multiple Sclerosis: Review of the Literature. Neurorehabilitation and neural repair. https://doi.org/10.1177/1545968306298934
461. Kotwal, A., Duggal, R., Sharma, V., Gupta, A., & Gupta, A. K. (2022). PERIPHERAL NERVOUS SYSTEM DISORDERS: A DIAGNOSTIC APPROACH. Global Journal For Research Analysis. https://doi.org/10.36106/gjra/7505767
462. Kozaki, K. (2018). VI. Age-dependent Cognitive Impairment and Dementia. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.107.2461
463. Kozakiewicz, M., & Just, M. (2015). Depressive disorders co-existing with Addison&amp;ndash;Biermer anemia &amp;ndash; case report. Neuropsychiatric Disease and Treatment. https://doi.org/10.2147/ndt.s83137
464. Krawiec, P., Batko, B., Skura, A., Adamek-Guzik, T., Cześnikiewicz‐Guzik, M., Krzanowski, M., Rydz-Stryszowska, I., Ryszawa, N., & Guzik, T. J. (2006). [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].. Przegląd Lekarski.
465. Krenn, M., Grisold, A., Wohlfarth, P., Rath, J., Çetin, H., Koneczny, I., & Zimprich, F. (2020). Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments. Frontiers in Molecular Neuroscience. https://doi.org/10.3389/fnmol.2020.00156
466. Krombach, J., Hörmann, S., Huber, C., Hölzle, P., & Förstl, H. (2021). Alt und depressiv oder dement? – Pseudodepression vs. Pseudodemenz. DMW - Deutsche Medizinische Wochenschrift. https://doi.org/10.1055/a-1180-2417
467. Kronenberg, G., & Endres, M. (2013). Schlaganfall und Psyche. Aktuelle Neurologie. https://doi.org/10.1055/s-0033-1354353
468. Krägeloh‐Mann, I. (2010). Clinical outcome: neurological sequelae following preterm birth. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511712166.004
469. Kumari, S., Nath, S., Narasimha, V. L., Sarkar, M. K., & Kumar, R. (2023). Psychosis Unmasking a Diagnosis of Systemic Lupus Erythematosus: a Case Report. East Asian Archives of Psychiatry. https://doi.org/10.12809/eaap2316
470. Kunze, S., Hibbeln, R., Himmelmann, M., Merse, O., & Oelmann, H. (2007). Neuropsychologische Faktoren des Fatigue-Syndroms bei MS-Patienten: Paradoxes Phänomen bei Fatigue?. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-987981
471. Kurlan, R., Richard, I. H., Papka, M., & Marshall, F. J. (2000). Movement disorders in Alzheimer's disease: More rigidity of definitions is needed. Movement Disorders. https://doi.org/10.1002/1531-8257(200001)15:1<24::aid-mds1006>3.0.co;2-x
472. Kuwabara, S. (2010). 1. Neuropsychiatric Lupus Erythematosus. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.99.1754
473. Kučikienė, O., Lesauskaitė, V., Macijauskienė, J., Vainoras, A., Blaževičienė, A., Samėnienė, J., Alekna, V., Satkunskienė, D., Naudžiūnas, A., & Krutulytė, G. (2009). Dažniausi hospitalizuotų pagyvenusio amžiaus pacientų sveikatos sutrikimai.
474. Köhler, J., & Heilmeyer‐Kohler, H. (2009). P4‐254: Dementia in multiple sclerosis: is it Alzheimer's or a new entity?. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2009.04.619
475. Kügler, J., Schrader, A., Spatz, R., & Ross, A. (1977). [Diagnostic value of the EEG. Neurologic diagnosis today].. PubMed.
476. Lacroix, M., Nguyen, C., Burns, R., Laporte, A., Rannou, F., & Feydy, A. (2022). Degenerative Lumbar Spine Disease: Imaging and Biomechanics. Seminars in Musculoskeletal Radiology. https://doi.org/10.1055/s-0042-1748912
477. Lafau, O., Roca, O., & Gea, P. M. (1997). Trastornos depresivos en patologías médicas.. Psiquiatria.com.
478. Lalov, J. V., Shtaimets, S. V., & Filatenkova, T. V. (2024). Late diagnosis of chronic inflammatory demyelinating polyneuropathy on the background of misdiagnosed alcoholic polyneuropathy: a clinical case. Medical alphabet. https://doi.org/10.33667/2078-5631-2024-12-30-35
479. Landau, W. (2011). ‘Causal relation between spasticity, strength, gross motor function, and functional outcome in children with cerebral palsy: a path analysis’. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2011.04006.x
480. Landers, D. M. (2002). Anorexia in Exercise and Sport. Medicine & Science in Sports & Exercise. https://doi.org/10.1097/00005768-200205001-01795
481. Landázuri, J. G. O. D., & Pueyo, F. J. O. (2020). La depresión del anciano vista por el geriatra. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
482. Lang, A. E., & Voon, V. (2011). Psychogenic movement disorders: Past developments, current status, and future directions. Movement Disorders. https://doi.org/10.1002/mds.23571
483. Lanska, D. J. (2006). Functional Weakness and Sensory Loss. Seminars in Neurology. https://doi.org/10.1055/s-2006-945516
484. Lauriat, T. L., & Samson, J. (2015). Endocrine Disorders Associated with Psychological/Behavioral Problems. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199352722.013.32
485. Lavoie, S., Polari, A., Goldstone, S., Nelson, B., & McGorry, P. D. (2019). Staging model in psychiatry: Review of the evolution of electroencephalography abnormalities in major psychiatric disorders. Early Intervention in Psychiatry. https://doi.org/10.1111/eip.12792
486. Lechi, A., Juvarra, G., Gemignani, F., & Bettoni, L. (1976). [Idiopathic orthostatic hypotension: Shy-Drager's syndrome (author's transl)].. PubMed.
487. Lee, C., Hsieh, M., Chen, C.-H., & Lai, T. (2009). Neuroimaging in Major Depressive Disorder: An Updated Review. 臺灣精神醫學. https://doi.org/10.29478/tjp.200903.0003
488. Lee, J. G., Park, S. W., Baek, J. H., & Kim, Y. H. (2012). Understanding the Molecular Biology in the Pathogenesis of Depression. The Korean Journal of Psychopharmacology.
489. Lemoine, P. (2013). Insomnies, hypersomnies, parasomnies en psychiatrie. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2013.09.087
490. Lennon, M. B. (1924). THE TRAUMATIC NEUROSIS. JAMA. https://doi.org/10.1001/jama.1924.02660100012004
491. Levenson, R. W., Sturm, V. E., & Haase, C. M. (2014). Emotional and Behavioral Symptoms in Neurodegenerative Disease: A Model for Studying the Neural Bases of Psychopathology. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev-clinpsy-032813-153653
492. León, J. S. T., Dulcey, L., Sandoval, E. S., Fontecha, E. R. A., & Quintero, D. K. V. (2022). Esclerosis lateral amiotrófica, revisión epidemiológica, clínica y terapéutica de una catastrófica enfermedad neurológica en términos pronósticos. Ciencia Latina Revista Científica Multidisciplinar. https://doi.org/10.37811/cl_rcm.v6i6.4026
493. León-Carrión, J., Domínguez-Morales, M. R., & Martín‐Hernández, J. (2001). Advances in the Prevention and Treatment of Age-Related Organic Memory Disorders. CRC Press eBooks. https://doi.org/10.1201/b14249-18
494. Li, H. (2012). Concomitant symptom and medicine related exacerbation in myasthenia gravis: how to analyse the clinical causal relationship. Zhongguo xiandai shenjing jibing zazhi.
495. Li, L., Liu, S., Zhuang, J.-L., Li, M.-M., Huang, Z., Chen, Y., Chen, X., Chen, C., Lin, S., & Ye, L. (2022). Recent research progress on metabolic syndrome and risk of Parkinson’s disease. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2022-0093
496. Lichtenstein, S. V. (2015). Multiple Sklerose – welche Optionen bietet die Ernährungstherapie?. Aktuelle Ernährungsmedizin. https://doi.org/10.1055/s-0035-1552701
497. Limongelli, G., D‘Alessandro, R., Maddaloni, V., Rea, A., Sárközy, A., & McKenna, W. J. (2013). Skeletal muscle involvement in cardiomyopathies. Journal of Cardiovascular Medicine. https://doi.org/10.2459/jcm.0b013e3283641c69
498. Lin, J. C., Mueller, C., Campbell, K. A., Thannickal, H. H., Daredia, A., Sheriff, S., Maudsley, A. A., Brunner, R., & Younger, J. (2021). Investigating whole‐brain metabolite abnormalities in the chronic stages of moderate or severe traumatic brain injury. PM&R. https://doi.org/10.1002/pmrj.12623
499. Liptak, G. S. (1998). THE CHILD WHO HAS SEVERE NEUROLOGIC IMPAIRMENT. Pediatric Clinics of North America. https://doi.org/10.1016/s0031-3955(05)70586-1
500. Liu, Y., Zhao, J., Fan, X., & Guo, W. (2019). Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2019.00286
501. Lodhia, K. R., Brahma, B., & McGillicuddy, J. E. (2005). Peripheral Nerve Injuries in Weight Training. The Physician and Sportsmedicine. https://doi.org/10.3810/psm.2005.07.141
502. Loeb, C. (1989). The Lacunar Syndromes. European Neurology. https://doi.org/10.1159/000116454
503. Londoño, F. U., Franco, J. G., Franco, L. F. M., & Tobón, L. A. L. (2005). Ejes neuroendocrinos del estrés, síndrome metabólico y alteraciones psiquiátricas del síndrome de Cushing. IATREIA. https://doi.org/10.17533/udea.iatreia.4249
504. Lorenzo, C. D. (2005). Abdominal Pain: Is It in the Gut Or in the Head?. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/01.scs.0000180302.94428.0c
505. Lothman, E. W. (1990). The biochemical basis and pathophysiology of status epilepticus.. PubMed.
506. Lyketsos, C. G. (2012). F1‐01‐02: Tackling overlap of neuropsychiatric symptoms in Alzheimer's and other dementias: Toward a unified approach to evaluation and treatment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2012.05.191
507. López, O. L., García‐Portilla, M. P., Becker, J. T., Reynolds, C. F., Sudilovsky, A., & DeKosky, S. T. (1995). Symptoms of Depression in Alzheimer's Disease, Frontal Lobe‐type Dementia, and Subcortical Dementia. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1995.tb38153.x
508. Lührs, A., & Haensch, C. (2018). Leitlinienorientierte Diagnostik autonomer Störungen – vom Symptom zur Therapie. Klinische Neurophysiologie. https://doi.org/10.1055/a-0634-4125
509. Maciag, E. J., Martín‐Noguerol, T., Ortiz-Pérez, S., Torres, C., & Luna, A. (2024). Understanding Visual Disorders through Correlation of Clinical and Radiologic Findings. Radiographics. https://doi.org/10.1148/rg.230081
510. Macovei, A. L., Dobrin, I., Chiriță, V., Burlui, A., Dobrin, P.-R., & Rezuş, E. (2019). Chronic fatigue and psychiatric comorbidities in patients with rheumatic disorders. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.03.08
511. Maddocks, I., Brew, B. J., Waddy, H., & Williams, I. (2005). Cognitive, behavioural and psychological symptoms. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545016.015
512. Maddocks, I., Brew, B. J., Waddy, H., & Williams, I. (2005). Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545016.020
513. Maddocks, I., Brew, B. J., Waddy, H., & Williams, I. (2005). Problems with muscles and movement. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545016.009
514. Madersbacher, H. (2022). Patient History. https://doi.org/10.1007/978-981-16-7939-1_12-1
515. Madhusudanan, M. (2006). Psychiatric symptoms in neurological practice. Annals of Indian Academy of Neurology. https://doi.org/10.4103/0972-2327.25979
516. Maegawa, G. (2017). Lysosomal Storage Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0068
517. Magner, M. (2019). Clinical Manifestation of Mitochondrial Disorders in Childhood. CRC Press eBooks. https://doi.org/10.1201/9780429443336-21
518. Majeske, M., Nistor, V., & Kellner, C. H. (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
519. Malaiyandi, D., & Živković, S. (2018). Neuromuscular Conditions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199375349.003.0013
520. Malek, N., & Greene, J. (2014). Cognition enhancers for the treatment of dementia. Scottish Medical Journal. https://doi.org/10.1177/0036933014561948
521. Malenfant, M., Tremblay, S., Laurin, D., & Lefèbvre, J. (2008). L'utilisation du citalopram pour traiter l'agitation et les symptômes psychotiques chez les patients souffrant de démence.
522. Malik, R. A., & Veves, A. (2005). Diabetic Neuropathy. Humana Press eBooks. https://doi.org/10.1385/1-59259-908-7:381
523. Maltseva, L., Lisnycha, V., Kobelatskyy, Y., & Kazimirova, N. (2021). Вплив додаткової нейропротекції Гліатиліном на перебіг септичного процесу і вираженість енцефалопатії в структурі синдрому поліорганної недостатності. EMERGENCY MEDICINE. https://doi.org/10.22141/2224-0586.17.2.2021.230634
524. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
525. Mantelet, S., & Hardy, P. (2002). Dépression et maladies somatiques. MT. Médecine thérapeutique.
526. Manzo-García, D. M., & Alvarez-Bobadilla, G. M. (2010). Evaluación del estado de conciencia con la prueba de Folstein, en pacientes bajo anestesia general, sometidos a cirugía de columna. Deleted Journal.
527. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
528. Marcone, S. (2018). La mémoire prospective dans le trouble cognitif léger avec ou sans trouble comportemental en sommeil paradoxal.
529. Marcopulos, B. A., Hedjar, L., & Arredondo, B. C. (2016). Dissociative Amnesia or Malingered Amnesia? A Case Report. Journal of Forensic Psychology Practice. https://doi.org/10.1080/15228932.2016.1142782
530. Marino, S., Ciurleo, R., Baglieri, A., Corallo, F., De, R., De, S., Guerrera, S., Timpano, F., Bramanti, P., & Nicola, S. D. (2012). Neuroimaging and Outcome Assessment in Vegetative and Minimally Conscious State. InTech eBooks. https://doi.org/10.5772/23003
531. Marrero, D. H., Pestano, M. M. A., Acosta, B. A., & Miranda, J. L. D. (2020). La ptosis no orgánica: a propósito de un trastorno.
532. Martelli, M. F., Zasler, N. D., & Grayon, R. (1999). Ethical considerations in medicolegal evaluation of neurologic injury and impairment following acquired brain injury. Neurorehabilitation. https://doi.org/10.3233/nre-1999-13107
533. Martin, L. J. (2002). Synaptic and Neuroglial Pathobiology in Acute and Chronic Neurological Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-105-3_25
534. Martin, T., Brigham, C. R., & Brooks, C. N. (2001). Clinical Update: Evaluation of Low Back Pain. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2001.janfeb02
535. Martins, M. B., Boff, C., & Ávila, C. T. (2021). Desafios da avaliação neuropsicológica: depressão x declínio cognitivo na pessoa idosa / Neuropsychological assessment: depression versus cognitive decline in the elderly. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv4n5-408
536. Martins, S., & Fernandes, L. (2012). Delirium in Elderly People: A Review. Frontiers in Neurology. https://doi.org/10.3389/fneur.2012.00101
537. Martone, G. (2019). The inflammation hypothesis and mental illness.
538. Martín, E. S. S., Juanes, J., Montero, R., & Aguiar, C. S. (2012). Demencia frontotemporal asociada al cromosoma 17 y otros síndromes parkinsonianos asociados a demencia. Revista de Neurología. https://doi.org/10.33588/rn.54s04.2012520
539. Martín, M. S., Martín, R. S., Espinoza, K. S., Calvo, L. S., Valverde, G. F., López, L. S., Rivera, M. P., Cabrera, Y. P., & Merino, B. L. (2019). Terapias alternativas: retando al alzheimer. International Journal of Developmental and Educational Psychology Revista INFAD de psicología. https://doi.org/10.17060/ijodaep.2019.n2.v2.1891
540. Martínez, A. R., Argüelles, P. P., Cucurella, M. M., Llort, A. J., Camacho, J. A., & Plana, J. C. (2008). Manifestaciones neurológicas en el síndrome hemolítico urémico. Revista de Neurología. https://doi.org/10.33588/rn.4704.2008249
541. Martínez, F. A., Cuellar, M. C. A., & Paz, L. L. R. (2018). Lo práctico, lógico y esencial en la discusión diagnóstica. DOAJ (DOAJ: Directory of Open Access Journals).
542. Martínez, V. M. (2008). Estudio comparativo de las alteraciones cognitivas de un grupo de adultos jóvenes diagnosticados de hipotiroidismo subclínico frente a un grupo de individuos control.
543. Martínez‐Castrillo, J. C., Vela, L., Val, J. D., & Alonso‐Cánovas, A. (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
544. Martínez‐Lapiscina, E. H., Sánchez‐Dalmau, B., Fraga‐Pumar, E., Ortiz-Pérez, S., Tercero-Uribe, A. I., Torres–Torres, R., & Villoslada, P. (2014). The visual pathway as a model to understand brain damage in multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458514542862
545. Masand, P. S. (2000). Novel Antipsychotics in the Treatment of Behavioral Disturbances and Psychoses Associated With Neurodegenerative Disorders. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v02n0302
546. Masgutova, S., Wenberg, S., & Retschler, M. (2008). MASGUTOVA METHOD OF REFLEX INTEGRATION FOR CHILDREN WITH CEREBRAL PALSY.
547. Masse, C., Chopard, G., Bennabi, D., Haffen, É., & Vandel, P. (2021). Cognitive functions in late life depression. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2021.0939
548. Matsumoto, R., Sakamoto, M., & Ikeda, A. (2017). [Autoimmune and Epilepsy].. PubMed. https://doi.org/10.11477/mf.1416200879
549. Matthews, R. N. (2022). Assessing and Intervening with Children with Seizure Disorders. https://doi.org/10.1002/9781119790563.ch20
550. Maud, A. (2006). Memory loss after stroke. Neurology. https://doi.org/10.1212/01.wnl.0000244752.95386.de
551. Mauri, M., & Ramacciotti, D. (2006). Sintomi Psichici e Somatici dei Disturbi dell'Umore: razionali di terapia. Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology.
552. Mayer, G. (2001). Narkolepsie. Aktuelle Neurologie. https://doi.org/10.1055/s-2001-15335
553. Mazza, M., Marca, G. D., Mennuni, G., Bria, P., & Mazza, S. (2005). Sleep disturbances and depression : A review. Minerva psichiatrica e psicologica.
554. Mazzoni, P., Kimhy, D., Khan, S., Posner, K., Maayan, L., Eilenberg, M., Walsh‐Messinger, J., Kestenbaum, C. J., & Corcoran, C. M. (2009). Childhood Onset Diagnoses in a Case Series of Teens at Clinical High Risk for Psychosis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2008.0105
555. McCarter, S. J., Feemster, J., Tabatabai, G., Sandness, D. J., Timm, P., McCarter, A. R., Talley, H. N., Johnson, K. L., Savica, R., Vemuri, P., Mielke, M. M., Machulda, M. M., Kantarci, K., Singer, W., Coon, E. A., Josephs, K. A., Boeve, B., Silber, M. H., & Louis, E. K. S. (2018). Diagnostic Yield of REM Sleep Muscle Activity for Presumed Synucleinopathy Neurodegeneration (N7.001). Neurology. https://doi.org/10.1212/wnl.90.15_supplement.n7.001
556. McCluskey, L., Geser, F., Elman, L., Deerlin, V. M. V., Robinson, J., Lee, V. M., & Trojanowski, J. Q. (2014). Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. https://doi.org/10.3109/21678421.2014.903973
557. McFadden, K. M. (2010). Cross-Addiction: From Morbid Obesity to Substance Abuse. Bariatric Nursing and Surgical Patient Care. https://doi.org/10.1089/bar.2010.9922
558. McGowan, J. C., Shkolnikov, Y. P., Sala, J. B., & Ray, R. M. (2008). Diffuse electrical injury: Questioning the scientific basis. Conference proceedings - Canadian Conference on Electrical and Computer Engineering. https://doi.org/10.1109/ccece.2008.4564890
559. McGuigan, C., O’Connell, K., McGovern, E., & McGurgan, I. (2019). Medical pathologies of the spinal cord. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746706.003.0059
560. McGurk, S. R., & Powchik, P. (2000). The Central Cholinergic System and Cognitive Dysfunction in Schizophrenia. https://doi.org/10.1093/oso/9780192629937.003.0014
561. McIntyre, R. S., Danielle, S., & Soczynska, J. K. (2014). Differentiating cognitive dysfunction from other dimensions of psychopathology in major depressive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199688807.003.0005
562. McKnight, C. A., & Caplan, J. P. (2020). Organic psychoses. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0629
563. Medeiro, M., Bazaes, S., Quintanilla, F., Acevedo, H., & Vallejos, J. (2021). Psicosis Secundaria A Meningioma. Revisión A Propósito De Un Caso. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272021000100072
564. Meeusen, R., Duclos, M., Foster, C., Fry, A. C., Gleeson, M., Nieman, D. C., Raglin, J. S., Rietjens, G., Steinacker, J. M., & Urhausen, A. (2013). Prevention, Diagnosis, and Treatment of the Overtraining Syndrome. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0b013e318279a10a
565. Meinck, H., & Ringleb, P. A. (2012). Erkrankungen des Rueckenmarks.
566. Meißner, C., Oehmichen, M., & Saternus, K. (2005). Fall or Shaken: Traumatic Brain Injury in Children Caused by Falls or Abuse at Home - A Review on Biomechanics and Diagnosis. Neuropediatrics. https://doi.org/10.1055/s-2005-872812
567. Melnichenko, G. А. (1997). Лабораторная диагностика надпочечниковой недостаточности. Проблемы Эндокринологии. https://doi.org/10.14341/probl199743539-47
568. Mendez, M. F. (2006). The Accurate Diagnosis of Early-Onset Dementia. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/q6j4-r143-p630-kw41
569. Mendez, M. F. (2017). What is the Relationship of Traumatic Brain Injury to Dementia?. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-161002
570. Merrison, A., & Hanna, M. G. (2009). Muscle disease: THE BARE ESSENTIALS. Practical Neurology. https://doi.org/10.1136/jnnp.2008.167171
571. Mesa, Y. G. (2010). El ejercicio físico voluntario como terapia para la enfermedad de Alzheimer: Estudio en ratones tripletransgénicos 3xTg-AD. TDX (Tesis Doctorals en Xarxa).
572. Mestres, J. S. (2015). Demencia en el adulto joven. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
573. Michalska, A., Szejko, N., Jakubczyk, A., & Wojnar, M. (2016). Nonspecific eating disorders - a subjective review. Psychiatria Polska. https://doi.org/10.12740/pp/59217
574. Middleton, J. (2001). Brain injury in children and adolescents. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.7.4.257
575. Miettinen, O. S., & Flegel, K. M. (2003). Elementary concepts of medicine: VII. Course of illness: manifestations, complications, outcome. Journal of Evaluation in Clinical Practice. https://doi.org/10.1046/j.1365-2753.2003.00420.x
576. Mihanović, M., Bodor, D., Kezić, S., Restek-Petrović, B., & Silić, A. (2009). Differential diagnosis of psychotropic side effects and symptoms and signs of psychiatric disorders.. PubMed.
577. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
578. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
579. Mimura, M. (2002). Managing the higher brain dysfunction. From the psychiatric point of view.. Shitsugoshō kenkyū/Shitsugoshou kenkyuu. https://doi.org/10.2496/apr.22.185
580. Mir, K. E., Bouchai, W. E., Chlihfane, R., & Barrimi, M. (2021). Crisis de angustias agudas que revelan una enfermedad de Basedow o “enfermedad de Graves”: a propósito de un cas.
581. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
582. Mishra, T., Kamble, N., Bhattacharya, A., Yadav, R., Srinivas, D., & Pal, P. K. (2024). Impact of Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease. Journal of Movement Disorders. https://doi.org/10.14802/jmd.23247
583. Mitropoulos, G. B. (2021). Being psychotic is not necessarily being ill: Psychotic continuum and the relevance of lacanian psychoanalytic approach. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.2127
584. Mitsikostas, D. D., Μoka, Ε., Orrillo, E., Aurilio, C., Vadalouca, A., Paladini, A., & Varrassi, G. (2022). Neuropathic Pain in Neurologic Disorders: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.22419
585. Miyamoto, S. T., & Valim, V. (2024). Fadiga e dor: manejo farmacológico e não farmacológico. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2024.23.1.28-31
586. Mograbi, D. C., & Morris, R. G. (2013). Implicit awareness in anosognosia: Clinical observations, experimental evidence, and theoretical implications. Cognitive Neuroscience. https://doi.org/10.1080/17588928.2013.833899
587. Moin, A., Prasad, B. N. S., Ramaswamy, S., & Nalloor, S. (2022). Neurosarcoidosis Camouflaging as Partial Miller: Fisher Syndrome. Indian Journal of Rheumatology. https://doi.org/10.4103/injr.injr_148_22
588. Monahan, Z., Heath, J., Santos, A. D., Ford, A. I., & Hartwell, M. (2023). Comorbidities associated with symptoms of subjective cognitive decline in individuals aged 45–64. Journal of Osteopathic Medicine. https://doi.org/10.1515/jom-2023-0230
589. Monteiro, M. I., Ferreira, A., Grebe, H., Gomes, L., & Costa, M. M. D. (2016). Psiquiátrico, aditivo ou orgânico:  um desafio nos adolescentes. DOAJ (DOAJ: Directory of Open Access Journals).
590. Moore, D. (2015). Neurocognitive Disorders. Psychiatry. https://doi.org/10.1002/9781118753378.ch83
591. Moore, D. P. (2008). Mental Disorders Due to a General Medical Condition. Psychiatry. https://doi.org/10.1002/9780470515167.ch52
592. Moore, D. P., & Puri, B. K. (2012). Textbook of Clinical Neuropsychiatry and Behavioral Neuroscience 3E.
593. Morand, A., Gauthier, K., Mazerolle, M., Pèlerin, A., Rigalleau, F., Sayette, V. D. L., Eustache, F., Desgranges, B., Huguet, P., & Régner, I. (2020). L’effet de menace du stéréotype en situation d’évaluation neuropsychologique : enjeux cliniques. HAL (Le Centre pour la Communication Scientifique Directe). https://doi.org/10.1684/nrp.2020.0607
594. Moreno, B., & Villoslada, P. (2007). Therapeutic Opportunities for Trophic Factors in Brain Inflammation. Current Pharmaceutical Analysis. https://doi.org/10.2174/157341207779802359
595. Moretti, R., Torre, P., Antonello, R. M., & Cazzato, G. (2005). Therapy of vascular dementia: perspectives and milestones. Therapy. https://doi.org/10.2217/14750708.2.4.649
596. Morris, J. G., & McManus, D. Q. (1991). The neurology of aging: normal versus pathologic change.. PubMed.
597. Moshirfar, M., Benstead, E. E., Sorrentino, P. M., & Tripathy, K. (2019). Ocular Neuropathic Pain. StatPearls.
598. Moshé, S. L., Tuchman, R. F., & Rapin, I. (2005). [Neurodevelopmental disorders and epilepsy].. PubMed.
599. Moura, C. D. (2019). A perda da visão como vivência de luto.
600. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
601. Murai, T., Ubukata, S., & Ueda, K. (2019). Interventions for Social / Behavioral Problems after Brain Injury : Essentials and Topics. Higher Brain Function Research. https://doi.org/10.2496/hbfr.39.5
602. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
603. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
604. Méquinion, M. (2014). Altérations périphériques et centrales dans un modèle murin de restriction alimentaire chronique : rôle de la ghréline.
605. Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013). Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-10-142
606. Nakamura, S. (2022). Integrated pathophysiology of schizophrenia, major depression, and bipolar disorder as monoamine axon disorder. Frontiers in Bioscience-Scholar. https://doi.org/10.31083/j.fbs1401004
607. Namlı, Z., ÖZBAY, A., & Tamam, L. (2022). Yetişkin Ayrılma Anksiyetesi Bozukluğu: Bir Gözden Geçirme. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry. https://doi.org/10.18863/pgy.940071
608. Napolitano, R. A., & Triaca, T. P. (2007). HEMINEGLIGÊNCIA: UM ESTUDO DE CASO. Arquivos de Ciências da Saúde da UNIPAR. https://doi.org/10.25110/arqsaude.v11i2.2007.1526
609. Nappo, R., & Simeoli, R. (2024). Il contributo dell'intelligenza artificiale nella diagnosi dei disturbi neurodegenerativi. RIVISTA SPERIMENTALE DI FRENIATRIA. https://doi.org/10.3280/rsf2024-003008
610. Naranđa, F. S. (2019). Značaj Empty selle u procjeni funkcije hipofize.
611. NASCIMENTO, R. T. L., LOPES, C. B., COTTA, D. D. S., ALENCAR, N. L. O. R. D., Valadão, A. F., & Motta, P. G. D. (2015). NEUROPATIA DIABÉTICA DOLOROSA - ASPECTOS CLÍNICOS, DIAGNÓSTICO E TRATAMENTO: UMA REVISÃO DE LITERATURA. Revista Uningá. https://doi.org/10.46311/2318-0579.43.euj1215
612. Natelson, B. H., & Lange, G. (2002). A status report on chronic fatigue syndrome.. Environmental Health Perspectives. https://doi.org/10.1289/ehp.02110s4673
613. Navarro, V., Fischer, C., & Convers, P. (2008). Champ 2- diagnostics différentiels des états de mal épileptiques☆. Réanimation. https://doi.org/10.1016/j.reaurg.2008.09.018
614. Negreiros, D., Fregni, F., & Scalco, A. Z. (2007). Afasia global sem hemiparesia: AVC ou transtorno conversivo?. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832007000100004
615. Nelson, M., Andel, R., Martínková, J., Čechová, K., Marková, H., & Hort, J. (2020). Moderating Effect of Cognitive Reserve on Brain Integrity and Cognitive Performance. Innovation in Aging. https://doi.org/10.1093/geroni/igaa057.912
616. Nesse, R. M., & Stein, D. J. (2012). Towards a genuinely medical model for psychiatric nosology. BMC Medicine. https://doi.org/10.1186/1741-7015-10-5
617. Nicholson, T. R., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., Mildon, B., Nielsen, G., Nicholson, C., Perez, D. L., Pick, S., Stone, J., Anderson, D. G., Asadi‐Pooya, A. A., Aybek, S., Baslet, G., Bloem, B., Brown, R. J., Chalder, T., Damianova, M., ... Tinazzi, M. (2019). Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.19060128
618. Niino, M. (2014). Cognitive impairment in multiple sclerosis. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.54.1058
619. Nivoli, G., Lorettu, L., Veneto, L. I., Milia, P., Nivoli, L., & Nivoli, A. (2006). Problemi gestionali delle gravi manifestazioni aggressive : Criminalità e spettro dell'umore. https://doi.org/10.1400/91497
620. Noachtar, S. (2012). EEG des Status epilepticus und seine Differentialdiagnosen. Klinische Neurophysiologie. https://doi.org/10.1055/s-0032-1301424
621. North, C. S., & Yutzy, S. H. (2018). Delirium and Dementia (Neurocognitive Disorders). Oxford University Press eBooks. https://doi.org/10.1093/med/9780190215460.003.0013
622. Novak, V., & Mendell, J. R. (2001). Evaluation of the Peripheral Neuropathy Patient Using Autonomic Reflex Tests. https://doi.org/10.1093/oso/9780195133011.003.0005
623. Nunes, T., Fragata, I., Ribeiro, F., Palma, T., Marôco, J., Cannas, J., Secca, M. F., Menezes, C. M., Carmo, I. D., Cunha, G., Castelo‐Branco, M., Guerreiro, M., & Mendonça, A. D. (2010). The Outcome of Elderly Patients with Cognitive Complaints but Normal Neuropsychological Tests. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2010-1210
624. Näätänen, R., Kujala, T., & Light, G. A. (2019). Neurological disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198705079.003.0006
625. Oertel, W. H., Vadász, D., Ries, V., Mayer, G., Eggert, K., Krenzer, M., Unger, M. M., Höglinger, G. U., Mollenhauer, B., Sixel-Döring, F., Trenkwalder, C., & Depboylu, C. (2013). Prodromale Marker der Parkinson-Krankheit. Aktuelle Neurologie. https://doi.org/10.1055/s-0033-1355379
626. Ojeda, B. S., Salazar, A., Dueñas, W. A. M., & Failde, I. (2011). El deterioro cognitivo: un factor a tener en cuenta en la evaluación e intervención de pacientes con dolor crónico. Revista de la Sociedad Española del Dolor.
627. Oliveira, C. D. S., Nobre, J. D. C., Silva, A. L. T. D., Martins, J. D. A., & Vandesmet, L. C. S. (2020). MÉTODOS DE DIAGNÓSTICO PARA DETECÇÃO DE ALTERAÇÕES HISTOLÓGICAS NEURAIS DECORRENTES DO ALZHEIMER. Mostra Científica em Biomedicina.
628. Ong, L. T. C., Galambos, G., & Brown, D. A. (2017). Primary Sjogren’s Syndrome Associated With Treatment-Resistant Obsessive–Compulsive Disorder. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2017.00124
629. Onyike, C. U. (2017). Assessment and diagnosis of the non-Alzheimer dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198701590.003.0127
630. Operto, F. F., Pastorino, G. M. G., Padovano, C., Scuoppo, C., Vivenzio, V., & Coppola, G. (2020). Psychogenic Seizures in Adolescents: An “Evergreen” Diagnostic Challenge. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.18662/brain/11.3sup1/131
631. Ortiz, G. (2006). Trastornos neurogenéticos y neurometabólicos paroxísticos. Revista de Neurología. https://doi.org/10.33588/rn.42s03.2006027
632. Ortiz, S. R., Carrillo-Albornoz, E. J. O., & Coque, J. A. R. (2016). La intervención policial con sujetos confuso-agitados: El denominado “delirio agitado”. Cuadernos de la Guardia Civil: Revista de seguridad pública.
633. Ortiz-Gonzalez, X. R. (2024). A Child Has Had a Progressive Decline in School Performance Over the Last Few Months. How Should This Be Evaluated?. CRC Press eBooks. https://doi.org/10.1201/9781003523659-17
634. Oscar‐Berman, M., & Mosher, S. M. (2010). Brain Injuries. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0143
635. Ospina, B., & Vélez, J. L. O. (2019). Espectro clínico y tratamiento del trastorno cognoscitivo y demencia asociada a la enfermedad de Parkinson. Acta neurológica colombiana. https://doi.org/10.22379/24224022248
636. Ownsworth, T., & Oei, T. P. S. (1999). Depresión después de una lesión traumática del cerebro: consideraciones sobre el concepto y el tratamiento. RET: revista de toxicomanías.
637. Oxman, T. E. (2015). Personality Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370054.ds18
638. Ozand, P. T., & Alessa, M. (2012). 39 Lysosomal Storage Diseases.
639. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
640. O’Brien, B. S., & Sher, L. (2013). Military sexual trauma as a determinant in the development of mental and physical illness in male and female veterans. International Journal of Adolescent Medicine and Health. https://doi.org/10.1515/ijamh-2013-0061
641. O’Brien, M. D. (2017). The Neurological Examination: Aeromedical Considerations. CRC Press eBooks. https://doi.org/10.1201/9781315238166-9
642. Pablos, E. G., Andrés, R. M. S., Villalobos, J. A. L., Polonia, F. F. I. S., Villagrá, G. H., González‐Sanguino, C., & Lorenzo, C. (2019). Pacientes con esquizofrenia de edad avanzada: Deterioro cognitivo y factores relacionados. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
643. Pagonabarraga, J., Álamo, C., Castellanos, M., Díaz, S., & Manzano, S. (2023). Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders. Brain Sciences. https://doi.org/10.3390/brainsci13020318
644. Palaninathan, V., Balasubramanian, S., & Kumar, D. S. (2015). Molecular imaging and neurodegenerative disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199671618.003.0009
645. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
646. Palmer, S. C., Zwieten, A. V., Saglimbene, V., Ruospo, M., & Strippoli, G. F. (2022). Neurocognitive Disorders. https://doi.org/10.1002/9781119105954.ch75
647. Panza, F., Frisardi, V., Capurso, C., D’Introno, A., Colacicco, A. M., Seripa, D., Pilotto, A., Vendemiale, G., Capurso, A., & Solfrizzi, V. (2009). POSSIBLE PREDICTORS OF VASCULAR COGNITIVE IMPAIRMENT–NO DEMENTIA. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2009.02236.x
648. Papapetropoulos, S., & Mash, D. C. (2005). Visual Hallucinations in Progressive Supranuclear Palsy. European Neurology. https://doi.org/10.1159/000090713
649. Paradela, E. M. P. (2011). Depressão em idosos. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE). https://doi.org/10.12957/rhupe.2011.8850
650. Park, H. S., Joo, E. Y., & Hong, S. B. (2009). Sleep onset Insomnia. Journal of Korean Sleep Research Society. https://doi.org/10.13078/jksrs09015
651. Parker, G., & Manicavasagar, V. (2005). Acute stress-related non-melancholic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544194.014
652. Passantino, A., & Masucci, M. (2016). Congenital and inherited neurologic diseases in dogs and cats: Legislation and its effect on purchase in Italy. Veterinary World. https://doi.org/10.14202/vetworld.2016.437-443
653. Passweg, J., Lalive, P. H., & Küntzer, T. (2009). Neuropathy associated with monoclonal gammopathy (dysglobulinemia).
654. Patchner, L. S., & DeWeaver, K. L. (2013). Disability: Neurocognitive Disabilities. Encyclopedia of Social Work. https://doi.org/10.1093/acrefore/9780199975839.013.542
655. Patricia, G. C. C., AAngela, G.-M., & Marina, R.-A. (2017). Diagnostic and therapeutical challenges of late-onset psychosis.. Journal of Psychology and Cognition. https://doi.org/10.35841/psychology-cognition.2.4.218-220
656. Patten, S. B. (2015). Major depressive disorder: reification and (maybe) rheostasis. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796015000682
657. Paulig, M. (2005). Multiple Sklerose – Diagnose und Behandlung neuropsychologischer Störungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1630031
658. Paulig, M. (2006). Multiple Sklerose: Fatigue. Nervenheilkunde. https://doi.org/10.1055/s-0038-1626815
659. Pauling, L. (1968). Orthomolecular Psychiatry. Science. https://doi.org/10.1126/science.160.3825.265
660. Pavone, P., Corsello, G., Ruggieri, M., Marino, S., Marino, S. D., & Falsaperla, R. (2018). Benign and severe early-life seizures: a round in the first year of life. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/s13052-018-0491-z
661. Pawar, J. A., & Nere, N. P. (2015). Misdiagnosed schizophrenia be Megaloblastic.
662. Payne, J. L., Lyketsos, C. G., Steele, C., Baker, L., Galik, E., Kopunek, S., Steinberg, M. H., & Warren, A. (1998). Relationship of Cognitive and Functional Impairment to Depressive Features in Alzheimer's Disease and Other Dementias. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.10.4.440
663. Payne‐James, J., Perera, C., & Aggrawal, A. (2023). Neglect. CRC Press eBooks. https://doi.org/10.1201/9781003138754-54
664. Paz, T. D. S. R., Silva, A. E. L., Martins, N. I. M., Brito, V. L. S. D., Leite, M. A. A., & Corrêa, C. L. (2019). Congelamento da marcha e de membros superiores na doença de Parkinson. Revista Brasileira de Neurologia.
665. Penninx, B. W., & Dyck, R. V. (2001). Depression and Somatic Comorbidity. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/0004867010060522
666. Pereira, K. K., & Marinho, V. (2015). Uso de anticolinesterásicos na doença de Alzheimer. Debates em Psiquiatria. https://doi.org/10.25118/2236-918x-5-3-3
667. Pereira, S. V., Dias, C. A., Horta, M. M. B., & Amaral, C. F. S. (2005). DEPRESSÃO NA ADOLESCÊNCIA E O SUCESSO DEPRESSÃO NA ADOLESCÊNCIA E O SUCESSO DEPRESSÃO NA ADOLESCÊNCIA E O SUCESSO DEPRESSÃO NA ADOLESCÊNCIA E O SUCESSO DEPRESSÃO NA ADOLESCÊNCIA E O SUCESSO E INSUCESSO ESCOLAR E INSUCESSO ESCOLAR E INSUCESSO ESCOLAR E INSUCESSO ESCOLAR E INSUCESSO ESCOLAR.
668. Perington, M. R., Smith, C. A., & Schillerstrom, J. E. (2019). Decisional Capacity and Personality Disorders: Substantially Unable or Substantially Unwilling?. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.14219
669. Pervin, F., Edwards, C. Y., & Lippa, C. F. (2015). Dementia With Lew Body. American Journal of Alzheimer s Disease & Other Dementias®. https://doi.org/10.1177/1533317515581704
670. Peterson, H. W., & Martin, M. (1973). Organic Disease Presenting as a Psychiatric Syndrome. Postgraduate Medicine. https://doi.org/10.1080/00325481.1973.11713534
671. Petraşcu, C. M., Coman, H., Voichiţa, M. D., & Manea, M. M. (2020). Severe depression after silent stroke. Psihiatru ro. https://doi.org/10.26416/psih.62.3.2020.3879
672. Petz, L. D. (1977). Neurological manifestations of systemic lupus erythematosus and thrombotic thrombocytopenic purpura... Stroke. https://doi.org/10.1161/01.str.8.6.719
673. Peyser, J. M. (2009). Experience in cognitive assessment in MS relevant to developing a simple rating system. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1984.tb02547.x
674. Pham‐Scottez, A. (2016). [Medical complications of anorexia nervosa].. PubMed.
675. Phillipou, A., Rossell, S. L., & Castle, D. (2018). Anorexia nervosa or starvation?. European Journal of Neuroscience. https://doi.org/10.1111/ejn.14158
676. Piendl, T. A. (2015). Auswirkungen von depressiven Störungen auf die kognitive Leistungsfähigkeit und die Fahrkompetenz.
677. Pigeon, W. R., & Perlis, M. L. (2008). Sleep and Psychiatric Illness. CRC Press eBooks. https://doi.org/10.3109/9781420058697-7
678. Pincus, J. H., & Tucker, G. (2002). Disorders of Cognitive Function. Behavioral Neurology. https://doi.org/10.1093/oso/9780195137811.003.0004
679. Pitchot, W., & Ansseau, M. (1995). [Clinical case of the month. Major depression in a diabetic patient].. PubMed.
680. Pitel, A.-L. (2007). Les troubles cognitifs dans l'alcoolisme chronique avec et sans syndrome de Korsakoff : analyse neuropsychologique et remédiation cognitive.
681. Pj, O. (1998). [Cognitive manifestations of Alzheimer's disease].. PubMed.
682. Plecko, B. (2021). Abklärung der akuten Bewusstseinsstörung bei Säuglingen, Kindern und Jugendlichen. Monatsschrift Kinderheilkunde. https://doi.org/10.1007/s00112-020-01097-2
683. Plotkin, K. E. (2004). Insomnia Caused by Medical and Neurological Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_10
684. Poewe, W., & Jankovic, J. (2014). Preface. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175845.001
685. Poley, E. B., Barrionuevo, A. C. R., & Vives, M. A. R. (1998). Enfoque diagnóstico del niño con epilepsia y deterioro neuropsicológico. Revista de Neurología. https://doi.org/10.33588/rn.26150.981073
686. Policarpo, A. C. D. F., Garcia, A. P. V., & Faustino, L. (2017). SÍNDROME NEUROLÉPTICA MALIGNA: relato de caso. Percurso Acadêmico. https://doi.org/10.5752/p.2236-0603.2017v7n13p125
687. Poole, R., & Higgo, R. (2006). Cognitive state assessment and organic disease. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544224.006
688. PORANKI, V. (2021). A CASE STUDY ON POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME WITH ECLAMPSIA. Asian Journal of Pharmaceutical and Clinical Research. https://doi.org/10.22159/ajpcr.2021.v14i1.39920
689. Poskitt, E., & Chiumello, G. (2002). Prader–Willi and other syndromes. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544675.011
690. Possin, K. L., & Kaufer, D. (2010). Parkinsonian Dementias. CONTINUUM Lifelong Learning in Neurology. https://doi.org/10.1212/01.con.0000368212.86835.a8
691. Poujois, A., Perret‐Liaudet, A., & Thomas-Antérion, C. (2010). Le piège de la maladie d'Alzheimer à présentation dysexécutive. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2010.0071
692. Poujois, A., Perret‐Liaudet, A., & Thomas-Antérion, C. (2010). Le piège de la maladie d'Alzheimer à présentation dysexécutive. Revue de neuropsychologie. https://doi.org/10.3917/rne.025.0028
693. Pourcher, E., Baruch, P., Bouchard, R. H., Filteau, M., & Bergeron, D. (1995). Neuroleptic Associated Tardive Dyskinesias in Young People with Psychoses. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.166.6.768
694. Powlishta, K. K., Storandt, M., Mandernach, T., Hogan, E., Grant, E., & Morris, J. C. (2004). Absence of Effect of Depression on Cognitive Performance in Early-Stage Alzheimer Disease. Archives of Neurology. https://doi.org/10.1001/archneur.61.8.1265
695. Pradeep, V. A. J. (2013). Study on Neurological Soft Signs in patients with ObsessiveCompulsive Disorder..
696. Pratibha, S. (2010). Etiology of Late Onset Seizures.
697. Praško, J., Doubek, P., Divéky, T., Grambal, A., Grambalová, Z., Herman, E., Hovorka, J., Kamarádová, D., Kovaczová, A., Látalová, K., & Šilhán, P. (2010). Úzkostné poruchy v neurologii. Neurologie pro praxi.
698. Presečki, P., & Mimica, N. (2007). Involuntary emotional expression disorder - new/old disease in psychiatry and neurology.. PubMed.
699. Presečki, P., Filipčić, I., Arbanas, G., & Mimica, N. (2014). Neurocognitive disorders in DSM-5.
700. Preuss, U. W., Siafarikas, N., Petrucci, M., & Wong, W. S. (2009). Depressive Störungen bei Demenzen und milder kognitiver Beeinträchtigung: Komorbidität, Ursache oder Risikofaktor?. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0028-1109454
701. Price, C. C., McCraney, S. E., Wiggins, M. E., Alonso, C. H., Dion, C., Arias, F., Hamlet, K., & Tighe, P. (2023). Perioperative Cognitive Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781108936941.034
702. Prigatano, G. P., Hendin, B., & Heiserman, J. E. (2014). Denial or unawareness of cognitive deficit associated with multiple sclerosis? A case report. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803395.2014.890700
703. Provini, F., Lombardi, C., & Lugaresi, E. (2005). Insomnia in Neurological Diseases. Seminars in Neurology. https://doi.org/10.1055/s-2005-867074
704. Prudenzano, M. P., Puca, F. M., Savarese, M., Genco, S., & Specchio, L. M. (1997). Stress, mood disorders and memory in headache.. PubMed.
705. Prvčić, I., Zec, M. R., & Barišić, I. (2008). Psychological aspects of learning disabilities. Paediatria Croatica. https://doi.org/10.13112/pc.925
706. Punjabi, N. M., & Haponik, E. E. (2000). Ask About Daytime Sleepiness!. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2000.tb03918.x
707. Płytycz, B., & Seljelid, R. (2002). Stress and immunity: minireview.. PubMed.
708. Quarrell, O., & Nance, M. (2009). The diagnostic challenge. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199236121.003.0009
709. Queißert, F., & Brücher, B. (2023). Neurology meets Urology. Deleted Journal. https://doi.org/10.1007/s00120-023-02168-4
710. Quijano‐Roy, S., & Banda, M. G. D. L. (2018). Distrofias musculares congénitas. Revista Médica Clínica Las Condes. https://doi.org/10.1016/j.rmclc.2018.08.002
711. Rabins, P. V., & Slavney, P. R. (2008). Overview of Psychiatric Symptoms and Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195309430.003.0008
712. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve Mild cognitive impairment.
713. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v94i3p162-168
714. Radecki, D. Z., & Gow, A. (2013). Oligodendrocyte Metabolic Stress in Neurodegeneration. Neurodegenerative Diseases. https://doi.org/10.5772/54461
715. Radermecker, R. (2023). [The placebo effect in functional disorders].. PubMed.
716. Rahman, S., Footitt, E., Varadkar, S., & Clayton, P. T. (2012). Inborn errors of metabolism causing epilepsy. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2012.04406.x
717. Raju, V. R. (2023). Awareness of medical issues in health sciences and in scientific technological education. IP Journal of Nutrition Metabolism and Health Science. https://doi.org/10.18231/j.ijnmhs.2023.018
718. Rana, A. Q., Ghouse, A. T., & Govindarajan, R. (2016). Sensory Peripheral Neuropathy. In clinical practice. https://doi.org/10.1007/978-3-319-39342-1_8
719. Ratnawati, R. (2021). DEMENSIA SEBAGAI GANGGUAN BERPIKIR PADA GANGGUAN BERBAHASA. Jaladri Jurnal Ilmiah Program Studi Bahasa Sunda. https://doi.org/10.33222/jaladri.v7i1.720
720. Reading, P., & Overeem, S. (2018). The Sleep History. https://doi.org/10.1002/9781118777251.ch1
721. Rebolleda, J. G. (2013). Estudio de los síntomas somáticos asociados a los trastornos depresivos y de ansiedad en una población de atención primaria.
722. Reich, S. G. (2006). Psychogenic Disorders. Seminars in Neurology. https://doi.org/10.1055/s-2006-945514
723. Reichard, J., & Zimmer‐Bensch, G. (2021). The Epigenome in Neurodevelopmental Disorders. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2021.776809
724. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
725. Renaud, D. L. (2004). Leber’s hereditary optic neuropathy. https://doi.org/10.1093/oso/9780195177442.003.0042
726. Rengel, K. F., Hayhurst, C. J., Pandharipande, P. P., & Hughes, C. G. (2019). Long-term Cognitive and Functional Impairments After Critical Illness. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000004066
727. Renjen, P. N., Priyal, P., Chaudhari, D., Mishra, A., Sahu, N., & Bhatnagar, A. (2023). STRATEGIC INFARCT AND COGNITIVE IMPAIRMENT: A NARRATIVE REVIEW. International Journal of Scientific Research. https://doi.org/10.36106/ijsr/8215795
728. Reuber, M., Schachter, S. C., Elger, C. E., & Altrup, U. (2009). Conditions Associated With Epilepsy. https://doi.org/10.1093/oso/9780195379532.003.0005
729. Reynolds, C. F., Alexopoulos, G. S., & Katz, I. R. (2002). Geriatric Depression: Diagnosis and Treatment. Generations.
730. Ribeiro, M., Niedermeyer, E., & Hertz, S. (1999). Mixed-Type Encephalopathies: Preliminary Considerations. Clinical Electroencephalography. https://doi.org/10.1177/155005949903000107
731. RIED, L. M. (2018). RELAÇÃO ENTRE A DEPRESSÃO E A DEMÊNCIA DO TIPO ALZHEIMER. https://doi.org/10.17771/pucrio.acad.36288
732. Riederer, P., & Gerlach, M. (1993). The Pathophysiological Basis of Parkinson’s Disease. Milestones in drug therapy. https://doi.org/10.1007/978-3-0348-6348-3_2
733. Riemann, D., Zerssen, D. V., Berger, M., Dose, M., Doerr, P., Krieg, C. J., Bossert, S., Pirke, K. M., Dolhofer, R., & Müller, O. A. (1986). The nature of neuroendocrine abnormalities in depression: a controversial issue in contemporary psychiatry.. PubMed.
734. Rigaud, J., Lheureux, P., & Sauder, P. (2006). Prise en charge symptomatique : neurologique, respiratoire, hémodynamique et hépatique des intoxications graves par médicaments et substances illicites. Réanimation. https://doi.org/10.1016/j.reaurg.2006.08.002
735. Riggio, S., Filipovic‐Jewell, Z., & Thakur, D. S. (2016). Neuropsychiatric Illnesses. https://doi.org/10.1002/9781118654231.ch19
736. Rinn, W. E. (1988). Mental Decline in Normal Aging: A Review. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198878800100304
737. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
738. Robinson, R. G. (2006). Biological markers. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544231.021
739. Rocha, E. L. D. (2019). O OLHAR DAS DIFICULDADES DE APRENDIZAGEM DECORRENTES DA ASFIXIA PERINATAL POR MEIO DA NEUROPSICOLOGIA HISTÓRICO CULTURAL. Estudos IAT.
740. Rockwood, K. (2012). Is the development of late-life cognitive impairment more dynamic than sexy?. Neurology. https://doi.org/10.1212/wnl.0b013e3182455724
741. Rodríguez, A. V. A. (2021). Síndrome dis-ejecutivo: perfil neuropsicológico e intervención neuropsicológica..
742. Rodríguez, M. J. M., Barceló, J. S., Millares, M. V., Alfonso, A. P., Guzmán, P. D. U., Barbazán, C. A., & Mahía, M. D. C. G. (2013). Es la edad de inicio del trastorno bipolar un buen marcador de dos entidades distintas. Revista gallega de psiquiatría y neurociencias.
743. Rodríguez, M., & Francisco, J. (2012). Perfil neuropsicológico, neurofisiológico y emocional de pacientes con acromegalia en diferentes estados de la enfermedad.
744. Roelcke, U. (2001). Pathophysiology of fatigue in multiple sclerosis. CRC Press eBooks. https://doi.org/10.3109/9780203212974-27
745. Rogers, N. L., & Kloss, J. D. (2004). Medical Conditions and Diseases. CRC Press eBooks. https://doi.org/10.3109/9780203998007-6
746. Rolak, L. A., & Fleming, J. O. (2007). The Differential Diagnosis of Multiple Sclerosis. The Neurologist. https://doi.org/10.1097/01.nrl.0000254705.39956.34
747. Rollnik, J. D., & Adner, A. (2020). Neuropsychologische Langzeitfolgen und Teilhabestörungen nach aneurysmatischer Subarachnoidalblutung (aSAB). Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/a-1003-6756
748. Romero-Luna, G., Mejía‐Pérez, S. I., Ramírez-Cruz, J., Aguilar-Hidalgo, K. M., Ocampo-Díaz, K. M., Moscardini-Martelli, J., Ramírez-Stubbe, V., & Santellán-Hernández, J. O. (2022). Schizophrenia-Like Psychosis Presented in a Patient With a Temporal Lobe Tumor: A Case Report. Cureus. https://doi.org/10.7759/cureus.29034
749. Ron, M. A. (2001). Explaining the unexplained: understanding hysteria. Brain. https://doi.org/10.1093/brain/124.6.1065
750. Rosier, V. (2008). P3‐174: Mild cognitive impairment: A new hope. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2008.05.1740
751. Rovai, D., Giannessi, D., Andreassi, M. G., Gentili, C., Pingitore, A., Glauber, M., & Gemignani, A. (2014). Mind injuries after cardiac surgery. Journal of Cardiovascular Medicine. https://doi.org/10.2459/jcm.0000000000000133
752. Rozzini, L., Chilovi, B. V., Conti, M. Z., Delrio, I., Borroni, B., Trabucchi, M., & Padovani, A. (2007). Neuropsychiatric Symptoms in Amnestic and Nonamnestic Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000111133
753. Rubin, J. N. (2020). HEALTH EFFECTS OF COASTAL DISASTERS AFTER THE WATER RECEDES. Abstracts with programs - Geological Society of America. https://doi.org/10.1130/abs/2020am-350916
754. Rubio, S. V. (2019). Funcionamiento neurocognitivo y psicosocial de pacientes con trastorno bipolar en una unidad de salud mental.
755. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
756. Ruff, R. M., Silver, C., Iverson, G. L., BARTH, J., BROSHEK, D., Bush, S. B., Koffler, S. P., & Reynolds, C. W. (2007). Learning disabilities: The need for neuropsychological evaluation. Archives of Clinical Neuropsychology. https://doi.org/10.1016/j.acn.2007.09.006
757. Ruggieri, V., & Arberas, C. (2013). Fenómenos paroxísticos no epilépticos motores en vigilia en la infancia. Revista de Neurología. https://doi.org/10.33588/rn.57s01.2013206
758. Ruiter, M. B. D., Elzinga, B. M., & Phaf, R. H. (2006). Dissociation: Cognitive Capacity or Dysfunction?. Journal of Trauma & Dissociation. https://doi.org/10.1300/j229v07n04_07
759. Ruscheweyh, R., Lehnen, N., & Henningsen, P. (2024). Migräne und psychosomatische Komorbiditäten. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/a-2331-0840
760. Röhr, S., Villringer, A., Angermeyer, M., Luck, T., & Riedel‐Heller, S. G. (2017). Outcomes of stable and unstable reports of subjective cognitive decline – results from the Leipzig Longitudinal Study of the Aged (LEILA75+). Das Gesundheitswesen. https://doi.org/10.1055/s-0037-1605826
761. Rönnbäck, L., Persson, M., & Olsson, T. (2007). »Trött i hjärnan« osynligt handikapp som kan ge stora problem. Läkartidningen/Läkartidningen.
762. S.P., A. (2016). Neuropsychiatric Manifestations as the Presentation of Addison’s Disease Masquerading the Illness. Journal of Medical Science And clinical Research. https://doi.org/10.18535/jmscr/v4i2.13
763. Sa, H. (2013). Diabetes Mellitus And The Brain: Special Emphasis To Cognitive Function. International Journal of Diabetology & Vascular Disease Research. https://doi.org/10.19070/2328-353x-130007
764. Saadat-Gilani, K. (2005). Bedeutung opioiderger Signalwege für die Modulation viszeraler Afferenzen bei funktionellen Magendarmerkrankungen.
765. Sabol, M. (2017). Procjena aktivnosti svakodnevnog života osoba s cerebralnom paralizom.
766. Sachdev, P. S. (2013). Posttraumatic Psychosis. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da09
767. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
768. Sagar, V. V. S. S., Ghule, A., Talwar, D., Kumar, S., & Acharya, S. (2021). Heavy Metal Encephalopathy Masquerading as Hepatic Encephalopathy – A Case Report. Journal of Evolution of Medical and Dental Sciences. https://doi.org/10.14260/jemds/2021/232
769. Saguil, A. (2005). Evaluation of the patient with muscle weakness.. PubMed.
770. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
771. Saksvik, S. B., Smevik, H., Stenberg, J., Follestad, T., Vik, A., Håberg, A. K., Asarnow, R. F., Kallestad, H., Skandsen, T., & Olsen, A. (2021). Poor sleep quality is associated with greater negative consequences for cognitive control function and psychological health after mild traumatic brain injury than after orthopedic injury.. Neuropsychology. https://doi.org/10.1037/neu0000751
772. Salavati, A. (2016). Assessing gross motor function, functional skills, and caregiver assistance in children with cerebral palsy (CP) and cerebral visual impairment (CVI).
773. Saletu‐Zyhlarz, G., Anderer, P., & Saletu, B. (2013). [Sleep disorders in psychiatry and their treatment].. PubMed.
774. Samudra, N., Fischer, D. L., Lenio, S., Lago, A. L., Ljubenkov, P. A., Rojas, J. C., Seeley, W. W., Spina, S., Staffaroni, A. M., Tablante, J., Wekselman, F., Lamoureux, J., Concha‐Marambio, L., Grinberg, L. T., Boxer, A. L., & VandeVrede, L. (2024). Clinicopathological correlation of cerebrospinal fluid alpha‐synuclein seed amplification assay in a behavioral neurology autopsy cohort. Alzheimer s & Dementia. https://doi.org/10.1002/alz.13799
775. Sand, T., & Schrader, H. (2009). Narkolepsi og andre hypersomnier. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.08.0655
776. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
777. Santeusanio, F. (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
778. Santos, R. S., Camargo, C. H. F., Abdulmassih, E. M. D. S., & Teive, H. A. G. (2015). Dysphagia in Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/60983
779. Sanz, L., Laureys, S., & Gosseries, O. (2018). Les états de conscience altérée : études comportementales et de neuro-imagerie. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2018.0481
780. Sarõ, A. (2005). Of Illusions, Hallucinations and Creutzfeldt-Jakob Disease (Heidenhain's Variant).
781. Savage, G. (2010). Neuropsychological assessment of dementia. CRC Press eBooks. https://doi.org/10.1201/b13196-20
782. Saviluoto, A., Stępień, K. M., Das‐Munshi, J., Cook, A. M., Ocak, U., & Barnacle, J. (2020). Advances in Respiratory Emergencies in Neurological Diseases.
783. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
784. Schaffer, C. B., & Donlon, P. T. (1983). Medical Causes of Psychiatric Symptoms in the Elderly. Clinical Gerontologist. https://doi.org/10.1300/j018v01n04_02
785. Scheau, C., Popa, G. A., Ghergus, A. E., Preda, E. M., Capsa, R. A., & Lupescu, I. G. (2013). Persistent repeated measurements by magnetic resonance spectroscopy demonstrate minimal hepatic encephalopathy: a case report.. PubMed.
786. Schildkrout, B. (2011). Characteristics That Make Somatic Diseases Difficult to Detect. https://doi.org/10.1002/9781118083598.ch3
787. Schildkrout, B. (2011). Specific Physical Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch7
788. Schindler, D., Bishop, D. F., Wolfe, D., Wang, A. M., Egge, H., Lemieux, R. U., & Desnick, R. J. (1989). Neuroaxonal Dystrophy Due to Lysosomal α-N-Acetylgalactosaminidase Deficiency. New England Journal of Medicine. https://doi.org/10.1056/nejm198906293202606
789. Schlotawa, L., Adang, L., Castro, M. D., & Ahrens‐Nicklas, R. C. (2019). Multiple Sulfatase Deficiency.
790. Schmidt, M. H., Dekkers, M., Baillieul, S., Jendoubi, J., Wulf, M.-A., Wenz, E., Fregolente, L., Vorster, A., Gnarra, O., & Bassetti, C. L. (2021). Measuring Sleep, Wakefulness, and Circadian Functions in Neurologic Disorders. Sleep Medicine Clinics. https://doi.org/10.1016/j.jsmc.2021.08.005
791. Schmidt, R. E. (2014). Diabetic neuropathies. https://doi.org/10.1002/9781118618424.ch28
792. Schneider, L. S., & Abou‐Saleh, U. B. M. T. (2002). Neurochemistry. https://doi.org/10.1002/0470846410.ch72
793. Schott, J. M. (2020). Alzheimer’s disease and other dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0574
794. Schredl, M., Schramm, F., Valli, K., Mueller, E. M., & Sandman, N. (2020). Nightmare Distress Questionnaire: associated factors. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.8824
795. Schroeder, R. W., Martin, P. K., & Walling, A. (2019). Neuropsychological Evaluations in Adults.. PubMed.
796. Schuler, M. (2005). Schmerzerkennung und Schmerzmessung bei Menschen mit Demenz. Aktuelle Neurologie. https://doi.org/10.1055/s-2005-919286
797. Schulz, J. B., Benecke, R., Dodel, R., Eggert, K., Fogel, W., Gerlach, M., Reichmann, H., Riederer, P., Schwartz, A., & Winkler, J. (2005). Strukturierte Diagnostik bei Parkinson-Syndromen. Aktuelle Neurologie. Sup./Aktuelle Neurologie. Supplement. https://doi.org/10.1055/s-2005-866880
798. Schwartz, M. (2019). Neurological Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862374.003.0021
799. Scott, D. A., Evered, L., & Silbert, B. (2014). Cardiac Surgery, the Brain, and Inflammation. Journal of ExtraCorporeal Technology. https://doi.org/10.1051/ject/201446015
800. Senzaki, A. (2018). Physical Activity/Exercise Therapy for Neuropsychological Dysfunction after Brain Injuries. The Japanese Journal of Rehabilitation Medicine. https://doi.org/10.2490/jjrmc.55.198
801. Seo, S. H., Lee, T.-J., Suh, Y., Shin, K. J., & Kim, B. J. (2005). Amyotrophic Lateral Sclerosis Combined with Abnormal Sensory Nerve Conduction.
802. Sepúlveda, A. D. (2007). DETERIORO Y DEMENCIA. Orientación para médicos no especialistas.. DOAJ (DOAJ: Directory of Open Access Journals).
803. Series, H., & Esiri, M. M. (2012). Vascular dementia: a pragmatic review. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.bp.110.008888
804. Setiawan, M. (2015). Komplikasi Neurologis Endokarditis Infektif. Cermin Dunia Kedokteran.
805. Settas, L., & Theodoridou, A. (2006). Demyelination in rheumatic diseases. Postgraduate Medical Journal. https://doi.org/10.1136/jnnp.2005.075861
806. Setyaningrum, D. A. W. (2019). Cedera olahraga serta penyakit terkait olahraga. Jurnal Biomedika dan Kesehatan. https://doi.org/10.18051/jbiomedkes.2019.v2.39-44
807. Shababi, M., Lorson, C. L., & Rudnik‐Schöneborn, S. (2013). Spinal muscular atrophy: a motor neuron disorder or a multi‐organ disease?. Journal of Anatomy. https://doi.org/10.1111/joa.12083
808. Shad, M. U., Keshavan, M. S., Tamminga, C. A., Cullum, C. M., & David, A. S. (2007). Neurobiological underpinnings of insight deficits in schizophrenia. International Review of Psychiatry. https://doi.org/10.1080/09540260701486324
809. Shaffer, D. (1973). Psychiatric Aspects of Brain Injury in Childhood: A Review. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.1973.tb15165.x
810. Shah, L. M., & Ross, J. S. (2016). Imaging of Degenerative and Infectious Conditions of the Spine. Neurosurgery. https://doi.org/10.1227/neu.0000000000001323
811. Shail, M. S. (2017). Neuropsychiatry in Demyelination Disease: Using Depression as a Prodrome for Early Diagnosis and Treatment of Multiple Sclerosis. Cureus. https://doi.org/10.7759/cureus.1813
812. Sharma, N., & Kolekar, H. M. (2017). Diagnosis of Vascular Cognitive Impairment Using EEG. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2017.00454.5
813. Shaygan, M. (2014). Chronic Pain with Neuropathic Characteristic.
814. Shaygan, M. (2014). Chronic Pain with Neuropathic Characteristic. https://doi.org/10.53846/goediss-4540
815. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
816. Shekhar, S., Harisingani, A., & Gupta, N. (2022). Abdominal Pain Followed by Altered Mental Status: A Rare Presentation of Guillain Barré Syndrome. Cureus. https://doi.org/10.7759/cureus.27550
817. Shelton, A. R., Duis, J., & Malow, B. A. (2020). Neurodevelopmental Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190929671.003.0023
818. Shevell, M. (2010). Classifying cerebral palsy subtypes. Future Neurology. https://doi.org/10.2217/fnl.10.46
819. Shi, S., Picon, E. L., Rioux, M., Panenka, W. J., & Silverberg, N. D. (2023). Catastrophizing is associated with excess cognitive symptom reporting after mild traumatic brain injury.. Neuropsychology. https://doi.org/10.1037/neu0000930
820. Shibasaki, H., & Hallett, M. (2022). Mental and cognitive functions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197556306.003.0023
821. Shibasaki, H., & Hallett, M. (2022). Sleep disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197556306.003.0027
822. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Disorders of Increased Muscle Stiffness or Overactivity. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0009
823. Shin, J. E., Park, K. S., & Nam, K. (2019). Chronic Functional Constipation. Korean Journal of Gastroenterology. https://doi.org/10.4166/kjg.2019.73.2.92
824. Shortland, P., & Mahns, D. A. (2016). Differing roles for parvalbumin neurons after nerve injury. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.189179
825. Shrivastava, D. (2022). Pharmacological Agents Used in Various Sleep Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003093381-28
826. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
827. Silva, N. D., Singhapathirana, S., & Silva, C. E. D. (2019). Miller Fisher Syndrome presenting as unilateral abducens nerve palsy: A case report. Research Square (Research Square). https://doi.org/10.21203/rs.2.9144/v1
828. Silva, R. D. A. D., Mograbi, D. C., Landeira‐Fernandez, J., & Cheniaux, E. (2014). O insight no transtorno bipolar: uma revisão sistemática. Jornal Brasileiro de Psiquiatria. https://doi.org/10.1590/0047-2085000000032
829. Simor, P., Demeter, G., Dobó, Z., Lázár, A. S., Csigó, K., Racsmány, M., & Harsányi, A. (2015). A kronotípus és az alvásminõség szerepe a mentálismegbetegedések tünettanában és prognózisában.
830. Sinanović, O. (2012). Psychiatric disorders in neurology.. PubMed.
831. Sinclair, L. I., Ballard, C., & Bennett, D. A. (2023). Differential gene expression analysis in individuals with depression in Alzheimer’s disease using RNAseq. Alzheimer s & Dementia. https://doi.org/10.1002/alz.078153
832. Sinclair, L. I., Mohr, A., Morisaki, M., Edmondson, M., Chan, S., Bone‐Connaughton, A., Turecki, G., & Love, S. (2023). Is later-life depression a risk factor for Alzheimer’s disease or a prodromal symptom: a study using post-mortem human brain tissue?. Alzheimer s Research & Therapy. https://doi.org/10.1186/s13195-023-01299-2
833. Singh, A., & Dubey, A. P. (2015). Role of Social Support as a Mediator in Negative Stressful Life Event and Somatic Complaints of Managerial Personnel. Indian Journal of Positive Psychology.
834. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
835. Sisalema, U., & Verónica, C. (2017). Análisis de esclerosis múltiple mas Ptosis Palpebral enfocado con la atención de enfermería.
836. Smail, R. C., & Ng, K. (2022). Cautious optimism for the future of migraine treatment. Internal Medicine Journal. https://doi.org/10.1111/imj.15844
837. Small, G. A., & Chuirazzi, D. M. (2003). Weakness. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547256.008
838. Smith, J., & Seirafi, J. (2013). Delirium and Dementia.
839. Smith, M. (2005). Mental Retardation Associated with Dysmorphology, Growth Retardation, or Overgrowth. https://doi.org/10.1093/oso/9780195174328.003.0004
840. Smith, M. E. (2005). Mental Retardation Associated with Other Neurological Defects. https://doi.org/10.1093/oso/9780195174328.003.0005
841. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
842. Smith, S. S. (2019). Insomnia and Clinical Sleep Disturbance in Later Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.419
843. Smyth, D. (2005). Journal scan. Cancer Nursing Practice. https://doi.org/10.7748/cnp.4.5.10.s8
844. Soares, H. L. R., Costa, R. A., & Mesquita, E. T. (2006). Depressão e as doenças cardiovasculares. Revista do Departamento de Psicologia UFF. https://doi.org/10.1590/s0104-80232006000200016
845. Sohail, Z., & Macaluso, M. (2015). Fatigue after Depression Responds to Therapy: What Are the Next Steps? A Sufficient Base of Evidence Is Often Lacking to Guide Pharmacotherapy for Fatigue. Current psychiatry.
846. Sohn, C., & Jeong, D. (1996). Childhood Hypersomnia and Sleep Apnea Syndrome. Sleep Medicine and Psychophysiology.
847. Sohn, E. H., & Kim, B. J. (2021). Clinical Scale for Neuropathic Pain. Journal of the Korean Neurological Association. https://doi.org/10.17340/jkna.2021.2.18
848. Sokolowski, K., Liu, J., Delatte, M. S., Authier, S., McMaster, O., & Bolon, B. (2024). The Role of Neuropathology Evaluation in the Nonclinical Assessment of Seizure Liability. Toxicologic Pathology. https://doi.org/10.1177/01926233241300065
849. Solmi, M., Bortolato, B., Veronese, N., Stubbs, B., Herrmann, N., & Carvalho, A. F. (2019). Pharmacological Interventions for Cognitive Dysfunction in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0018
850. Solorzano, J. M. M., Quijije, J. K. L., Pin, T. D. R. M., & Vera, J. V. C. (2020). Causas y efectos de los pacientes diagnosticados con el mal de Parkinson. RECIMUNDO. https://doi.org/10.26820/recimundo/4.(4).octubre.2020.496-508
851. Sommer, C., Cruccu, G., Anand, P., Attal, N., Baron, R., Garcı́a-Larrea, L., Haanpää, M., Jensen, T. S., Serra, J., & Treede, R. (2010). Assessment of Neuropathic Pain. https://doi.org/10.1002/9781444328394.ch8
852. Sonika, S., & Agarwal, K. (2024). An Analytical Study of Impacts of Naad Yoga Therapy in Patients of Insomnia, Stress, Memory and Overall Brain Health. International Journal For Multidisciplinary Research. https://doi.org/10.36948/ijfmr.2024.v06i02.15550
853. Souza, L. C. D., Sarazin, M., Goetz, C., & Dubois, B. (2009). Clinical Investigations in Primary Care. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. https://doi.org/10.1159/000197897
854. Soyka, M. (2005). Alkoholabhängigkeit – Neuropsychiatrische Komplikationen. Suchttherapie. https://doi.org/10.1055/s-2005-923723
855. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
856. Spetruk, P., & Opala, G. (2005). Wieloaspektowy charakter depresji występującej po udarze mózgu. Udar Mózgu.
857. Srivastava, G., & Tripathi, R. K. (2018). Sleep and Sleep Disorders in Old Age. Advances in medical diagnosis, treatment, and care (AMDTC) book series. https://doi.org/10.4018/978-1-5225-3480-8.ch017
858. Stafstrom, C. E., Moshé, S. L., Swann, J. W., Nehlig, A., Jacobs, M., & Schwartzkroin, P. A. (2006). Models of Pediatric Epilepsies: Strategies and Opportunities. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00674_1.x
859. Stahl, S. M. (2002). Can Psychopharmacologic Treatments That Relieve Symptoms Also Prevent Disease Progression?. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v63n1101
860. Stahl, S. M., & Morrissette, D. A. (2018). Introduction. https://doi.org/10.1017/9781107706842.003
861. Stefano, G. B., Esch, T., Fricchione, G. L., & Benson, H. (2002). The role of stress in neurodegenerative diseases and mental disorders.. PubMed.
862. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
863. Steinhausen, H., & Gillberg, C. (2006). Brain disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543807.002
864. Stella, F., Radanovic, M., Balthazar, M. L. F., Canineu, P. R., Souza, L. C. D., & Forlenza, O. V. (2014). Neuropsychiatric symptoms in the prodromal stages of dementia. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000050
865. Sterkers, O., & Bouccara, D. (2009). Hearing loss among handicapped persons. La Revue du praticien.
866. Stewart, J. T. (2006). The frontal/subcortical dementias: common dementing illnesses associated with prominent and disturbing behavioral changes.. PubMed.
867. Stone, J., & Sharpe, M. (2020). Functional neurological symptom disorder (conversion disorder). Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0133
868. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
869. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
870. Strippoli, G. F., Montinaro, V., Manno, C. S., Palma, M., Lepore, V., Schena, F., & Pertosa, G. B. (2002). [Chorea in hemodialysis: Is chorea just a neurological syndrome or is it related to uremia or dialysis?].. PubMed.
871. Struck, M. (2000). Krankheitskonzepte bei Schlafstörungen. Deutscher Universitätsverlag eBooks. https://doi.org/10.1007/978-3-322-85178-9_7
872. Stuchlı́k, A., Petrásek, T., Hatalov, H., Rambousek, L., Nekovářová, T., & Valeš, K. (2012). Behavioral Tests for Evaluation of Information Processing and Cognitive Deficits in Rodent Animal Models of Neuropsychiatric Disorders. InTech eBooks. https://doi.org/10.5772/37844
873. Subramanian, P., & Palanisamy, V. (2023). Neurocognitive Disorder. Pondicherry Journal of Nursing. https://doi.org/10.5005/jp-journals-10084-13167
874. Sugiyama, A., & Kuwabara, S. (2019). [Neuropsychiatric Systemic Lupus Erythematosus: From the Standpoint of Department of Neurology].. PubMed. https://doi.org/10.11477/mf.1416201298
875. Suh, B. C. (2021). Etiology and epidemiology of neuropathic pain. Journal of Korean Medical Association. https://doi.org/10.5124/jkma.2021.64.7.461
876. Sun, F., Liu, J., Chen, F., Zhu, J., Gao, Z., Ren, Z., Ying, S., Chen, Z., Yongchun, M., Wang, Z., & Jin, W. (2019). Differences in Neurobiology of Different Syndrome of Melancholia in the Viewpoint of TCM. NeuroQuantology. https://doi.org/10.14704/nq.2019.17.5.2369
877. Sunarti, S., & Helena, H. (2018). Gangguan Tidur pada Lanjut Usia. Journal of Islamic Medicine. https://doi.org/10.18860/jim.v2i1.5009
878. Suzuki, S. (2024). [Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events].. PubMed. https://doi.org/10.11477/mf.1416202650
879. Suárez-Escudero, J. C. (2014). Discapacidad y neurociencias: la magnitud del déficit neurológico y neuro psiquiátrico. Acta neurológica colombiana.
880. Szerman, N., Ferre, F., Basurte-Villamor, I., Vega, P., Mesías, B., Marín-Navarrete, R., & Arango, C. (2020). Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2020.589155
881. Szmulewicz, D. J., & Roberts, L. J. (2023). A patient with neuropathy and ataxia: what do I have to consider?. Current Opinion in Neurology. https://doi.org/10.1097/wco.0000000000001200
882. Szyguła‐Jurkiewicz, B., Szymik, M., Mrozowska, B., Schmidt, B., & Michalak, A. (2011). Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca. Leki psychotropowe u chorych po ostrym zawale serca. Choroby Serca i Naczyń.
883. Sánchez, V., & la, D. D. (2013). Análisis no lineal de registros magnetoencefalográficos de pacientes con Trastorno Obsesivo Compulsivo mediante la complejidad de Lempel-Ziv.
884. Sîrbu, C. A., Mezei, R.-M., Falup‐Pecurariu, C., Bratu, O. G., Sirbu, A., Ghinescu, M., & Ioniţă‐Radu, F. (2020). Autonomic dysfunctions in multiple sclerosis: Challenges of clinical practice (Review). Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2020.9326
885. SÖNMEZ, İ., MUT, S. E., & Bozkurt, A. İ. (2016). Psychiatric Symptoms and Disorders in Multiple Sclerosis: Review. Turkiye Klinikleri Journal of Neurology. https://doi.org/10.5336/neuro.2016-51118
886. Taboada, J. (2005). El diagnóstico por imagen en el niño con problemas neuropsicológicos. Parte 2. Plasticidad y Restauración Neurológica.
887. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
888. Taniguchi, S., & Takeda, A. (2015). I. New Insights into Symptoms in Parkinson's Disease Including Non Motor Featrures. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.104.1546
889. Tantri, N. K., & Anindita, G. K. (2024). Kecemasan Kesehatan Fisik Pada Lansia Very Old. Jurnal Pengabdian Masyarakat Darul Ulum. https://doi.org/10.32492/dimas-undar.v3i2.3201
890. Taskov, K., Kozhuharov, H., & Boncheva, I. (2015). The Stigma "Mental Illness". Varna Medical Forum. https://doi.org/10.14748/vmf.v4i2.1445
891. Tate, J., & Vinquist, K. (2018). Intellectual Disability. https://doi.org/10.2310/psych.13006
892. Tatulian, S. E., Vasiliev, S. V., Yavorskaya, V. V., & Zheltyakova, Z. A. (2005). The Influence of Somatoneurological Decompensations in the Course of Old-Age Depressive Disorders. International Journal of Mental Health. https://doi.org/10.2753/imh0020-7411340410
893. Taylor, P. J., Lindsay, W. R., O’Brien, G., & Taylor, J. L. (2013). Offenders with intellectual disabilities. Routledge eBooks. https://doi.org/10.1201/b15462-13
894. Tedeschi, G., Russo, A., & Tessitore, A. (2015). Functional neuroimaging: the adaptive mechanisms in migraine. The Journal of Headache and Pain. https://doi.org/10.1186/1129-2377-16-s1-a6
895. Terrazas, E. E., López, A. G., Hernando, M., & Barquero, M. J. G. (2011). "Depresión": Imprecisión diagnóstica y terapéutica. Importantes consecuencias en la práctica clínica. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352011000300005
896. Thaisetthawatkul, P., & Dyck, P. J. B. (2023). Asymmetric Diabetic Neuropathy: Radiculoplexus Neuropathies, Mononeuropathies, and Cranial Neuropathies. Contemporary diabetes. https://doi.org/10.1007/978-3-031-15613-7_10
897. Thakur, N., Black, M., Russo, S. N., & Koenig, M. K. (2022). Neurometabolic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0020
898. Thimm, A., & Bellon, M. (2011). The psychosocial effects of psychogenic non-epileptic seizures (PNES).
899. Thomas, N., & Pantelis, C. (2015). Psychotic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp535
900. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
901. Tierney, B. (2005). Fetal Alcohol Spectrum Disorder (FASD): Finding Information about Preventable Birth Defects. Indiana libraries.
902. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
903. Tonković, D., Adam, V. N., Kovačević, M., Bogović, T. Z., Drvar, Z., & Baronica, R. (2012). [Perioperative disorders of mental functions].. PubMed.
904. Torales, J., Malatesta, E. M., González, L. L., González, I., López, R. D. A., Barrios, J. I., García, O. E., O’Higgins, M., Castaldelli-Maia, J. M., & Ventriglio, A. (2020). Psychodermatology: An introduction to its concepts, nosology and approach models. Anales de la Facultad de Ciencias Médicas (Asunción). https://doi.org/10.18004/anales/2020.053.02.127
905. Torpy, J. M. (2008). Delirium. JAMA. https://doi.org/10.1001/jama.300.24.2936
906. Torpy, J. M. (2008). Mild Cognitive Impairment. JAMA. https://doi.org/10.1001/jama.300.13.1610
907. Torpy, J. M. (2009). Mild Cognitive Impairment. JAMA. https://doi.org/10.1001/jama.302.4.452
908. Torry, Z. D., & Weiss, K. J. (2012). Medication Noncompliance and Criminal Responsibility: Is the Insanity Defense Legitimate?. SSRN Electronic Journal.
909. Torry, Z. D., & Weiss, K. J. (2012). Medication Noncompliance and Criminal Responsibility: Is the Insanity Defense Legitimate?. The Journal of Psychiatry & Law. https://doi.org/10.1177/009318531204000208
910. Toy, E. C., & Klamen, D. L. (2006). Case Files Psychiatry.
911. Treviño, E. S. G. (1986). Aspectos neurobiológicos de los síndromes esquizofrénicos. Salud Mental.
912. Triki, C. (2015). Epilepsie chez les personnes avec déficience intellectuelle. African & Middle East Epilepsy Journal.
913. Tripathi, M., & Vibha, D. (2009). Reversible dementias.. PubMed.
914. Trojan, D. A., & Cashman, N. R. (2004). Post-poliomyelitis syndrome. Muscle & Nerve. https://doi.org/10.1002/mus.20259
915. Trojanowska, M. (2017). Społeczny i medyczny wymiar seksualności osób z niepełnosprawnością na przykładzie osób chorych na stwardnienie rozsiane. Acta Universitatis Lodziensis Folia Sociologica. https://doi.org/10.18778/0208-600x.60.08
916. Trojian, T. H., & Jow, V. (2009). Night Eating Syndrome Presenting as Anorexia in an Athlete. Current Sports Medicine Reports. https://doi.org/10.1249/jsr.0b013e3181ae53bb
917. Tsapakis, E. M., & Aitchison, K. J. (2008). Biological treatments: general considerations. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544125.026
918. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
919. Tsunoyama, K., Sakakibara, R., Yamaguchi, C., Uchiyama, T., Yamamoto, T., Yamanishi, T., Takahashi, O., Sugiyama, M., Kishi, M., & Ogawa, E. (2011). Pathogenesis of reduced or increased bladder sensation. Neurourology and Urodynamics. https://doi.org/10.1002/nau.20953
920. Tuchman, R., Moshé, S. L., & Rapin, I. (2005). Trastornos del neurodesarrollo y epilepsia. Revista de Neurología. https://doi.org/10.33588/rn.40s01.2004649
921. Tune, L. E. (1998). Depression and Alzheimer's disease. Depression and Anxiety. https://doi.org/10.1002/(sici)1520-6394(1998)8:1+<91::aid-da14>3.0.co;2-m
922. Tung, T. C., Humes, E. D. C., & Demétrio, F. N. (2005). Depressão e comorbidades clínicas. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832005000300007
923. Turkistani, O., Albalawi, A., Thabit, R. K., Alamri, H., Alshehri, N., Alsufyani, S., Qahtani, A. A., Mohammed, N., Althemairi, A., Ashour, L., & Alsuwilem, O. (2023). Relationship Between Sleep Disorders and Mental Health. Journal of Healthcare Sciences. https://doi.org/10.52533/johs.2023.30601
924. Uhlmann, C., Widmann, B., & Baier, H. (2011). Erfassung kognitiver Defizite bei Patienten mit Intelligenzminderung und Epilepsie. Aktuelle Neurologie. https://doi.org/10.1055/s-0030-1266064
925. Ukmar, M., Magnaldi, S., & Mucelli, R. P. (1995). Il ritardo mentale ad impronta evolutiva in età pediatrica: Aspetti RM. Rivista di Neuroradiologia. https://doi.org/10.1177/197140099500800105
926. Usui, K., Terada, K., & Inoue, Y. (2012). Diagnostic approach for studying epileptic seizure. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.52.857
927. Uzoni, A., Ciobanu, O., Sandu, E., Bugă, A. M., & Popa‐Wagner, A. (2015). Aging, inflammation and depressive behavior: a review. Reviews in Health Care. https://doi.org/10.7175/rhc.v6i2.1170
928. Uğurlu, G. K., Uğurlu, M., Kılıç, M., Apaydın, Z. K., & Çayköylü, A. (2020). Acute psychotic symptoms caused by overlapping central nervous system pathologies: a case report. European Journal of Medical Case Reports. https://doi.org/10.24911/ejmcr/173-1575624797
929. Valle, A. (2019). PHYSICAL ACTIVITY EFFECTS IN OLDER PEOPLE AT RISK WITH FRAGILITY SYNDROME.. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/8619
930. Variend, H., & Gopal, Y. V. (2008). Late-onset depression: issues affecting clinical care. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.bp.106.003400
931. Vasilyeva, Y. B. (2019). Clinical Features of Traumatic Brain Injury in Various Kinds of Brain Damage. Russian Sklifosovsky Journal Emergency Medical Care. https://doi.org/10.23934/2223-9022-2019-8-3-295-301
932. Vasquez-Baiocchi, M. A. J., & Burneo, J. G. (2021). Epilepsias mioclónicas progresivas. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v83i4.3891
933. Vaz, D. P., Lança, S. M., Scharlach, R. C., Ganança, M. M., & Gazzola, J. M. (2010). Doença de Corpúsculos de Lewy: um relato de caso.. Revista Equilíbrio Corporal e Saúde.
934. Velasco-Rey, M. C., Sánchez-Muñoz, M., Lopez, M., Trujillo-Borrego, A., & Sánchez-Bonome, L. (2012). Psychotic depression induced by Obstructive Sleep Apnoea Syndrome (OSAS): a case reported.. PubMed.
935. Ventriglio, A., Gentile, A. J., Baldessarini, R. J., & Bellomo, A. (2015). Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets. Current Pharmaceutical Design. https://doi.org/10.2174/1381612821666150105121244
936. Verberne, W. R., Snijders, T. J., Liem, K. S., Baakman, A. C., & Veldhuijzen, D. S. (2013). [Applications of 'quantitative sensory testing'].. PubMed.
937. Vermeulen, M., & Huizinga, T. (2006). [Neurological or psychiatric symptoms in patients with systemic lupus erythematosus (SLE): terminological problems, pathogenesis, diagnosis and therapy].. PubMed.
938. Vernino, S., & Vincent, A. (2013). Autoimmune and paraneoplastic autonomic neuropathies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198566342.003.0054
939. Verny, M. (2000). Approche diagnostique d'un syndrome démentiel chez le sujet âgé. La Revue de gériatrie.
940. Verny, M., & Greffard, S. (2019). Contribution of geriatric model to the management of an epileptic seizure or epilepsy.. HAL (Le Centre pour la Communication Scientifique Directe). https://doi.org/10.1684/pnv.2019.0791
941. Verny, M., Boller, F., Hugonot-Diener, L., & Saxton, J. (2002). Clinical features and assessment of severe dementia. A review<sup>1</sup>. European Journal of Neurology. https://doi.org/10.1046/j.1468-1331.2002.00356.x
942. Villamar, S., & Lorena, J. (2019). Factores psicosociales y depresión geriátrica en un paciente.
943. Visentini, A., Rucco, V., D'Osualdo, F., & Zucchi, A. (1989). Problemi di diagnostica differenziale nelle sindromi lombosciatalgiche. Rivista di Neuroradiologia. https://doi.org/10.1177/19714009890020s104
944. Vitiello, M. V. (2006). Sleep disturbances in Alzheimer’s disease. Birkhäuser-Verlag eBooks. https://doi.org/10.1007/3-7643-7440-3_11
945. Vizcarra, J. A., Lang, A. E., Sethi, K. D., & Espay, A. J. (2015). Vascular <scp>P</scp>arkinsonism: <scp>D</scp>econstructing a <scp>S</scp>yndrome. Movement Disorders. https://doi.org/10.1002/mds.26263
946. Volpe, B. T. (1997). Delayed Neuronal Degeneration Results from Endogenous Glutamate Excess. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1997.tb48390.x
947. Vukmir, R., Valeriano, J., & Oblack, A. (2023). Brain Death. Cambridge University Press eBooks. https://doi.org/10.1017/9781316338513.027
948. Vulser, H., & Lebeau, G. (2019). Post-Traumatic Stress Disorder Following Intraoperative Awareness. Neuromethods. https://doi.org/10.1007/978-1-4939-9891-3_5
949. Vurdelja, R. B., Budinčević, H., & Prvan, M. P. (2008). Central poststroke pain.
950. Víu, C. M. D., & Blasco, J. M. (2011). Salud laboral y salud mental: estado de la cuestión. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2011000500001
951. Wahyuni, A., & Berawi, K. (2016). Pengaruh Aktivitas dan Latihan Fisik terhadap Fungsi Kognitif pada Penderita Demensia. Jurnal Majority.
952. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
953. Walker, S. M. (2013). Neuropathic pain in children. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199642656.003.0021
954. Wallace, D. J., & Fisher, H. K. (2022). Sleep Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780197502112.003.0044
955. Wallner, R., Senczyszyn, A., Budrewićz, S., & Rymaszewska, J. (2019). Zaburzenia poznawcze i neuropsychiatryczne w chorobie Parkinsona. Polski Przegląd Neurologiczny. https://doi.org/10.5603/ppn.2019.0018
956. Wang, S. (2013). Research development of posttraumatic growth and metal health. Chinese Journal of Injury Repair and Wound Healing.
957. Wang, Y., Haishan, S., Hou, L., Zhong, X., Chen, X., Ling, L., Wu, Z., Dong, Z., Yuefen, Z., Tan, Y., Luo, X., Sha, L., & Ning, Y. (2016). Clinical and neuropsychological characteristics of general paresis misdiagnosed as primary psychiatric disease. BMC Psychiatry. https://doi.org/10.1186/s12888-016-0925-3
958. Wass, J., Mistry, N., & Turner, M. R. (2009). When to consider thyroid dysfunction in the neurology clinic. Practical Neurology. https://doi.org/10.1136/jnnp.2008.167163
959. Weeß, H.-G. (2006). Multifaktorielles Symptom vieler Schlafstörungen - Tagesschläfrigkeit birgt ein hohes Risiko. Der Klinikarzt. https://doi.org/10.1055/s-2006-942076
960. Wei, D. Y., & Drake, M. J. (2015). Undiagnosed neurological disease as a potential cause of male lower urinary tract symptoms. Current Opinion in Urology. https://doi.org/10.1097/mou.0000000000000243
961. Weinshenker, B. G., & Mowzoon, N. (2006). Acute Treatments. CRC Press eBooks. https://doi.org/10.3109/9781420018714-15
962. WELTI, W. (1956). Delirium with Low Serum Sodium. Archives of Neurology And Psychiatry. https://doi.org/10.1001/archneurpsyc.1956.02330290103014
963. Wentzlaff, S., Knauss, J., & Mohr, S. (2012). Fallbericht: Dementia Pugilistica (D.P.) bzw. chronisch traumatische Encephalopathie. Zeitschrift für Neuropsychologie. https://doi.org/10.1024/1016-264x/a000069
964. Weterle-Smolińska, K. A., Banasiuk, M., Dziekiewicz, M., Ciastoń, M., Jagielska, G., & Banaszkiewicz, A. (2015). Gastrointestinal motility disorders in patients with anorexia nervosa – a review of the literature. Psychiatria Polska. https://doi.org/10.12740/pp/35482
965. Whelan, T. B., Schteingart, D., Starkman, M. N., & Smith, A. (1980). Neuropsychological Deficits in Cushing??s Syndrome. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-198012000-00008
966. Wierenga, C. E., & Bondi, M. W. (2011). Dementia and Alzheimer's Disease: What We Know Now. Generations.
967. Wijdicks, E. F. M. (2015). The Clinical Determination of Brain Death: Rational and Reliable. Seminars in Neurology. https://doi.org/10.1055/s-0035-1547531
968. Wilbur, J. (2023). Dementia: Dementia Types.. PubMed.
969. Willroth, E. C., James, B. D., Graham, E. K., Kapasi, A., Bennett, D. A., & Mroczek, D. K. (2022). Well-being and Cognitive Resilience to Dementia-related Neuropathology. https://doi.org/10.31234/osf.io/sbh85
970. Winckler, P. (1995). ZUR STRAFRECHTLICHEN VERANTWORTLICHKEIT ALTERSSCHWACHER UND ALTERSKRANKER KRAFTFAHRER NACH SELBSTVERSCHULDETEN UNFAELLEN.
971. Winokur, G. (1970). Genetic Findings and Methodological Considerations in Manic Depressive Disease. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000193237
972. Wolkowitz, O. M., Epel, E. S., Reus, V. I., & Mellon, S. H. (2010). Depression gets old fast: do stress and depression accelerate cell aging?. Depression and Anxiety. https://doi.org/10.1002/da.20686
973. Wolter, D. K. (2006). Alkohol-assoziierte kognitive Beeinträchtigungen. Zeitschrift für Gerontopsychologie & -psychiatrie. https://doi.org/10.1024/1011-6877.19.4.207
974. Wong, V., & Chung, B. H. (2006). Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?. Current Pediatric Reviews. https://doi.org/10.2174/157339606776894621
975. Wreksoatmodjo, B. R. (2014). Beberapa Kondisi Fisik dan Penyakit yang MerupakanFaktor Risiko Gangguan Fungsi Kognitif (Some Physical Conditions and Diseases as Risk Factors for Cognitive Decline).
976. Wright, C. B., Vonsattel, J. P., Bell, K. L., & Honig, L. S. (2006). Dementia with Cerebrovascular Disease. Science of Aging Knowledge Environment. https://doi.org/10.1126/sageke.2006.10.dn1
977. Wyrwich, K. W., Auguste, P., Buchanan, J., Rüdell, K., Lacey, L., Leibman, C., Symonds, T., & Brashear, H. R. (2014). Psychometric Properties of the Dependence Scale in Large Randomized Clinical Trials of Patients With Mild and Moderate Alzheimer’s Disease. American Journal of Alzheimer s Disease & Other Dementias®. https://doi.org/10.1177/1533317514527336
978. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
979. Yadav, B. (2021). Risk Factors for Dementia and Cognitive Impairments.
980. Yamadori, A. (2009). A thrill of neuropsychology. Higher Brain Function Research. https://doi.org/10.2496/hbfr.29.9
981. Yan, R. M., Cardonne, M. M., Reyes, E. J. M., & Leyva, A. G. (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
982. Yang, T., Guo, R., Ofengeim, D., Hwang, J.-Y., Zukin, R. S., Chen, J., & Zhang, F. (2021). Molecular and Cellular Mechanisms of Ischemia-Induced Neuronal Death. Stroke. https://doi.org/10.1016/b978-0-323-69424-7.00005-3
983. Yano, S., & Silver, K. (2020). Hereditary and Metabolic Diseases of the Central Nervous System in Adults. CRC Press eBooks. https://doi.org/10.1201/9780429299476-10
984. Yim, C. D., & Ahn, S.-K. (2022). Relationship Between Dizziness With Cognitive Impairment. Korean Journal of Otorhinolaryngology - Head and Neck Surgery. https://doi.org/10.3342/kjorl-hns.2022.00773
985. Yirmiya, D., Rimmerman, N., & Reshef, R. (2015). Depression as a Microglial.
986. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
987. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
988. Zappert, J. (1933). Zerebrale Kinderlähmung. https://doi.org/10.1007/978-3-7091-9961-9_3
989. Zhuo, L., Zhu, S., Sun, T., Wang, R., Ren, L., & Liu, L. (2012). Sudden death of neuromyelitis optica: A case report of clinical missed diagnosis. Romanian Journal of Legal Medicine. https://doi.org/10.4323/rjlm.2012.247
990. Ziemssen, T. (2013). Neurovegetative Funktionsstörungen bei extrapyramidalmotorischen Erkrankungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628502
991. Zieschang, T., & Schütze, S. (2023). Allgemeine Aspekte demenzieller Erkrankungen. Deleted Journal. https://doi.org/10.1007/s00108-022-01462-1
992. Zoellner, L. A., Graham, B., & Bedard‐Gilligan, M. (2019). Trauma- and Stressor-Related Disorders. Routledge eBooks. https://doi.org/10.4324/9780429028267-10
993. Zorumski, C. F., & Rubin, E. H. (2009). What Illnesses Do Psychiatrists Treat?. https://doi.org/10.1093/oso/9780195386400.003.0002
994. Zulfiqar, S., Qureshi, A., Dande, R., Puri, C., Persaud, K., & Awasthi, S. (2021). The many manifestations of a single disease: neuroborreliosis. Journal of Community Hospital Internal Medicine Perspectives. https://doi.org/10.1080/20009666.2020.1831746
995. Zwiernik, J., Zwiernik, B., Cebulski, Z., & Siwek, T. (2011). New symptoms in a patient with diagnosed porphyria – untypical clinical course or another disease? Extended differential diagnosis of multiple sclerosis. Polish Annals of Medicine. https://doi.org/10.1016/s1230-8013(11)70028-5
996. Álvarez, E. F. (2004). Estereotipias primarias frente a estereotipias secundarias. Revista de Neurología. https://doi.org/10.33588/rn.38s1.2004082
997. Édouard, T., & Tauber, M. (2011). Syndromic growth disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199235292.003.7086
998. Özugur, S. (2016). Quantification of synapse loss in human brains with mixed Alzheimer’s and Lewy body disease.
999. Čeko, M., Bushnell, M. C., & Gracely, R. H. (2011). Neurobiology Underlying Fibromyalgia Symptoms. Pain Research and Treatment. https://doi.org/10.1155/2012/585419
1000. Şirəliyeva, R. K., & Məmmədova, M. N. (2019). Uşaq serebral iflici, motor və mental gerilik və aminoasidopatiyalar. NATIONAL JOURNAL OF NEUROLOGY. https://doi.org/10.28942/nnj.v1i1.211
1001. Šajfar, L. (2015). Demencija i uloga medicinske sestre.
1002. Šibor, J., Holý, L., & Rezáková, O. (2005). RÁMCOVÝ (ŠKOLNÍ) VZDĚLÁVACÍ PROGRAM VE VZTAHU K DUŠEVNÍM ABEHAVIORÁLNÍM PORUCHÁMSTRES.
1003. Šumarac-Dumanović, M., Micić, D., Macut, Đ. P., Kendereški, A., Zorić, S., Cvijović, G., & Pejković, D. (2002). Hipoglikemijski sindromi - dijagnostički i terapijski pristup i prikaz dva slučaja. ABC - časopis urgentne medicine.